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Summary  
To recognize pathogen threats, the innate immune system is equipped with pattern recognition 
receptors (PRRs) that bind to and are activated by pathogen-associated molecular patterns 
(PAMPs). Most PAMPs are conserved across species of microbes but at the same time not 
present in the host, allowing for the efficient discrimination between endogenous and foreign 
material. However, viruses rely on the host transcriptional and translational machinery to 
produce every viral component, and therefore do not really contain foreign molecules. It has 
become apparent that viruses instead are mainly detected via their nucleic acid genomes in the 
endosomes or cytosol of the host cell. However, virus sensing based on their nucleic acids 
comes at the risk of erroneous recognition of self-DNA - a process that leads to 
autoinflammation and possibly autoimmune disease. In particular, the receptor cGAMP synthase 
(cGAS) detects the mere presence of any DNA in the cytosol by binding its sugar phosphate 
backbone, and thus shows no apparent preference for sequence or specific molecular 
structures. 
Within this work, evidence is provided that specific damage-associated DNA modifications 
strongly enhance cGAS-dependent innate immune activation. DNA modifications occurring after 
UV irradiation, incubation with cytostatic agents, ROS exposure or as a consequence of 
neutrophil extracellular trap (NET) release were shown to potentiate the interferon (IFN) release 
in response to cytosolic DNA. However, this differential immune response was not due to higher 
affinity binding of the modified DNA to cGAS itself, but rather due to an impaired degradation by 
the cytosolic exonuclease TREX1. Resistance to TREX1 promoted an accumulation of the 
modified DNA in the cytosol, leading to a prolonged activation of the cGAS/STING-signaling 
pathway and the release of type I IFN.  
One well-known autoimmune disease driven by autoantibodies recognizing double-stranded 
DNA is lupus erythematosus (LE). Using the lupus-prone mouse model MRL/lpr, UV-damaged 
DNA (UV-DNA) was shown to be able to induce lupus-like lesions. Thus, UV-DNA could be a 
potential cause for the phototoxicity often observed in LE patients. Moreover, intravenous 
administration of UV-DNA induced a type I IFN response in MRL/lpr mice, which could be linked 
to F4/80-positive monocytes/macrophages. 
Together, these data show that under certain conditions self-DNA is transformed into a damage-
associated molecular pattern (DAMP) that provides an additional layer of information to 
distinguish danger and damage from healthy states 
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1. Introduction 
 
1.1. The Immune System 
The immune system (from Latin immunis = free or untouched) is the combination of various 
defense systems that evolved to protect higher organisms against pathogens, foreign 
substances and abnormal cells. In vertebrates, the immune system can be divided into innate 
and adaptive immune system.  
 
The innate immune system is of ancient origin and found in all organisms in some form. Its 
features are germline encoded and recognize and respond to general molecular patterns that 
are ideally essential to pathogens but foreign to the host. As such, the receptors and effectors of 
the innate immune system are immediately available and can provide the first line of defense. 
Cells of the innate immune system include natural killer (NK) cells, mast cells, neutrophils, 
eosinophils, basophils, monocytes/ macrophages, and dendritic cells (DC). These cells are 
responsible for the identification and removal of foreign substances, the recruitment of further 
immune cells to the site of infection and finally the activation of the adaptive immune system for 
a more specific immune response. 
 
The adaptive immune system is antigen-specific, since it makes use of DNA recombination and 
somatic hypermutation to generate a vast diversity of antigen-specific receptors (Brack et al., 
1978; Schatz et al., 1992). Exposure to pathogens bearing a particular antigen leads to the 
selective expansion of cells which can recognize them. After initial exposure, it can take several 
days until the adaptive immune system becomes protective. However, during this primary 
immune response, memory cells are generated that remain inside the body and can initiate a 
rapid secondary immune response if the body encounters the same threat again. Cells of the 
adaptive immune system include B and T lymphocytes (B and T cells). The main function of B 
cells involves the production of specific antibodies that can either neutralize their target directly 
or tag the pathogen for attack by other immune cells. CD4-positive T helper (TH) cells assist 
other immune cells by secreting cytokines that regulate or support immunologic processes, while 
CD8-positive cytotoxic T (Tc) cells destroy host cells that are infected by viruses or have become 
malignant.  
 
One important link between innate and adaptive immune system are professional antigen 
presenting cells (APCs) such as DCs or macrophages from the innate immune system. They 
internalize pathogens and digest them into smaller fragments, which are then presented on 
Major Histocompatibility Complex (MHC) class II molecules to TH cells from the adaptive 
immune system. The interaction of the T cell receptor (TCR) with the antigen-MHC class II 
complex then leads to the activation of the T cell, but only if also an additional co-stimulatory 
signal is provided by the APC. To ensure that the adaptive immune system is only activated in 
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case of pathogen invasion or danger, APCs only upregulate the co-stimulatory signals if their 
pattern recognition receptors (PRRs) have been activated by pathogen associated molecular 
patterns (PAMPs). 
 
1.2. Pattern Recognition Receptors  
The innate recognition of foreign substances and structures is based on a limited number of 
receptors encoded in the germline. The so-called pattern recognition receptors (PRRs) 
recognize pathogen-associated molecular patterns (PAMPs) that are frequently found on 
pathogens, but ideally absent on host molecules (Janeway, 1989a/b; Gordon, 2002; Janeway 
and Medzhitov, 2002). There are different classes of PRRs. However, this work will focus on 
signaling PRRs that recognize nucleic acids (NAs) within the cytosol and subsequently trigger 
intracellular signaling cascades, which result in the expression of pro-inflammatory cytokines, 
chemokines, antimicrobial proteins and antiviral molecules (Takeuchie and Akira, 2010).  
 
1.2.1. Immune Sensing Of Nucleic Acids 
The recognition of nucleic acids (NAs) is especially important for the detection of viral infections, 
since viruses make us of the cellular host machinery for replication and have not many other 
features suitable for identification. Safeguards such as specific NA modifications or the location 
of the PRRs ensure that self-NAs do normally not cause an immune response. In the endosome, 
toll-like receptors (TLRs) detect RNA and DNA species, while RIG-I-like receptors (RLRs) and 
various DNA sensors detect NAs in the cytosol.  
 
1.2.1.1. Endosomal Toll-like Receptors  
The membrane bound toll-like receptors (TLRs) are the best-characterized PRR family (Gürtler 
and Bowie, 2013). They contain an extracellular leucine rich repeats (LRRs) domain, which is 
important for ligand recognition (Martin and Wesche, 2002), and an intracellular Toll/ interleukin-
1 receptor homology (TIR) domain, necessary for the recruitment of adapter proteins and 
intracellular signaling. The TLR-family members TLR3, TLR7, TLR8 and TLR9 are located in the 
endosomes of immune cells, where they detect different NA species. The compartmentalization 
of these receptors appears to be a safeguard which better allows the distinction between ‘self’ 
and ‘non-self’ NAs, since endogenous NAs do normally not occur inside the endosomes (Barton 
et al., 2006).  
TLR3 was originally identified as a receptor that recognizes polyinosine-polycytidylic acid 
(poly(I:C)), a synthetic analog of double stranded (ds) RNA. Later, it was shown that TLR3 also 
detects naturally occurring dsRNA that is derived from protozoa and fungi (Aksoy et al., 2005; 
Carvalho et al., 2012), present in the genome of dsRNA viruses, or generated during replication 
or transcription of various single stranded (ss) RNA and DNA viruses (Alexopoulou et al., 2001; 
Weber et al., 2006). TLR7 and TLR8 are structurally related and are both sensors for ssRNA 
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(Heil et al., 2004; Lund et al., 2004). In humans, TLR7 expression is restricted to plasmacytoid 
DCs (pDCs) and B cells (Krug et al., 2001). In contrast, it is widely expressed in murine cells. 
TLR8 is found in human monocytes, macrophages and myeloid DCs (mDC), where it seems to 
complement the absence of TLR7 (Krug et al., 2001; Hornung et al., 2002). In mice, TLR8 is 
found in splenic DC subsets and pDCs, yet its precise function there is not known (Jurk et al., 
2002; Alexopoulou et al., 2012).  
TLR9 recognizes unmethylated CpG motifs in dsDNA that occur approximately once per 16 
bases in bacteria. In vertebrates these motifs are much less frequent and usually highly 
methylated (Bird, 1986). Stacey and colleagues showed that the methylation of CpG motifs 
blocked the immune stimulatory properties of bacterial DNA (Stacey et al., 1996). In addition to 
its endosomal localization, CpG methylation is a further reason why under normal circumstance 
vertebrate DNA does not trigger a TLR9-dependent immune response. In mice, TLR9 is 
expressed by B cells, monocytes, macrophages, pDCs and conventional DCs (cDCs), while, in 
humans, it is only found in pDCs and B cells (He et al., 2013). 
For the activation of TLR3, TLR7, TLR8 and TLR9, acidification of the endosome is required in 
order to degrade pathogens and make their nucleic acids accessible. Upon recognition of their 
respective foreign NA ligands, TLRs dimerize to build homo- or heterodimers (Kawai and Akira, 
2007). For TLR7, TLR8 and TLR9 signal transduction is initiated by the recruitment of the 
adapter protein myeloid differentiation factor 88 (MyD88) (Medzhitov et al., 1998; Kawai et al., 
1999), while TLR3 makes use of the TIR domain-containing adapter molecule (TRIF) (Kawai et 
al., 2001; Hoshino et al., 2002; Yamamoto et al., 2003).  
These adaptor molecules bind to the TIR domain of the TLRs (Figure 1), which in turn results in 
the phosphorylation of interferon regulatory factors (IRF) 3 and 7 (Schoenemeyer et al., 2005; 
Takaoka et al., 2005; Kawai et al., 2004). Once phosphorylated, IRFs translocate from the 
cytoplasm to the nucleus, where they act as transcription factors and cause the induction of type 
I IFNs and IFN-dependent genes (Fujita et al., 1989; Harada et al., 1996; Marié et al., 1998; 
Sato et al., 2000). TLR signaling also results in an activation of the nuclear factor kappa-light-
chain-enhancer of activated B-cells (NF"B)-dependent signaling pathway, which is important for 
the induction of pro-inflammatory cytokines such as IL-1, IL-6 and tumor necrosis factor alpha 
(TNF-!). Moreover, extracellular signal-regulated kinase (ERK), the mitogen activated protein 
kinase (MAPK) p38 and Jun N-terminal kinase (JNK), are activated by the TLR signaling 
pathway (Ninomiya-Tsuji et al., 1999; Sakurai, 2012). Together, ERK, p38 and JNK activate the 
transcription factor activating protein-1 (AP-1), which then leads to the expression of pro-
inflammatory cytokines. 
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Figure 1: Endosomal Toll-like receptors (adapted from Krieg, 2010) 
The endosomal Toll-like receptors TLR3, TLR7/8, and TLR9 detect dsRNA, ssRNA, or unmethylated CpG DNA, 
respectively. Activation leads to the recruitment of the adaptor proteins TRIF (TLR3) or MyD88, which signal via IRFs 
and NFkB transcription factors leading to the upregulation of type I IFNs and inflammatory cytokines. 
 
1.2.1.2. Cytosolic RNA Sensing By RIG-l-like Receptors  
Apart from endosomal sensing by TLRs, pathogenic RNA is also detected in the cytosol by RIG-
I-like receptors (RLRs). RLRs are ubiquitously expressed and include Retinoic acid inducible 
gene-I (RIG-I), Melanoma differentiation- associated gene 5 (MDA5) and Laboratory of genetics 
and physiology 2 (LGP2) (Yoneyama et al., 2004; Kang et al., 2002; Andrejeva et al., 2004). 
Both, RIG-I and MDA5, contain a C-terminal RNA helicase domain with RNA-dependent ATPase 
activity and two N-terminal caspase-recruitment domains (CARDs) required for downstream 
signaling (Figure 2). LGP2 does not contain a CARD-domain and is thought to act as a primary 
regulator of the RIG-I/ MDA5-inititated signaling pathway (Miyoshi et al., 2001; Yoneyama et al., 
2005). Signaling occurs through CARD interactions with the interferon promoter-stimulating 
factor 1 (IPS-1) adaptor protein (also known as mitochondrial antiviral signaling protein (MAVS), 
virus-induced signaling adaptor (VISA) or CARD adaptor inducing IFN-# (CARDif)), which 
recruits RIG-I and MDA5 to the outer membrane of the mitochondria (Kawai et al., 2005; Meylan 
et al., 2005; Seth et al., 2005; Xu et al., 2005). Receptor-adaptor interaction results in the 
!"#$%&&&&&&&&&&&&&&&&&&""#$%&&&&&&&&&&&&&&&&&&&!"'$%
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activation of IRF3 and IRF7, which then translocate to the nucleus where they induce the 
transcription of type I IFN genes. IFNs then upregulate the expression of IRF3, IRF7, RIG-I and 
MDA5 in a positive feedback loop. In addition, RLR signaling also leads to the activation of the 
transcription factors ATF2, c-Jun (Yoshida et al., 2008) and NF"B, which then cause the 
expression of pro-inflammatory cytokines. 
RIG-I and MDA5 both detect viral RNA, but they have different ligand specificity. The synthetic 
dsRNA poly(I:C) was the first ligand described for RIG-I (Yoneyama et al., 2004). Two years 
later, it was shown that the 5$-triphosphate end of RNA (3pRNA) of in vitro transcribed RNA or 
generated by viral polymerases is responsible for RIG-I–mediated detection of RNA molecules 
(Hornung et al., 2006; Pichlmair et al., 2006). Consistent with this notion, RIG-I recognizes 
ssRNA viruses that exhibit prior or during their replication phase a 5´- triphosphate in their RNA 
genome, including hepaciviruses and members of the Paramyxoviridae, Rhabdoviridae, and 
Orthomyxoviridae virus genera (Kato et al., 2006). In 2009, Schlee and colleagues specified the 
ligand for RIG-I as a 5$-triphosphate short blunt end dsRNA structure (3pRNA) as contained in 
the panhandle of negative strand viral genomes (Schlee et al., 2009). 
The cytoplasmic presence of 3pRNA allows discrimination between self and viral RNA, because 
free 5$-triphosphates are normally absent from self-RNA as a result of substantial 
posttranscriptional modifications (Hornung et al., 2006; Pichlmair et al., 2006). However, some 
dsRNAs lacking a 5´-triphosphate have also been proposed to act as RIG-I agonists (Takahasi 
et al., 2008; Kato et al., 2008). Additionally, it was shown that small self-RNA produced by the 
antiviral endoribonuclease RNase L could also activate the RIG-I signaling pathway (Malathi et 
al., 2007). In contrast to RIG-I antagonists, little is known about MDA5 specific ligands. MDA5 is 
associated with the recognition of Picornaviridae (Kato et al., 2006), murine norovirus 
(McCartney et al., 2008) and murine hepatitis virus (Roth-Cross et al., 2008). A subset of 
viruses, including dengue virus, West Nile virus and reovirus, was shown to be recognized by 
both MDA5 and RIG-I (Loo et al., 2008). Comparison of RIG-I and MDA5 interaction with 
poly(I:C) suggests that the length of dsRNA is important for differential recognition by RIG-I and 
MDA5. Long poly(I:C) fragments are recognized by MDA5, whereas RIG-I shows a preference 
for shorter RNA fragments (Kato et al., 2008).  
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Figure 2: RLR signaling (Bruns and Hovarth, 2012) 
Upon ligand binding, RIG-I and MDA5 recruit the adaptor protein IPS-1, which activates TANK-binding kinase 1 
(TBK1) and inhibitor of nuclear factor kappa-B kinase (IKK). This results in the activation of NFkB and IRF 
transcription factors, which translocate to the nucleus and induce antiviral genes. 
 
1.2.1.3. Cytosolic DNA Sensing 
Ten years ago, it was shown that cytosolic DNA could activate the immune system in a TLR9-
independent fashion (Okabe et al., 2005; Yasuda et al., 2005). Before any cytosolic DNA 
receptor was discovered, it became clear that the signaling cascade comprises TBK1 and IRF3 
(Ishii et al., 2006; Stetson and Medzhitov, 2006). Later, the endoplasmatic reticulum (ER)-
resident transmembrane protein STING (stimulator of interferon genes), also known as MITA 
(mediator of IRF-3 activation), was identified as crucial adaptor upstream of TBK1 (Ishikawa and 
Barber, 2008; Zhong et al., 2008; Sun et al., 2009; Ishikawa et al., 2009). STING functions as a 
scaffold protein to specify and promote the phosphorylation of IRF3 by TBK1 (Tanaka and Chen, 
2012). Over the years many cytosolic DNA receptors upstream of STING have been suggested 
(Figure 3).  
DNA-dependent activator of IRFs (DAI) was the first cytosolic DNA receptor candidate to be 
discovered (Takaoka et al, 2007; Wang et al., 2008). It was shown to trigger type I IFN 
expression in murine L929 fibroblasts upon dsDNA-binding and TBK1-IRF3 interaction. 
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Furthermore, the interaction of DAI with Receptor-interacting protein (RIP) 1 and 3 was 
described to activate NF"B (Kaiser et al., 2008; Rebsamen et al., 2009). However, DAI was 
dispensable for DNA-induced responses in many human cells and DAI-knockout mice 
responded normally to DNA (Lippmann et al., 2008; Ishii et al., 2008). Thus, a restricted and 
maybe cell-type specific role for DAI in DNA recognition was suggested.  
RNA polymerase (Pol) III was the second cytosolic DNA receptor described. Prior to that, Pol III 
was only known to transcribe transfer RNAs and other small non-coding RNA molecules. But in 
2009, it was shown that Pol III is also able to transcribe AT-rich dsDNA into 3pRNA, which is 
then recognized by RIG-I (Ablasser et al., 2009; Chiu et al., 2009). However, transfection of AT-
poor dsDNA did not result in the production of type I IFNs, indicating a limited role of Pol III in the 
recognition of cytosolic DNA.  
In the same year, the PYHIN protein absent in melanoma 2 (AIM2) was identified by four 
independent groups as a sensor of cytosolic DNA (Bürckstümmer et al., 2009; Fernandes-
Alnemri et al., 2009; Hornung et al., 2009; Roberts et al., 2009). Upon DNA sensing, AIM2 
recruits the adaptor protein ASC (apoptosis-associated speck-like protein containing a CARD) 
as well as caspase-1 in order to form the AIM2 inflammasome, which then cleaves pro-IL-1# and 
pro-IL-18 into their mature forms. Thus, AIM2 was shown to induce the release of IL-1ß and IL-
18 in response to DNA, but does not have a role in the induction of type I IFNs.  
Another PYHIN protein called IFN-inducible protein 16 (IFI16) was also suggested as DNA 
sensor, since it induced a STING-dependent IFN-ß response upon DNA binding (Unterholzner et 
al., 2010). In accordance with that, knockdown of human IFI16 or its murine ortholog in mice, 
p204, inhibited DNA and DNA-virus induced gene induction in a variety of cell types (Duan et al., 
2011; Conrady et al., 2012; Horan et al., 2013). 
In 2011, a central kinase in the DNA damage response (DDR), DNA-dependent protein kinase 
(DNA-PK), was described to result in the activation of NF"B and IRFs, and in the production of 
IFNs (Brzostek-Racine et al. 2011). Thus, a link between viruses creating DNA breaks during 
integration or lytic replication and the induction of an IFN response was made. DNA-PK consists 
of a catalytic subunit and its binding partners Ku70 and Ku80. Together, they bind to DNA 
breaks, promote cell cycle arrest, and thus, allow DNA damage repair. Zhang and colleagues 
demonstrated via knockdown that Ku70 plays a role in the DNA-induced production of IFN-!1 in 
HEK293 cells (Zhang et al. 2011a). In another study, Ferguson et al. showed that the DNA-PK 
complex is required for the production of IFN-ß, ISGs and IL-6 in response to HSV-1 and 
Modified Vaccinia Ankara infection (Ferguson et al., 2012). However, Ku70 had only an effect on 
type III but not on type I IFNs, and additionally, the DNA-PK complex was shown to be 
dispensable for the IFN response to intracellular DNA in murine bone marrow (bm)-derived 
macrophages (Stetson and Medzhitov, 2006).  
Mre11 (Meiotic recombination 11), another DNA damage factor has also been suggested as 
STING-dependent cytosolic DNA sensor, since murine bmDCs and mouse embryonic fibroblasts 
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(MEFs) had defects in dsDNA-induced type I IFN production after Mre11 knockdown (Kondo et 
al. 2013). However, Mre11 was dispensable for type I IFN production in response to pathogens 
such as HSV-1 and Listeria monocytogenes (Kondo et al. 2013), posing in question the 
physiological role of Mre11 during infection. 
Members of the DExD/H box helicase protein family have also been implicated in the sensing of 
cytosolic DNA. In 2010, Kim and colleagues described DHX9 and DHX36 as MyD88-dependent 
DNA sensors in the cytosol of pDCs (Kim et al., 2010). DHX36 induced IRF7 nuclear 
translocation and IFN-! production in response to CpG-A oligodeoxynucleotides (ODNs), while 
DHX9 led to NF"B activation and TNF-!/ IL-6 production after stimulation with CpG-B ODNs. 
Furthermore, pDCs in which DHX9 or DHX36 were knocked down showed a significantly 
reduced cytokine response to the DNA virus HSV (Kim et al., 2010). However, DHX9 and 
DHX36 were also described to sense RNA and induce MAVS- and TRIF- dependent signaling 
(Zhang et al., 2011a/b). Thus, DHX9/ 36 might not be real DNA sensors, but rather act further 
downstream in different NA recognition pathways (Paludan and Bowie, 2013).  
In 2011, Zhang et al. demonstrated that the helicase DDX41 could bind both DNA and STING. 
Furthermore, a reduction of DDX41 expression correlated with a reduced type I IFN response to 
DNA and DNA viruses in mDCs and human monocytes (Zhang et al., 2011c). DDX41 has also 
been shown to bind the bacterial cyclic dinucleotides (CDNs) cyclic di-AMP and cyclic di-GMP 
(Parvatiyar et al. 2012). CDNs act as second messengers in bacteria and stimulate a STING-
dependent immune response (Barker et al. 2013; Burdette et al. 2011; Jin et al. 2011; McWhirter 
et al. 2009). Before DDX41 was identified, Burdette and colleagues demonstrated that STING 
could sense CDNs directly (Burdette et al. 2011). Later, Parvatiyar et al. proposed that DDX41 
works upstream of STING. They demonstrated a specific and direct interaction of cyclic di-GMP 
and STING with immunoprecipitation and immunoblot analysis. Furthermore, knockdown of 
DDX41 expression in mouse and human cell lines as well as in different primary cells resulted in 
a reduced induction of IFN-# and TNF in response to CDNs or Listeria bacteria. Thus, they 
suggested that DDX41 assists STING in binding to CDNs (Parvatiyar et al. 2012). 
The binding of dinucleotides to STING has recently also been suggested as major step in the 
sensing of cytosolic DNA. In 2013, the group of Zhijian J. Chen identified cyclic GMP-AMP 
(cGAMP) as an endogenous second messenger that is produced in many different cell types 
following DNA stimulation (Wu et al. 2013; Sun et al. 2013). It binds to and activates STING, 
resulting in the phosphorylation and dimerisation of IRF3. With quantitative mass spectrometry 
and classical protein purification strategies the human C6ORF150 and the mouse protein 
E330016A19 were identified as enzyme that synthesizes cGAMP, and then renamed cyclic 
GMP-AMP synthase (cGAS) (Sun et al. 2013). Overexpression of cGAS induced IFN-ß 
expression, whereas knockdown of cGAS inhibited IFN-ß induction by DNA transfection or DNA 
virus infection (Sun et al., 2013; Ablasser et al. 2013; Zhang et al. 2013). The binding of cGAS to 
DNA and the production of cGAMP in a DNA-dependent manner have further been supported by 
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detailed structural analysis of the enzyme in the presence and absence of DNA (Civril et al. 
2013; Diner et al. 2013; Gao et al. 2013a/b). It was shown that the binding of DNA to cGAS 
results in conformational changes that make the catalytic pocket accessible to its substrate. 
Thus, cGAS could be a DNA receptor in its own right.  
As already mentioned, there were a lot of cytosolic DNA receptor candidates described over the 
last years. Up to now, it remains unclear if “the one“ has already been found and how the 
different candidates are linked together. Possible explanations for the high number of candidates 
might be functional redundancy, as well as cell type or ligand specificity of certain receptors. It is 
also conceivable that different receptors act over time, meaning that some may be more 
important in the initial sensing of intracellular DNA, while others take over this function at a later 
date. In addition, it might be that some proposed cytosolic DNA sensors are not real receptors, 
since detailed molecular mechanisms of the signaling pathways are often missing. The only 
proposed cytosolic DNA receptor that provides a clear molecular mechanism for signaling and 
STING activation is the enzyme cGAS. Thus, further investigation in this field is absolutely 
necessary (Unterholzer, 2013). 
 
 
Figure 3: Possible cytosolic DNA receptors (Unterholzner, 2013) 
Multiple cytosolic DNA sensors have been proposed to activate a STING-dependent signaling pathway that leads to 
the activation of the transcription factors IRF3 and NF"B, and the induction of type I IFN.  Of these candidates, only 
RNA polymerase III initiates a STING-independent pathway involving the transcription of poly(dA:dT) to dsRNA, which 
is then sensed by RIG-I. 
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1.3. Type I Interferon System 
PRRs can induce the production of various proinflammatory cytokines, such as interleukin-1 (IL-
1), IL-6, IL-12 and TNF-". However, the focus of this study lies on interferons (IFNs), which 
stimulate an “antiviral state” to block viral replication and to interfere with cellular and virus 
processes. 60 years ago, IFNs were described as antiviral cytokines released by virus infected 
cells and named after their ability to “interfere” with viral replication (Isaacs and Lindenmann, 
1957).  
Based on their receptor, IFNs are typically divided into three classes. Type I IFNs bind to the 
IFN-alpha receptor (IFNAR) that is composed of IFNAR1 and IFNAR2 chains (de Weerd et al., 
2007). Human type I IFNs include IFN-alpha, -beta, -delta, -epsilon, -kappa and -omega 
(Roberts et al., 1998; Liu, 2005; LaFleur et al., 2001; Adolf, 1995). Interferon-gamma is the only 
type II IFN and binds to IFN-gamma receptor (IFNGR) consisting of IFNGR1 and IFNGR2, 
whereas IFN-lambda is a type III IFN and signals through a receptor complex consisting of 
IL10R2 and IFNLR1 (Kotenko et al., 2003; Sheppard et al., 2003). 
All IFNs fight pathogens and tumor cells, however IFN-" and IFN-ß are the substantial 
mediators of anti-viral immunity. The IFN-#!gene is only present as a single copy in humans and 
mice (Weissmann and Weber, 1986). Transcriptional activation of IFN-ß requires activating 
transcription factor 2 (ATF2)/c-Jun, NF"B, and the interferon regulatory factors (IRF) 3 and 7. 
These transcription factors build up together an enhanceosome of regulatory elements 
(Goodbourn and Maniatis, 1988; Leblanc et al., 1990; Du and Maniatis, 1992; Carey, 1998) that 
recruits co-activators, chromatin- remodeling proteins and the transcriptional machinery to the 
promoter region to initiate gene expression.  
The IFN-" gene family consists of more than a dozen members. Their promoters include 
sequences that are known to bind members of the IRF transcription factor family (Fujita et al., 
1988; Miyamoto et al., 1988). Particularly important for the transcription of IFN-" are IRF3 and 7 
(Sato et al., 2001). 
By interacting with IFNAR, type I IFNs initiate the Janus kinase (JAK)- signal transducer and 
activator of transcription (STAT) signaling pathway (Platanias, 2005). JAK1 and Tyrosine kinase 
2 (TYK2) bind to the activated IFNARs and phosphorylate both STAT1 and STAT2. As a result, 
an IFN-stimulated gene factor 3 (ISGF3) complex forms that is made of STAT1, STAT2 and 
IRF9. The ISGF3-complex translocates to the nucleus where it binds to IFN-stimulated response 
elements (ISREs) within the promoters of IFN- stimulated genes (ISGs). The first ISGs were 
discovered more than 30 years ago (Larner et al., 1984; Knight and Korant, 1979), and over 
time, more than 300 ISGs were discovered by microarray studies. ISGs have antiviral, 
antiproliferative, and immunomodulatory properties (de Veer et al., 2001). Protein kinase R 
(PKR) is a classical ISG (Feng et al., 1992; Lee and Esteban, 1993). It phosphorylates the alpha 
subunit of the eukaryotic translation initiation factor eIF2 (Hovanessian, 1989), which in turn 
stops the initiation of protein synthesis and prevents viral replication (Hershey, 1989). Moreover, 
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PKR phosphorylates IkB that normally sequesters the transcription factor NFkB in the cytosol 
(Zamanian-Daryoush et al., 2000). Upon phosphorylation, IkB releases NFkB, which can then 
travel to the nucleus and becomes activated. In turn, NFkB upregulates the expression of IFNs 
and with the help of this positive feedback loop the antiviral signal spreads further. Another IFN-
induced enzyme is ribonuclease (RNase), which destroys all RNA within the cell. It thereby 
reduces protein synthesis, and thus, causes apoptosis of the host cell (Dougherty et al., 1981).  
Another function of IFNs is the upregulation of co-stimulatory molecules and the enhanced 
expression of MHC class I and MHC class II molecules. In turn, more viral peptides are 
presented to cytotoxic T cells, causing the enhanced killing of infected cells. Additionally, more 
helper T cells are activated which then coordinate the activity of other immune cells (Zhou, 
2009). But IFNs cannot only indirectly affect T cell responses by acting on APCs, they can also 
directly promote T cell activation and keep the activated T cells alive (Conrad, 2003). 
Additionally, all IFNs are capable of activating NK cells, and increasing their cytotoxicity through 
the induction of TNF-related apoptosis-inducing ligand (TRAIL) (Sato et al., 2001). 
To limit the extent and duration of type I IFN responses, regulatory molecules are also induced 
by IFNs as part of a negative feedback loop. The suppressor of cytokine signaling (SOCS) 
proteins 1 and 3 compete with STATs for binding to IFNAR and suppress JAK activity (Fenner et 
al, 2006), whereas USP18, a type I IFN-inducible ubiquitin specific peptidase, binds to IFNAR2 
and blocks the interaction between JAK1 and IFNAR (Malakhova et al., 2006). Another 
mechanism that suppresses type I IFN-mediated responses is the downregulation of cell surface 
IFNAR. Internalization of IFNAR is induced by various pro-inflammatory cytokine signaling 
pathways such as IL-1, TLRs, immunoreceptor tyrosine-based activation motif (ITAM)-
associated receptors and oxidative or metabolic stress (Fuchs et al., 2013; Bhattacharya, et al., 
2013; Huynh et al., 2012; Huangfu et al., 2011). TLR stimulation and crosslinking of ITAM-
associated receptors can also activate protein tyrosine phosphatases SHP-1, SHP-2 and PTP-
1B, which dephosphorylate JAK1, STAT1 and TYK2 (You et al., 1999; Myers et al., 2001). In 
addition, specific miRNAs were shown to regulate the type I IFN response (Nazarov, et al., 2013; 
Liu et al., 2009; Gracias et al., 2013). 
 
1.4. UV Radiation 
UV radiation (UVR) can be divided into UV-A (315-400 nm), UV-B (280-315 nm) and UV-C (100-
280 nm) light. Due to the absorption of short-wave UVR below 310 nm by atmospheric oxygen 
and the blockage of mid-range UVR by the ozone layer, only UV-A (95 %) and 5-10 % of UV-B 
reach the earth surface. UV-C is usually completely filtered off by the stratospheric ozone layer 
(van der Leun, 2004).  
Even though UV radiation constitutes only 10 % of the sunlight, it has a high energetic potential 
and can ionize molecules and thereby induce chemical reactions (Maverakis et al., 2010). The 
depth of penetration into the skin correlates with the wavelength of radiation. Long-wave UV-A 
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can penetrate deep into the dermis and affect fibroblasts and matrix metalloproteinases, as well 
as DCs, T cells, mast cells and endothelial cells. UV-A is also the main cause of photoaging of 
the skin, with irregular pigmentation, enlarged capillary vessels, hornification and reduced 
elasticity of the connective tissue (Krutmann, 2003). Moreover, UV-A can induce an immediate 
pigment darkening that involves oxidative modification of melanin (Beitner, 1988). Both UV-A 
and UV-B are able to induce tanning, although UV-B is more efficient. UV-B reaches only the 
epidermis and affects keratinocytes, Langerhans cells and melanocytes (Kindl and Raab, 1998). 
However, it possesses much more energy than UV-A, and it is mainly UV-B that causes 
sunburn. If keratinocytes are too long exposed to UV-B, they undergo apoptosis as a protective 
mechanism against the carcinogenic effect of irreversibly and severely damaged DNA. Those 
cells are known as sunburn cells (SBCs) (Kerr et al., 1972). Chronic UVR exposure however 
cannot be compensated by SBCs. It is a strong environmental mutagen and can result in fatal 
cancer (Brash et al., 1991). However, for the photo-isomerisation of 7-dehydrocholesteral and 
ergosterol to previtamin D2 and D3, UV-B is indispensable (Norman, 1998; Okamura et al., 
1993).  
UV-C provides the highest energy and has a very strong mutagenic potential. Due to strong 
attenuation by the atmosphere, no significant UV-C radiation on earth results from natural 
sources. However, studies with UV-C lamps have shown that UV-C can irritate the skin and 
induce sunburn (Maverakis et al., 2010). 
 
1.4.1. UV- induced DNA Damage 
The skin is the organ that is mainly affected by solar UV radiation. One of the most important 
chromophores is the epidermal DNA with its aromatic bases that absorb the radiation energy. 
Since DNA has an absorption maximum at 260 nm, UV-C lamps are widely used to study UV 
radiation induced DNA damage (Batista et al., 2009).  
DNA damage is induced by the absorption of UV photons that generate lesions usually referred 
to as photoproducts. The most common photoproducts are cyclobutane pyrimidine dimers 
(CPDs) and (6-4) pyrimidine-pyrimidone photoproducts (PP) (Ravanat et al., 2001) (Figure 4). 
CPDs are formed from the photo (2 + 2) cycloaddition of the 5,6-double bond of two adjacent 
pyrimidine nucleotides (Torizawa et al., 2004). Thus, there are thymidine-thymidine (T-T), 
thymidine-cytosine (T-C), cytosine-thymine (C-T) and cytosine-cytosine (C-C) CPDs, with T-T 
dimers occurring most frequently (Setlow and Carrier, 1966). (6-4)-PPs arise from the linkage of 
the C6 position of the 5´- pyrimidine to the C4 position of the 3´- pyrimidine in an adjacent pair 
(Rosenstein and Mitchell, 1987). They can be further transformed to Dewar valence isomers by 
photoisomerization (Taylor et al., 1988). Several studies showed that CPDs are at least three 
times more often formed than (6-4)-PPS after UV-C irradiation, (Mitchell, 1988; Kao et al., 1993), 
but the formation ratio varies and is related to the specific DNA sequence and UV wavelength. 
After UV-A or UV-C radiation CPDs are especially formed at T-T sequences (Sage, 1993), 
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whereas T-C sequences are more susceptible to (6-4)-PPs and occur after UV-C radiation 
(Lippke et al., 1981). Both, CPDs and (6-4)-PPs cause a conformational change of the DNA 
double helix that results in the blockage of replication and transcription processes. The 
replication arrest leads to the production of DNA double-strand breaks (DSBs) at the sites of 
collapsed replication forks (Limoli et al., 2002; Batista et al., 2009). Furthermore, replication 
stresses and free radicals may also cause DSBs by preventing the topoisomerase-mediated 
DNA religation (Strumberg et al., 2000; Box et al., 2001; Ohnishi et al., 2009; Banáth and Olive, 
2003). 
DNA cannot only be damaged directly by UV irradiation, but also indirectly through the 
generation of ROS. Upon UV exposure, the radiation energy is absorbed by photosensitizers like 
porphyrins, bilirubin, melanin, flavins, pterins, vitamins, NAD(P)H, trans-urocanic acid and 
tryptophan (Wondrak et al., 2005), which are promoted to an excited singlet state and undergo 
intersystem crossing with oxygen to initially produce superoxide (O2-). Superoxide is biologically 
toxic and known to denature enzymes, lipids and also DNA. Thus, an enzyme called superoxide 
dismutase (SOD) rapidly converts superoxide into hydrogen peroxide (H2O2), which is then 
further processed by an enzyme named catalse that catalyzes the decomposition of H2O2 to 
water and oxygen. Hydrogen peroxide does not directly cause DNA damages but it can be 
transformed into hydroxyl radicals (HO.), which are highly reactive (Halliwell and Aruoma, 1991). 
Next to superoxide and hydrogen peroxide, ROS include also hypochlorous acid (HOCl), ozone 
(O3) and singlet oxygen (1O2), which can be easily converted into radicals or have an oxidative 
effect themselves. 
The DNA damages by ROS comprise single and double strand breaks, DNA base modifications 
or DNA-protein crosslinking, depending on whether DNA bases or deoxyribose are attacked 
(Ward, et al., 1987; Hönigsmann and Dubertret, 1996). Particularly critical are base 
modifications, since they result in mutations if not repaired immediately. Among the oxidatively 
modified bases, 8-hydroxy-2’-desoxy-guanosine (8-OHG), respectively 8-oxo-2’-desoxy-
guanosine (8-oxoG), are the most abundant and best investigated (Figure 5) (Kasai et al., 1984; 
Floyd et al., 1988; Kasai, 1997).  8-OH-G is formed by many agents with different mechanisms 
of action (Kohda et al., 1980; Kohda et al., 1990; Kasai et al., 1992; Epe et al., 1996). It base 
pairs preferentially with adenine rather than cytosine and thus generates GC-TA transversion 
mutations after replication (Grollman and Moriya, 1993; Kasai, 1997; Wood et al., 1990).  
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Figure 4: Cyclobutane Thymine Dimers and (6-4)-Pyrimidine-Pyrimidone Photoproducts  
Upon UV irradiation two main classes of DNA photoproducts are formed: Cyclobutane pyrimidine dimers (CPDs) and 
(6-4) pyrimidine-pyrimidone photoproducts ((6-4)-PPs). CPDs contain a four membered ring arising from the photo (2 
+ 2) cycloaddition of the 5,6-double bond of two adjacent pyrimidines. (6-4)-PPs are formed by the linkage of the C6 
position of a 5´- pyrimidine, to the C4 position of a 3´- pyrimidine. 
 
 
 
 
 
Figure 5: Oxidation of guanosine (adapted from 8-OHG EIA ELISA kit manual) 
8-hydroxy-2-deoxy guanosine (8-OHG) or 8-oxo-2-deoxy guanosine are produced by the oxidative damage of DNA by 
reactive oxygen species (ROS) and serve as an established marker of oxidative stress.  
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1.4.2. Repair Of UV-induced DNA Damages  
To prevent malignant transformation, cells have evolved a variety of mechanisms to detect and 
repair DNA damages. The tumor suppressor gene p53 controls the integrity of the DNA during 
the cell cycle and becomes activated in response to various stressors, one being UV irradiation 
(Maltzman and Czyzyk, 1984). P53 can activate DNA repair proteins and arrest growth at the 
G1/ S regulation point, so that the repair proteins have enough time to fix the DNA damage 
(Kuerbitz et al., 1992). One mechanism to repair UV damage is called photoreactivation or "light 
repair“. Photolyase enzymes specifically bind to CPDs or (6–4)-PPs and reverse the damage by 
using the energy of light. Antenna molecules like methenyltetrahydrofolate or 8-hydroxy-7,8-
didemethyl-5-deazariboflavin transfer the absorbed energy to a deprotonated reduced flavin 
adenine dinucleotide which then donates an electron to the pyrimidine dimer, resulting in the 
splitting of the dimer into two monomeric units (Cook, 1970; Sutherland, 1974; Kim et al., 1992). 
Photoproducts are also repaired through processes that do not relate on light and are much 
more complex. Nucleotide excision repair (NER) and base excision repair (BER) pathways 
handle DNA single strand breaks (Hedge et al., 2008), which can then be filled by different 
polymerases and ligases. Double-strand breaks are either repaired through nonhomologous end 
joining (NHEJ), which does not require a homologous template and can rejoin broken DNA ends 
directly end-to-end, or through homologous recombination repair (HRR), which is dependent on 
homology to guide repair (Moore and Haber, 1996, Pastwa and B%asiak, 2003). If DNA damage 
cannot be repaired, the cellular DNA damage response (DDR) activates apoptotic pathways. 
 
1.4.3. UV-induced Apoptosis 
Overexposure to UV irradiation often results in keratinocytes undergoing apoptosis as a 
protective mechanism against the carcinogenic effects of UV light (Daniels et al., 1961). 
Apoptosis is also known as programmed cell death and characterized by a sequence of ordered 
events leading to the elimination of cells without releasing harmful substances into the 
surrounding area (Kerr et al., 1972). This is contrary to necrosis, which is an unordered and 
accidental form of cell death caused by external factors and characterized by cellular swelling 
and rupture, often leading to inflammation (Wyllie et al., 1980). Mechanisms of UV-induced 
apoptosis include (i) UV-induced DNA damages followed by p53 activation and leakage of the 
pro-apoptotic factor cytochrome c from mitochondria; (ii) UV-induced death receptor (DR) 
activation, resulting in caspase cascades and the translocation of pro-apoptotic proteins of the 
Bcl-2 family like Bax (bcl-2- associated x protein) to mitochondria, which causes the release of 
cytochrome c; (ii) UV-induced overproduction of ROS, which then damage proteins and DNA, 
and additionally increase the release of cytochrome c from impaired mitochondria (Lee et al., 
2013). A failure in the clearance of apoptotic cells can result in the exposure of self-antigens, 
including self-DNA, which under certain circumstances might become immunogenic.  
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1.5. Deoxyribonucleases 
Deoxyribonucleases (DNases) are enzymes that induce the degradation of DNA by catalyzing 
the hydrolytic cleavage of phosphodiester linkages in the DNA backbone. DNases are essential 
to maintain genome stability and to regulate immune responses by limiting the availability of NA-
receptor ligands. They can be divided into endonucleases that cleave residues within the DNA 
strand and exonucleases that only cut at the DNA ends.  
The three main types found in metazoans are DNase I, DNase II and DNase III (also known as 
three prime repair exonuclease 1, short TREX1). DNase I is an endonucleases that yields 5´-
phosphate-terminated polynucleotides with a free hydroxyl group at the 3´end. Its function is 
waste management and the fragmentation of DNA during apoptosis (Samejima and Earnshaw, 
2005).  
DNase II is also an endonuclease and performs best at an acidic pH (Catchside and Holmes, 
1947). Lysosomal localization and ubiquitous tissue distribution alluded to a role in the 
degradation of exogenous DNA encountered by phagocytosis (Odaka and Mizuochi, 1999). In 
1998, Krieser and Eastman reported that overexpression of DNase II was sufficient to induce 
cell death in Chinese hamster ovary cells (Krieser and Eastman, 1998). However, loss-of-
function analyses in C. elegans, Drosophila and mice have failed to demonstrate any 
requirement for DNase II in the induction or procession of apoptosis (Evans and Aguilera, 2003).  
DNase III/ TREX1 is the most prominent DNA 3'–5' exonuclease in mammalian cells and 
especially found in the cytosol. Even though this enzyme was first purified in 1969 (Lindahl et al. 
1969), its gene was not identified before 1999 (Höss et al., 1999; Mazur and Perrino, 1999). 
TREX1 has a preference for ssDNA or mispaired 3' termini and generates 5' mono- or 
dinucleotides (Höss et al., 1999; Mazur and Perrin, 1999; Bebenek et al., 2001). Based on 
homology with known editing enzymes and its exonuclease function, TREX1 was suggested to 
have a role in DNA replication or gap filling during DNA repair (Brucet et al., 2007). However, 
TREX1 knockout mice did not confirm a role of TREX1 in DNA editing, since they did not show 
higher numbers of spontaneous mutations. Instead, they displayed an autoimmune-like 
inflammatory myocarditis and a dramatically reduced lifespan (Morita et al., 2004).  
 
1.6. Lupus Erythematosus 
Impaired clearance of apoptotic cells is strongly correlated with the progression of the 
autoimmune disease systemic lupus erythematosus (SLE) (Franz et al., 2006). It is thought that 
an inadequate clearance of apoptotic cells leads to a prolonged disposition of chromatin-protein 
complexes in the extracellular space, which results in the generation of autoantibodies that are 
especially directed against nuclear antigens (antinuclear antibodies = ANA) (Lahita, 1992; Tan, 
1989). Since the immune system looses the ability to distinguish self from non-self, it starts to 
attack the body’s own cells and tissues, resulting in inflammation and tissue damage. The name 
lupus erythematosus (latin for wolf and redness) comes from two characteristic symptoms: a 
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distinct rush as well as skin lesions in the face of lupus patients. Due to this typical butterfly rash 
that is provoked by UV exposition, lupus was initially thought to be a skin disease (Biett, 1824). 
Only 48 years later, lupus was found to have also a systemic character (Kaposi, 1872). 
The two major forms of lupus are cutaneous LE (CLE) and systemic LE (SLE). If only the skin is 
affected, the disease is classified as CLE. Generally, CLE is histologically characterized by a 
lympho–histocytic interface dermatitis due to lymphocytes that enter the endothelium and cause 
apoptosis of basal keratinocytes (Clark et al., 1973; Sepehr et al., 2010). Based on clinical 
morphology, average duration of skin lesions and histopathologic examination, CLE can be 
further subdivided into chronic, subacute and acute CLE (Fabbri et al., 2003).  
The most common form of lupus is SLE, which can affect many organ systems, including skin, 
kidney, joints, central nervous system, blood vessels, heart and lungs. SLE can cause different 
clinical symptoms that might vary from mild to severe forms. Common complaints include fever, 
joint paints, muscle aches, fatigue, skin alterations as well as kidney, lung or heart problems 
(Tan et al., 1982). Changes in the skin are not limited to CLE patients, but are also found in SLE 
patients, especially after exposure to UV light. This photosensitivity is a symptom found in up to 
83 % of LE patients (Sanders et al., 2003) and can result in cutaneous lesions with variable 
severity, but also in inflammation of different inner organs. 
Characteristical laboratory abnormalities in SLE include the increase of the blood sedementation 
rate, elevated antibody numbers, anemia, thrombocytopenia and the appearance of 
autoantibodies (Parodi and Rebora, 1997; Tan, 1989; Tan et al., 1982). Almost all SLE patients 
are positive for ANAs that bind to contents of the cell nucleus. The subtypes of ANAs are found 
to different extent in Lupus patients (Table 1) and can together with autoantigens form 
immunocomplexes that accumulate at the dermoepidermal junction and finally activate the 
complement system. This so-called Lupus band contains all major immunoglobulin classes (IgG, 
IgM, and IgA) and various complement components (Burnham et al., 1963; Crowson et al., 
2009). 
Percentage Autoantibody 
40-90 % anti-dsDNA antibodies 
10-30 % anti-Sm antibodies 
40-60 % anti-SSA/Ro and anti-SSB/La antibodies 
20% anti-Histon antibodies 
30-40 % anti-Cardiolipin antibodies  
30-40 % anti-rRNP and anti-snRNP antibodies 
 
Table 1: Characteristic autoantibodies in SLE (according to Tan et al., 1982) 
 
Because SLE is characterized by large amounts of autoantibodies, the loss of B cell tolerance is 
believed to be important for the initial phase of the disease. B cells can additionally function as 
autoantigen-presenting cells for T cells, and worsen the disease by the release of cytokines and 
chemokines (Lund, 2008), which then amplify autoimmunity through innate and adaptive 
immune system dysregulation (Marian and Anolik, 2012). Not only B cells, but also plasmacytoid 
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dendritic cells (pDCs) can be activated by co-stimulation of TLRs and Fc receptors via immune 
complex binding. Upon activation, they secrete large amounts of IFN-!, which then leads to the 
activation and maturation of DC subsets and stimulation of both T and B cells (Rönnblom et al, 
2001). Indeed, high IFN levels (Kariuki et al., 2010) as well as mutations of genes involved in 
TLR and IFN signaling pathways (e.g. IRAK1, IRF5, and STAT4) were identified as SLE risk 
variants (Kariuki et al., 2010; Remmers et al., 2007; Harley et al., 2008; Jacob et al., 2009). 
However, there remains a need for further research in the etiology of LE. It is supposable that, 
next to age and gender, other genetic factors play a predisposing role in the onset and 
progression of the disease. Likely candidates are certain HLA haplotypes (HLA-B8, -DR2, -DR3 
und -DQ2), but also mutations in the gene loci of TREX1 (Green et al., 1986; Rahman and 
Isenberg, 2008; Wakeland et al., 2001)  
 
1.7. Lupus And Neutrophil Extracellular Traps  
Neutrophils account for the largest group of white blood cells and provide the first line of defense 
of the innate immune system (Nathan, 2006). They have long been shown to be associated with 
SLE. However, their role in the pathogenesis of SLE was not clear until the discovery of 
neutrophil extracellular traps (NETs). NETs are web-like chromatin structures that are decorated 
with histones, myeloperoxidase, neutrophil elastase, cathepsin G, lactoferrin, LL-37 and HMGB1 
(Brinkmann et al., 2004; Mantovani et al., 2011). They are released to immobilize and eventually 
kill invading microbes.  
Sera of lupus patients often contain anti-neutrophil cytoplasmic antibodies (ANCAs) (Fauzi et al., 
2004), which are directed against major components of NETs. Thus, an imbalance between NET 
formation and clearance was suggested to play a role in SLE. Indeed, two independent studies 
demonstrated that up to 65% of SLE patients have a decreased ability to degrade NETs (Hakkim 
et al., 2010; Leffer et al., 2012), and the persistence of NETs may lead to the production of 
autoantibodies against NETs and worsen the disease.   
Different NET release mechanisms have been described over the last years. The major route of 
NET formation seems to occur as the result of NETosis, a specific type of cell death (Figure 6 ii) 
(Brinkmann et al., 2004; Steinberg et al. 2007). During NETosis, the chromatin decondenses into 
the cytoplasm while the plasma membrane remains intact. This allows the antimicrobial granular 
cargo to mix with the DNA. Afterwards, the plasma membrane bursts and the NETs are 
released. However, two other forms of NET generation were described to leave the cells viable 
so that they retain their ability to phagocyte pathogens (Yousefi et al., 2009; Yipp et al., 2012). 
Yousefi and colleagues explained the viability of the cells with the type of DNA released. They 
described that only mitochondrial DNA was extruded, while the nucleus remained intact (Figure 
6 iii) (Yousefi et al., 2009). However, others showed that nuclear DNA was released by viable 
neutrophils through a vesicular mechanism (Figure 6 i) (Yipp et al., 2012). Experimentally, 
NETosis is usually induced by the addition of microorganisms or the protein kinase C (PKC) 
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activator Phorbol-12-myristate-13-acetate (PMA) (Brinkmann et al., 2004; Urban et al., 2006), 
but LPS, IL5/IFN$ + LPS/C5a/eotaxin, GM-CSF + LPS/ C5a, IL-8, glucose oxidase, H2O2, or TNF 
were also described to cause the release of NETs (Remijsen et al., 2011b).  
To date, ROS such as superoxide generated by the NADPH oxidase Nox2 are thought to be the 
driving force for the formation of death mediated NETs. Especially, since patients with chronic 
granulomatosis, which have a nonfunctional NADPH oxidase, are not able to make NETs (Fuchs 
et al., 2007). Additionally, myeloperoxidase (MPO) seems to be required for the expulsion of 
NETs, but also this mechanism is not fully understood. Metzler et al. showed that neutrophils 
completely deficient in MPO fail to form NETs, while neutrophils from partially MPO-deficient 
donors maintained their ability to make NETs. Extracellular products of MPO did not rescue NET 
formation, suggesting that not downstream products of MPO, but the enzyme itself is 
responsible for NET expulsion (Metzler et al., 2011). Possibly, neutrophil elastase and MPO are 
required to partly degrade histones to allow decondensation of the chromatin (Papayannopoulos 
et al., 2010). 
 
Figure 6: The formation of NETs (Phillipson and Kubes, 2011) 
Different mechanisms of NET expulsion have been described. NETs can be released through DNA-containing 
vesicles that leave the cells viable (i), but they can also be withdrawn through a cell-death mediated mechanism (ii). 
Additionally, NET release by mitochondria has also been observed (iii). 
 
1.8. The MRL/lpr Mouse Model 
MRL/lpr mice develop a systemic autoimmune disease similar to SLE in humans. These mice 
are derived from inbreeding of strain MRL/Mp, which originates from crosses among the 
standard inbred strains LG/J, AKR/J, C3H/Di and C57BL/6 (The Jackson Laboratory). It is 
expected that 75 % of the genome is derived from strain LG/J (Harlan laboratory), which 
develops antinuclear antibodies and rheumatoid factor as well as renal disease (Peng et al, 
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1996). Thus, it is not remarkable that MRL/lpr mice also suffer from fatal renal disease 
characterized by glomerulonephritis, interstitial nephritis, vasculitis, and proteinuria (Kelley and 
Roths, 1985). With increasing age, high concentrations of several autoantibodies such as ANA 
and anti-dsDNA antibodies are found in MRL/lpr mice, resulting in large amounts of circulating 
immune complexes (Andrews et al, 1978; Hewicker et al, 1990). Since serum autoantibodies are 
not present at birth, a breakdown in tolerance must happen during lifetime, which might be 
explained by MRL/lpr being homozygous for the lymphoproliferation spontaneous mutation 
(Faslpr). The Faslpr mutation is a deletion in the structural gene for the Fas antigen (Watanabe-
Fukunaga et al, 1992; Watson et al, 1992), a transmembrane receptor that upon ligand binding 
leads to apoptotic cell death mediated by caspases 3/8 activation (Waring and Müllbacher, 
1999). The Fas-mediated apoptosis pathway plays an important role in the homeostasis of 
lymphocytes. Under normal conditions, T and B cells start to express the Fas ligand after 
activation and become progressively more sensitive to Fas-mediated apoptosis the longer they 
are activated (Hahne et al, 1996). The activation-induced cell death (ACID) is required to prevent 
an excessive immune response and eliminate autoreactive T and B cells. In MRL/lpr mice, the 
absence of the Fas antigen results in failure of lymphocytes to undergo programmed cell death 
(Watson et al, 1992). This accumulation of aberrant T and B cells comes along with a massive 
enlargement of lymph nodes and spleen. Other conspicuous symptoms are the development of 
skin rash and ear necrosis with increasing age. As observed in humans, female MRL/lpr mice 
develop more often clinical symptoms and die at an average age of 17 weeks of age, while 
males are less affected and die at an average age of 22 weeks. This compares to approximately 
50 weeks in females on the C57BL/6J background (Roths, 1987). Cytokines seem to play an 
important role in the disease pathogenesis. Like in SLE patients, disease severity in MRL/lpr 
mice is linked to the Th1 cytokines IFN-gamma and IL-12, which stimulate different immune cells 
in the destruction of invading organisms and infected cells (Takahashi et al, 1996; Peng et al, 
1997; Schwarting et al, 1999; Balomenos et al, 1998). Furthermore, IL-18 serum levels are 
increased in both SLE patients and MRL/lpr mice, stimulating IFN-gamma production, Fas-
mediated cytotoxicity, and developmental regulation of Th1 (Nakanishi et al, 2001). TNF-alpha, 
another proinflammatory cytokine, was also found to be elevated in MRL/lpr mice (Yokoyama et 
al, 1995). Due to many analogies with human SLE patients, the MRL/lpr mouse is the most 
commonly studied mouse model of lupus. 
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1.9. Aim 
The aim of this work was to uncover the molecular mechanism responsible for a phenomenon 
that had been observed in the Barchet laboratory. Previous experiments showed that direct and 
indirect UV irradiation greatly enhanced the immunostimulatory properties of DNA. In vitro, 
increased type I IFN and pro-inflammatory cytokine responses upon “UV-DNA” stimulation were 
observed in human monocytes, but also in murine myeloid DCs, macrophages and 
keratinocytes. Oxidative DNA modifications were identified as cause for the increased 
immunogenicity of UV irradiated DNA and it was shown that this DNA is recognized in the 
cytosol via STING. However, the mechanism behind the described phenomenon was not 
discovered. 
 
 
The aim of this thesis was to answer the following questions: 
- What is the molecular mechanism behind the observed phenomenon? 
- Which DNA uptake facilitators (soluble factors or receptors) are responsible for the 
transport into the cytosol? 
- What is the role of oxidatively damaged DNA in systemic lupus erythematosus (SLE) and 
the cutaneous form of lupus? 
- Which cell types respond to oxidatively damaged DNA in vivo? 
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2. Material And Methods 
 
2.1. Materials 
 
2.1.1. Equipment 
Equipment Manufacturer 
Analytical balance U4100-OD2.2 Sartorius (Göttingen) 
Autoclave VX-150 Systec (Wettenberg) 
Bacterial incubator VWR International (Darmstadt) 
Beakers  Schott (Mainz) 
Cell culture incubator MCO-20AIC Sanyo (San Diego, USA) 
Centrifuges 5415 D, 5415 R, 5430 R, 5810 R Eppendorf (Hamburg) 
Centrifuge Galaxy mini VWR (Darmstadt) 
Electroporator Gene Pulser II Bio Rad (Munich) 
Electrophoresis Power Supply EV231 Peqlab (Erlangen) 
ELISA reader Apollo LB912 Berthold (Bergisch-Gladbach) 
ELISA Vacupette  VWR (Darmstadt) 
Erlenmeyer flasks  Schott (Mainz) 
Flex cycler Analytic Jena (Jena) 
Flow cytometer LSR II BD Biosciences (Heidelberg) 
Fluorescence Microscope Axiovert Observer Carl-Zeiss (Göttingen) 
Freezer (- 20°C), different models AEG-Electrolux(Nürnberg),Siemens(Munich) 
Freezer (-80°C) HFU 586 basic Thermo Electron (Oberhausen) 
Freezer (-150°C) ultra low freezer Sanyo (San Diego, USA)) 
Freezing container VWR (Darmstadt) 
Fridge  AEG-Electrolux (Nürnberg) 
Gel documentation system Peqlab (Erlangen) 
Gel chamber with gel tray and comb  Peqlab (Erlangen) 
Ice machine AF20 Scotsman (Pogliano (I)) 
Lab dancer VWR (Darmstadt) 
Magnetic stirrer VWR (Darmstadt) 
Microbiological Safety Cabinet Type 1.8 Thermo Fisher Scientific (Schwerte) 
Microscope Type Wilovert 30 Wilhelm Hund GmbH (Wetzlar) 
Microwave NN-E205W Panasonic (Hamburg) 
Multichannel pipettes Ergonomic High-
Performance (1-10 µl, 5-50 µl, 20-200 µl) 
VWR (Darmstadt) 
Neubauer counting chamber Brand (Wertheim) 
Nitrogen tank  Taylor Wharton (Mildstedt) 
PCR Thermocycler "Flex-Cycler"  Analytik Jena (Jena) 
pH-Meter HI8424 HANNA Instruments (Kehl am Rhein) 
Pipetboy acu  Integra Biosciences (Fernwald) 
Pipettes  Eppendorf (Hamburg) 
Prepare cutlery Labotec Labor-Technik (Göttingen) 
Shaker KS 260 basic IKA (Staufen) 
Spectral photometer Nanodrop 1000 Peqlab (Erlangen) 
Sterile Workbench Thermo Fisher Scientific (Waltham MA, 
USA) 
Suction pump Midisart 2000 Sartorius (Göttingen) 
Thermomixer comfort Eppendorf (Hamburg) 
Threaded bottles  Schott (Mainz) 
Ultrapure water purification system Purelab classic ELGA (Celle) 
UV-C irradiation device Saalmann (Herford) 
Vertical Gel electrophoresis system  Bio-Rad (München) 
Volumetric flasks  Schott (Mainz) 
Vortex Genius 2 Scientific Industries (New York, USA) 
Wallac Envision 2104 Multilabel Reader Perkin-Elmer (Waltham MA, USA) 
Water bath Isotemp 210 Thermo Fisher Scientific (Schwerte) 
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2.1.2. Expendable Materials 
Material Manufacturer 
Cell culture flasks   Sarstedt (Nürnbrecht) 
Cell culture plates, flat- and round-bottom  TPP (Trasadingen (CH)) 
Cell culture plates  Sarstedt (Nürnbrecht) 
Cell strainer (40 µm)  BD Biosciences (Heidelberg) 
Cover slips (18 x 18 mm) Marienfeld (Lauda-Königshofen) 
Cryo tubes   Greiner Bio-One (Solingen) 
Disposable cannulas Sterican (0,4 x 20 mm, 0,45 
x 20 mm) 
Braun (Melsungen) 
Disposable gloves Dermaclean  Ansell Healthcare (Brussels (B)) 
ELISA plates Greiner Bio-One (Solingen)  
FACS tubes  Sarstedt (Nürnbrecht)  
Falcon tubes  Greiner Bio-One (Solingen) 
Microtainer tubes  BD Biosciences (Heidelberg) 
Pipette tips  Greiner Bio-One (Solingen) 
Pipette tips with aerosol filter Biozym (Hess. Oldendorf) 
Petri dishes  Greiner Bio-One (Solingen) 
Plastic pipettes   Corning Costar (Bodenheim) 
Reaction tubes (0,2 ml)  BIOplastics (Landgraaf (NL)) 
Reaction tubes (0,5 ml, 1,5 ml, 2 ml)  Eppendorf (Hamburg)  
Sterile filter 500 ml Filter system  Corning Costar (Bodenheim) 
Sterile filter (0,2 µm)   Whatman (Dassel) 
Syringes Discardit II (2 ml, 5 ml, 10 ml)  BD Biosciences (Heidelberg) 
Syringe filter (0,45 µm)  Thermo Fisher Scientific (Bonn) 
Syringe Omnifix® F (1 ml)  Braun (Melsungen) 
 
2.1.3. Chemicals 
Chemical Manufacturer 
Acetic acid  Carl Roth (Karlsruhe) 
Acetyl CoenzymeA  Genaxxon BioScience (Ulm) 
Adenosine triphosphate (ATP) Sigma-Aldrich (Steinheim) 
Agarose  Applichem (Darmstadt) 
Ampicillin Carl-Roth (Karlsruhe) 
Ampuwa Fresenius (Bad Homburg) 
Bacto Tryptone  BD Biosciences (Heidelberg) 
Bacto Yeast Extract  BD Biosciences (Heidelberg) 
BD OptEIA Substrate Reagent A and B BD Biosciences (Heidelberg) 
BD Pharmlyse BD Biosciences (Heidelberg) 
Blasticidine S Hydrochloride, 25mg Carl Roth (Karlsruhe) 
Bovines Serum Albumin (BSA)  Sigma-Aldrich (Steinheim) 
Calcium chloride  Carl Roth (Karlsruhe) 
Chloroform  Carl Roth (Karlsruhe) 
Deoxynucleoside triphosphates (dNTPs) Invitrogen (Karlsruhe) 
Di-methylsulphoxide (DMSO)  Carl Roth (Karlsruhe) 
Di-Sodiumhydrogen phosphate  Carl Roth (Karlsruhe) 
Dithiothreitol (DTT) Carl Roth (Karlsruhe) 
DNA-Hybridisation buffer 10 x  New England Biolabs (Ipswich, GB) 
DNA Loading Dye 6 x Fermentas (St. Leon-Rot) 
DreamTaq™ Green Buffer 10 x  Fermentas (St. Leon-Rot) 
Dulbecco’s Modified Eagle Medium (DMEM)  Gibco (Karlsruhe) 
Dulbecco’s PBS PAA Laboratories (Pasching) 
Dynabeads MyOne T1 Streptavidin, 2ml Invitrogen (Karlsruhe) 
ECL Western Blotting Substrate Pierce Thermo Scientific (Rockford, USA) 
Ethanol  Carl Roth (Karlsruhe) 
Ethylendiamintetra acetic acid (EDTA)  PAA Laboratories (Pasching) 
FastDigest® Buffer 10 x  Fermentas (St. Leon-Rot) 
Fetal calf serum (FCS)  Gibco (Karlsruhe) 
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Ficoll Biochrom (Berlin) 
Geneticinedisulfate (G418)  Sigma-Aldrich (Steinheim) 
Glucose   Sigma-Aldrich (Steinheim) 
GM-CSF (murine)  Cell supernatant of J55811  
HEPES   Carl Roth (Karlsruhe) 
Hydrogen peroxide, 30 %  Carl Roth (Karlsruhe) 
Isoflurane  Abbott (Wiesbaden) 
Isopropanol (C3H8O)  Carl Roth (Karlsruhe) 
Magnesium carbonate hydroxide  Carl Roth (Karlsruhe) 
Magnesium chloride   Sigma-Aldrich (Steinheim) 
Magnesium sulfate   Carl Roth (Karlsruhe) 
MEM nonessential amino acids  Gibco (Karlsruhe) 
MEM Sodium-Pyruvate 100 x  Gibco (Karlsruhe) 
2-Mercaptoethanol  Carl Roth (Karlsruhe) 
Optimem  Gibco (Karlsruhe) 
Passive lysis buffer 5x Promega (Madison, USA) 
Penicillin/Streptomycin 100 x  Cambrex BioWhittaker (New Jersey, USA) 
Phenol  Carl Roth (Karlsruhe) 
Polybrene  Sigma-Aldrich (Steinheim) 
Puromycine dihydrochloride  Sigma-Aldrich (Steinheim) 
Potassium chloride  Carl Roth (Karlsruhe) 
RPMI 1640  Gibco (Karlsruhe) 
Sodium carbonate  Carl Roth (Karlsruhe) 
Sodium chloride  Carl Roth (Karlsruhe) 
Sodium dihydrogen phoshate-Monohydrate Carl Roth (Karlsruhe) 
Sodiumdodecyl sulfate (SDS)  Carl Roth (Karlsruhe) 
Sodiumhydrogen carbonate   Carl Roth (Karlsruhe) 
Sodium hydroxide   Carl Roth (Karlsruhe) 
Sodium phosphate  Carl Roth (Karlsruhe) 
SYBR® Safe DNA gel stain 40000 x  Invitrogen (Karlsruhe) 
Tris-Acetate-EDTA (TAE) 50 x Carl Roth (Karlsruhe) 
Taq Buffer 5 x  Promega (Madison, USA) 
Tricine Carl Roth (Karlsruhe) 
Tris   Carl Roth (Karlsruhe) 
Tris-hydrochloride different pHs,1M  Carl Roth (Karlsruhe) 
Trizol  Invitrogen (Karlsruhe) 
Tryphan blue   Carl Roth (Karlsruhe) 
Trypsin EDTA  Gibco (Karlsruhe) 
Tween 20  Carl Roth (Karlsruhe) 
  
 
2.1.4. ELISA  
Human IFN-" ELISA (eBioscience (Vienna, Austria)): 
- Monoclonal Coating Antibody to human IFN-alpha  
- Human IFN-alpha Standard protein  
- HRP-Conjugate anti-human IFN-alpha monoclonal antibody  
 
Murine IFN-" ELISA (PBL Biomedical Laboratories (New Jersey, USA)): 
- MAb to Mouse Interferon-Alpha, neutralizing, Clone RMMA-1  
- Mouse Interferon-Alpha  
- PAb to Mouse Interferon-Alpha, Rabbit Serum, neutralizing  
- Donkey Anti-Rabbit F(ab)2-Peroxidase  
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2.1.5. Transfection Reagents 
Transfection reagent Manufacturer 
Dotap Carl Roth (Karlsruhe) 
LipofectamineTM 2000 Invitrogen (Karlsruhe) 
TransIT LT-I  Mirus (Madison, USA) 
 
2.1.6. Enzymes 
Enzyme Manufacturer 
DNase I Roche (Mannheim) 
DNase II, type V (bovine) Sigma-Aldrich (Steinheim) 
DNase II, type IV (porcine) Sigma-Aldrich (Steinheim) 
DreamTaq™ DNA Polymerase Fermentas (St. Leon-Rot) 
Fast AP Fermentas (St. Leon-Rot) 
Phusion High!Fidelity DNA Polymerase New England Biolabs (Frankfurt a. M.) 
Proteinase K Sigma-Aldrich (Steinheim) 
T4 DNA PK Thermo Scientific (St. Leon-Rot) 
 
2.1.7. Western Blot And FACS Antibodies 
Antibody Manufacturer 
Monoclonal ANTI-FLAG M2 antibody Sigma-Aldrich (Steinheim) 
B220-PerCp-Cy5.5, Clone RA3-6B2 BD Biosciences (Heidelberg) 
CD11b-APC, Clone M1/70 Biolegend (San Diego, USA) 
CD11c-PE-Cy7, Clone HL3 BD Biosciences (Heidelberg) 
CD4-BV421, Clone RM4-5 Biolegend (San Diego, USA) 
CD8-PerCp-Cy5.5, Clone 53-6.7 Biolegend (San Diego, USA) 
F480- BV421, Clone BM8 Biolegend (San Diego, USA) 
GR-1-PerCp-Cy5.5, Clone RB6-8C5 BD Biosciences (Heidelberg) 
Ly6C-APC, Clone AL-21 BD Biosciences (Heidelberg) 
 
2.1.8. Kits 
Kit Manufacturer 
HiPure Plasmid Filter Midiprep Kit Invitrogen (Karlsruhe) 
InnuPREP PCR Pure Kit Analytic Jena (Jena) 
MyBudget Gel Extraction Kit Bio-Budget Technologies GmbH  (Krefeld) 
Pure Link Quick Plasmid Miniprep Kit Invitrogen (Karlsruhe) 
 
2.1.9. MACS Beads From Miltenyi Biotec 
CD11b MicroBeads, mouse/ human 
CD11c MicroBeads, mouse 
CD3% MicroBeads, mouse 
CD19 MicroBeads, mouse 
Monocyte isolation kit II, human 
 
2.1.10. Oligonucleotides 
Desalted and HPLC-purified oligonucleotide (ODNs) were purchased from Metabion (Planegg-
Martinsried). The lyophilized ODNs were dissolved in Diethylpyrocarbonat (DEPC)-H2O and stored at -
20°C. 
 
PCR  
GFP-fw-(bio) 5´-(Biotin)-GGC CAC AAC CAT GGT GAG CA-3´ 
GFP-rev-full length 5´-TTA CTT GTA CAG CTC GTC CAT-3 
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Real-time-PCR  
mbeta-actin_sgfw 5´-TCC AGC CTT CCT TCT TGG GT-3´ 
mbeta-actin_sgrev 5´-GCA CTG TGT TGG CAT AGA GGT-3´ 
mIFN-"4_sgfw 5´-AAG CCT GTG TGA TGC AGG A-3´ 
mIFN-"4_sgrev 5´-GCA CAG AGG CTG TGT TTC TTC-3´ 
 
2.1.11. Nucleic Acids 
Poly(I:C) was purchased from Invitrogen (Karlsruhe) and poly(dAdT) was purchased from Sigma-Aldrich 
(Munich). They were dissolved in DEPC-H2O with a concentration of 1 µg/ µl and stored at -20°C until use. 
 
2.1.12. Media, Solutions, Substrates And Buffers 
All solutions, buffer and culture media were stored at 4°C. FCS was inactivated by heat (30 minutes, 
56°C) before use. Solutions were sterile filtrated or autoclaved. 
 
Dulbecco's Modified Eagle's Medium (DMEM): 
DMEM 41965 
10 % (v/v) FCS 
2 mM L-Glutamine 
1 mM MEM Sodium-Pyruvate 
100 U/ ml Penicillin/Streptomycin 
 
DNase II Buffer: 
80 mM Sodium acetate 
25 mM MgCl2 
adjusted to pH 5.0 with HCl 
 
ELISA Assay Buffer (hIFN-!): 
1 x PBS 
2 % (v/v) FCS 
0,05 % (v/v) Tween 20 
 
ELISA Assay Buffer (mIFN-!): 
1 x PBS 
10 % (v/v) FCS 
(0,05 % (v/v) Sodiumazide) 
 
ELISA Coating Buffer (mIFN-!): 
0,2 M Sodium phosphate pH 6,5 
12,49 g Na2HPO4 and 15,47 g NaH2PO4 solved in H2O 
pH adjusted to 6,5 and filled up to 1 L with H2O 
 
ELISA Washing Buffer: 
1 x PBS 
0,05 % (v/v) Tween 20 
 
FACS Buffer: 
1 x PBS 
2 % (v/v) FCS 
 
Freezing Medium: 
90 % (v/v) FCS 
10 % (v/v) DMSO 
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HEPES Buffered Saline (HBS, 2 x): 
4 g NaCl 
0,18 g KCl 
0,05 g Na2HPO4 
2,5 g HEPES 
0,5 g Glucose 
250 ml H2O  
pH adjusted to pH 7,1 with NaOH 
 
IBc Buffer: 
10 ml of 0.1MTris–MOPS (pH 7,4) 
1 ml of 0.1 M EGTA/Tris (pH 7,4) 
20 ml of 1 M sucrose 
Bring volume to 100 ml with distilled water 
Adjust pH to 7,4 
 
Laemmli Buffer (5 x): 
10 % SDS 
125 mM Tris-HCl pH 6.8 
50 % Glycerol 
4 % DTE 
0.65 % BPB 
 
Native Protein Purification buffer (5 x): 
250 mM NaH2 PO4 pH 8.0 
2.5 mM NaCl 
 
Native Protein Binding Buffer (1 x): 
20 mM Tris"HCl pH 7.9 
500 mM NaCl 
2 mM Imidazole 
adjusted to pH 8.0 
 
Native Protein Wash buffer (1 x): 
20 mM Tris"HCl pH 7.9 
500 mM NaCl 
20 mM Imidazole 
 
Native Protein Elution buffer (1 x): 
20 mM Tris-HCl pH7.9 
500 mM NaCl 
250 mM Imidazole 
adjusted to pH 8.0 
 
Pull-down Lysis Buffer: 
PBS 
1% NP-40 Substitute 
Proteinase inhibitor tablet from Roche 
 
Pull-down Wash Buffer: 
PBS 
0,2 % NP-40 Substitute 
 
RPMI Medium: 
RPMI 1640 
10 % (v/v) FCS 
2 mM L-Glutamine 
0,1 mM MEM nonessential amino acids 
1 mM MEM Sodium-Pyruvate 
100 U/ ml Penicillin/Streptomycin 
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Tail Buffer: 
100 mM Tris 
5 mM EDTA 
0,2 % (v/v) SDS 
200 mM NaCl 
 
 
2.1.13. Primary Cells And Cell Lines 
Cell name Source 
HEK293T cells Human embryonic kidney cell line purchased from Invitrogen (Darmstadt) 
Human primary cells Isolated from Buffy Coats purchased from the Institute of experimental 
Hematology and Transfusion Medicine (Bonn) 
Murine primary cells Isolated from wild type or knockout mice 
RMA cells NK-cell hybridoma (H2Kb) (Gays et al., 2000) 
THP1 cells Human monocytic cell line from Sigma 
129-Macrophages Macrophage cell line generated from 129/SV wild type mice 
 
 
2.1.14. Mice 
C57BL/6J Janvier (Saint Berthevin, France) 
MRL/lpr Harlan Laboratories (Indianapolis, USA) 
StingGt/Gt  Mice with point mutation (T596A) in STING that results in a null allele due 
to an isoleucine-to-asparagine substitution (I199N), made by Russel 
E.Vance 
Tlr9-/- TLR9-deficient mice, provided by Dr. Andreas Limmer 
Trex1 -/- TREX1-deficient mice, provided by Prof.Dr. Jörg Wenzel 
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2. 2. Methods 
 
2.2.1. Cell Culture 
 
2.2.1.1. General Preconditions 
All operations were carried out under a laminar flow hood using disposable gloves, sterile 
devices, solutions and growth media. Cultivation of primary cells and cell lines took place in CO2 
incubators (5 % CO2 v/v) at 37°C and 95 % humidity.  
 
2.2.1.2. Subculturing Of Cells  
All cell lines were regularly passaged to assure the quality of the growth medium and to prevent 
overgrowth. The production of catabolic metabolites changes the pH value of the medium. By 
the use of purchasable Dulbecco's Modified Eagle's Medium (DMEM) and Roswell Park 
Memorial Institute (RPMI) media containing phenol red as pH indicator (pH 7.4 = light red) the 
wastage of the medium can be seen as a color change from red to yellow. The cells were split 
every other day. 
 
2.2.1.3. Determination Of The Cell Number 
To determine cell number and vitality, the cells were stained with tryphan blue and counted with 
the help of a Neubauer counting chamber (side length 1 mm, depth 0.1 mm). Tryphan blue is an 
acidic dye that only stains dead cells, while living cells are protected by their intact cell 
membrane and appear white under a microscope. To determine the number of living cells, the 
cell suspension was 1:5- 1:20 diluted with 0.04 % Tryphan blue in Phosphate buffered saline 
(PBS). 10 µl of this mixture were applied to the Neubauer counting chamber covered with a 
glass slip. Engravings mark a field with nine large squares of 1 mm&. Living cells in four of these 
squares were counted under a microscope (magnification of 10) and subsequently the cell 
number was divided by four. The volume over a large square is 0.1 'l (area * depth = volume), 
thus, the cell number per ml can be estimated by multiplying the cell number per large square by 
the factor of dilution and 104.  
 
2.2.1.4. Freezing And Thawing Of Cells  
1 x 107 cells were frozen in 1 ml FCS with 10 % Dimethylsulfoxide (DMSO). The cryo tubes were 
put into a freezing container containing Isopropanol and placed at -80°C for 24 hours. For 
permanent storage the deep frozen tubes were transferred at -150°C. The cells were rapidly 
thawed at 37°C, then slowly diluted in 50 ml warm growth medium for washing and finally 
resuspended in fresh medium. 
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2.2.2. Isolation And Generation Of Cells 
 
2.2.2.1. Preparation Of Murine Bone Marrow DCs 
Bone marrow (bm) cells were isolated from the hind legs of mice and differentiated to DCs. 
Therefore, mice were sacrificed via cervical dislocation and the hind legs were detached from 
the hip without damaging the thighbone. Remaining muscles were removed and lower leg and 
thigh were separated by superextending the knee joint. The medullary canal was opened and 
the bone marrow was flushed out with the help of a syringe filled with medium. Afterwards, the 
cell suspension was centrifuged for five minutes with 300 x g at room temperature (RT); the 
sediment was taken up in 10 ml BD Pharmlyse and incubated for five minutes at RT. 
Subsequently, the cells were washed with medium and finally counted. For differentiation 
towards bmDCs, bm cells of one mouse were placed in five 10 cm-plates and cultivated for 
seven days in 15 ml RPMI- medium with 3 % granulocyte-macrophage colony-stimulating factor 
(GM-CSF). Afterwards, cells were harvested and counted. For following stimulation experiments, 
2 x 105 cells were plated in each well of a 96-well plate in a volume of 150 'l. 
 
2.2.2.2. Isolation Of Murine Spleen Cells 
Mice were anaesthetized with Isoflurane and killed by cervical dislocation. After sterilization of 
the mouse, the spleen was isolated, freed from fat and placed into a cell strainer. Using the 
rounded end of the forceps, the spleen was mashed through the cell strainer into a petri dish 
filled with 1 x PBS. The cell strainer was rinsed with 10 ml PBS and the suspended cells were 
transferred into a 50 ml falcon. After centrifugation at 1500 rpm for 10 minutes at 4°C, erylysis 
was performed for five minutes at RT with Pharmlyse (BD). 
 
2.2.2.3. Isolation Of Human Peripheral Blood Mononuclear Cells  
Peripheral blood mononuclear cells (PBMC) were isolated from buffy coats kindly provided by 
the University Medical Center of Bonn. In a first step, the blood was equally distributed in 3 x 50 
ml falcons and mixed 1:2 with 1x PBS. 14 ml Ficoll (Biochrom, Berlin) were overlaid with the 
blood/ PBS solution and centrifuged at 800 x g without brake for 20 minutes at RT. Ficoll is a 
sucrose gradient, which has a higher density than PBMCs, but a lower density than erythrocytes 
and granulocytes; thus, the blood- PBS solution was separated into four phases by 
centrifugation. The PBMCs were transferred into a new falcon and the volume was filled up to 50 
ml with 0,9 % NaCl. After centrifugation (450 x g for 10 minutes at RT), an erylysis was 
performed for five minutes at RT with Pharmlyse (BD). Subsequently, the cells were washed 
with 0,9 % NaCl and then taken up into 50 ml RPMI before the number of PBMCs was 
determined. For stimulation experiments, 2 x 105 cells/ 96-well were used. Otherwise, the cells 
were subjected to MACS separation for the enrichment of monocytes.  
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2.2.2.4. Magnetic-activated Cell Sorting  
Magnetic-activated cell sorting (MACS) is based on the incubation of cells with magnetic 
microbeads that are coated with antibodies against a particular surface antigen. Cells that 
express this antigen attach to the beads and stay on a column placed in a strong magnetic field, 
while other cells that do not express the particular antigen can flow through. With this method 
one can either deplete or enrich the cells of interest. 
Human monocytes were isolated with the Human Monocyte Isolation Kit II from Miltenyi Biotec. 
With this kit, all cells of human PBMCs with the exception of monocytes are labeled with 
biotinylated antibodies. Anti-Biotin microbeads bind to these antibodies and hold the cells that 
are not of interest onto the column. Since monocytes were not labeled with an antibody, they 
can flow through the column and are collected. According to the user manual, human PBMCs 
were resuspended in 30 'l MACS buffer per 107 cells and incubated with 10 µl FcR-Blocking-
reagent and 10 µl Biotin-ab-cocktail. After 10 minutes at 4°C, 30 'l MACS buffer and 20 µl anti-
Biotin microbeads were added and the cells were further incubated for 15 minutes at 4°C. 
Thereafter, the cell suspension was washed with 2 ml MACS buffer and taken up in 500 'l 
MACS buffer per 108 cells. Next, the cell suspension was loaded onto a LS MACS column 
placed in the magnetic field of a MACS separator. The column was washed two times with 1 ml 
MACS buffer and the flow-through was collected in a fresh 50 ml falcon. The cells were taken up 
in 0,9 % NaCl and counted. For stimulation experiments, 2 x 105 cells/ 96-well were used.  
Murine CD3%+ splenocytes were depleted with the MicroBead kit from Miltenyi Biotec. The cells 
were first labeled with 10 µL of CD3%-Biotin per 107 cells for 10 minutes at 4°C, and 
subsequently magnetically labeled with 20 'l of Anti-Biotin MicroBeads per 107 cells for 15 
minutes at 4°C. Thereafter, cells were applied onto a LD MACS column and unlabeled cells that 
passed through were collected.  
Murine CD19+ splenocytes were depleted with CD19 MicroBeads from Miltenyi Biotec. The cells 
were labeled with 10 µL of CD19 MicroBeads per 107 total cells for 15 minutes at 4°C and then 
loaded onto MS MACS columns. Unlabeled cells that passed through were collected. 
 
2.2.2.5. Isolation Of Human Neutrophils From Fresh Blood 
For the isolation of human neutrophils, 9 ml fresh blood were collected in an 
Ethylenediaminetetraacetic acid (EDTA) blood collection tube, layered over 5 ml Histopaque 
1119 (Sigma) and centrifuged for 20 minutes at 800 x g and 21°C without brake. Afterwards, 
cells were resuspended in 2 ml PBS and laid over a five-layer Percoll gradient of 85-80-75-70-65 
% Percoll (Sigma). After centrifugation at 800 x g for 20 minutes and 21°C (no brake!), 
neutrophils between the 65 and 85 % layers were harvested into a fresh falcon and washed with 
PBS. Remaining red cells were eliminated by erylysis for four minutes at RT. The isolated 
neutrophils were suspended in RPMI with 5 % FCS and directly used. 
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2.2.2.6. Isolation Of Murine Neutrophils From Bone Marrow 
Murine neutrophils were isolated from bone marrow with the help of a Percoll gradient. Percoll 
consists of colloidal silica particles, which have been coated with polyvinylpyrrolidone (PVP). It is 
used to establish density gradients that can be used to isolate cells. For the isolation of 
neutrophils, marrow cavities of the tibias and femurs were flushed with PBS. After erylysis for 
five minutes at RT, the remaining cells were laid on a three-step Percoll gradient (55 %, 65 % 
and 75%) and centrifuged for 20 minutes at 1000 x g and 21°C without brake. Neutrophils 
recovered at the interface of the 65 and 75% fractions were >85% pure as assessed by 
fluorescence activated cell-sorting (FACS) analysis 
 
2.2.3. Stimulation And Treatment Of Cells  
 
2.2.3.1. Transfection Of Nucleic Acids  
LipofectamineTM 2000 (Invitrogen) and TransIT-LT1 (Mirus) are reagents that allow the 
transfection of eukaryotic cells with nucleic acids or proteins. Hereby, the transfected substances 
reach predominantly the cytosol of a cell. For transfection of DNA, 1,2 µl TransIT-LT1 
transfection reagent were diluted in 25 µl Optimem and incubated for five minutes at RT. 
Meanwhile, 400 ng DNA were diluted in 25 µl Optimem. Afterwards, the diluted reagent was 
added and the whole mixture was incubated for 20 minutes at RT to allow the formation of 
nucleic acid complexes. 45 µl of the nucleic acid mixture were then added to a 96-well plate 
containing 2 - 4 x 105 cells/ 150 'l medium per well. For transfection of 3pRNA, 100 ng 3pRNA 
and 0,2 'l Lipofectamine (Invitrogen) were used.  
 
2.2.3.2. UV Irradiation Of Cells And DNA 
For the irradiation of cells and nucleic acids with UV-A or UV-B light a Multitester SBB LT 400 
(Saalmann, Herford) was used. Irradiation with UV-C light was done with an UV-crosslinker from 
Peqlab Erlangen (254 nm). Not more than 20 'l DNA per 96-well was placed in a round bottom 
plate without lid, irradiated with the desired UV doses and directly used for stimulation. Cells 
were irradiated in not more than 500 'l per 6-well and DNA was isolated after one hour. 
 
2.2.3.3. HOCl/ H2O2-treatment Of Cells And DNA  
0,5 -1 x 107 cells were placed in 6-well plates and treated with different concentrations of HOCl 
(10 'M, 100 'M, 1 mM) or H2O2 (100 'M, 1 mM, 10 mM). After 60 minutes incubation at 37°C, 
the cells were washed with 1 x PBS and then DNA was isolated like described. For direct H2O2-
treatment of DNA, DNA was isolated of RMA-mOVA cells and incubated for three minutes with 
different amounts of HOCl/ H2O2 (1 'M, 10 'M, 100 'M).  Afterwards, the DNA was precipitated 
with Ethanol. Therefore, 2/3 volume of 100 % Ethanol and 1/10 volume of Sodiumacetate was 
added to the DNA and five minutes incubated at -80°C. Next, the samples were centrifuged for 
Materials and Methods 
 34!
15 minutes with maximal speed at 4°C. The pellet was washed with 500 µl 70 % Ethanol and 
again centrifuged for five minutes. The supernatant was taken off and the DNA was dried at 
37°C. At last, the DNA was taken up in H2O or PBS.  
 
2.2.3.4. Induction Of NETosis 
NETosis of human and murine neutrophils was induced by an incubation in 40 nM Phorbol-12-
myristate-13 acetate (PMA) for three hours at 37°C.  
 
2.2.3.5. Incubation Of DNA With Human LL37 Peptide 
To complex genomic DNA with the human cathelicidin LL37, the DNA was incubated with LL37 
(Innovagen) in a ratio of 1:2 for 30 minutes at RT in a total volume of 20 'l. Afterwards, the 
volume was increased with 1x PBS to 100 'l and cells were stimulated with 45 'l/ 96-well.  
 
2.2.4. Enzyme Linked Immunosorbent Assays  
To determine the level of a specific antigen in a sample, often Sandwich-ELISAs are carried out. 
The principle of this method relies onto two antibodies that bind the same antigen. Importantly, 
they bind different epitopes so that they do not hinder each other. The first antibody is the 
coating or capture antibody. After its binding to a microtiter plate, remaining antigen-binding sites 
on the plate itself are blocked by the incubation with a buffer containing FCS or BSA. After a 
washing step, the samples are added and the capture antibody binds the specific antigen. 
Another washing step then ensures that unbound components of the samples are removed. 
Next, the second antibody named the detection ab is added to the wells and binds to the 
captured antigen. Thereby, an antibody-antigen-antibody complex (Sandwich) is generated. 
Either the detection ab itself is coupled to an enzyme which catalyzes the reaction of a given 
substrate into a detectable form, or a secondary ab is used which binds universally to the Fc-
region of other antibodies and is coupled to an enzyme that allows the detection of the desired 
antigen. Often the enzyme HRP (horseradish peroxidase) is used which catalyzes the oxidation 
of tetramethylbenzidine (TMB) with H2O2 and stains the solution blue. This reaction is then 
stopped with an acid and the color changes from blue to yellow. For quantitative verification, 
standard rows with known antigen concentrations are added in addition to the other samples. 
With the help of a calibration curve one can then determine the amount of antigen being present 
in a specific sample. 
 
2.2.4.1. Murine IFN-! ELISA 
To determine the level of murine IFN-! in cell culture supernatants, the wells of a 96-well-ELISA-
plate were coated with 50 µl of the primary antibody RMMA-1 (1 mg/ml) diluted 1:1000 in 0,2 M 
Sodium phosphate buffer (pH 6,5) and incubated at 4°C overnight. The next day, the plate was 
washed three times with 150 µl washing buffer and blocked with 150 µl Assay buffer for three 
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hours at RT. After three washing steps, 50 µl samples were applied undiluted to the ELISA plate. 
Additionally, an 8-rowed serial dilution of the recombinant IFN-! standard (100 U/ ml) was 
prepared with concentrations ranging from 5000 to 0 pg/ ml. Both, samples and standard row, 
were incubated for 16 - 48 hours at 4°C. After three washing steps, the plate was incubated with 
50 µl of a polyclonal anti-mouse-IFN-! detection antibody made in rabbit (80 NU/ µl) diluted 
1:1000 in assay buffer. Prior to the incubation with 50 µl of a HRP-conjugated secondary 
antibody, the ELISA plate was washed 10 times. The anti-rabbit- F(ab)2-Peroxidase made in 
donkey was diluted 1:10000 in assay buffer and applied for three hours in the dark at RT. After 
10 washing steps, the plate was incubated with 50 µl substrate solution (BD OptEIA Substrate 
Reagent A and B) until the first five standard dilutions turned blue. The color reaction was 
stopped with 50 µl 2 M H2SO4 and the color intensity was measured with an ELISA reader at 450 
and 570 nm.  
 
2.2.4.2. Human IFN-! ELISA 
To detect human IFN-!, the ELISA plate was incubated with diluted coating antibody to human 
IFN-alpha (final concentration 1 'g/ ml) in 1x PBS overnight at 4°C. To block unspecific binding 
sites, 50 µl assay buffer (1 x PBS with 0,5% BSA and 0,05 % Tween) were applied for one hour 
at RT. After three washing steps, 50 µl diluted samples (1:2 in assay buffer), 50 µl standard 
(highest concentration 500 pg/ ml) and 25 µl HRP (1:1000) conjugate were added 
simultaneously for two hours at RT. Subsequently, the plate was washed three times and the 
substrate (BD OptEIA Substrate Reagent A and B) was added. The color reaction was stopped 
with 2 M H2SO4 and color intensity was measured at 450 and 570 nm. 
 
2.2.4.3. 8-OHG EIA ELISA 
The amount of 8-Hydroxy-2-deoxy-guanosine (8-OHG) incorporated in DNA samples was 
quantified using the competitive 8-OHG EIA ELISA from Streß Marq Biosciences (Victoria). The 
kit is based on the principle that 8-OHG of a DNA sample competes with a tracer consisting of 
an 8-OHG-Acetylcholinesterase (AChE) conjugate for the binding to a limited 8-OHG antibody. 
Since the concentration of the tracer is kept constant, the amount of the tracer bound to the 
antibody is inversely proportional to the amount of 8-OHG being present in the DNA sample. The 
ELISA plate is coated with a polyclonal goat anti-mouse IgG antibody to which the 8-OHG-
antibody complex binds. After washing away unbound reagents, Ellmann´s reagent is added that 
contains acetylthiocholine and 5,5’-Dithio-bis 2- nitrobenzoic acid. The acetylcholinesterase of 
the tracer hydrolyzes acetylthiocholine to thiocholine which then reacts with 5,5’-Dithio-bis-2-
nitrobenzoic acid to 5-Thio-2-nitrobenzoic acid. This product has a yellow color and an 
absorbance maximum at 412 nm. The color intensity is proportional to the amount of ELISA 
plated- bound 8-OHG tracer and inversely proportional to the amount of free 8-OHG of the 
analyzed DNA sample.  
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According to the user manual, DNA samples were first digested using nuclease P1 to hydrolyze 
3’-5’ phosphodiester and monoester bonds. After dephosphorylation with alkaline phosphatase, 
50 µl of the sample and a standard row starting with 3 ng/ ml were applied to the pre-coated 
ELISA plate. Additionally, 50 µl tracer and 50 µl monoclonal 8-OHG antibody were added. To 
measure non-specific binding (NSB), only 50 µl 8-OHG-Tracer and 100 µl buffer were added to 
two wells. To determine the maximal amount of tracer that can be bound by the antibody (B0), 
two wells were filled with 50 µl tracer, 50 µl monoclonal 8-OHG antibody and 50 µl buffer. In 
addition, two blank controls were made (Blk). After 20 hours at 4°C, the ELISA plate was 
washed five times and subsequently 200 'l Ellmann´s reagent was added. Regularly the 
absorption at 410 nm was measured, and as soon as the B0 control minus background was 
between 0,3 and 1,0 the absorption of the samples was measured. For analysis, the absorption 
value of the Blk control was subtracted from the samples. Next, the NSB value was subtracted 
from the B0 control (= corrected B0) and the samples. Then the sample values were divided by 
the corrected B0 and multiplied by 100 to give the ratio of sample to B0 control (% B/B0). The 
data of the standard were linearized using a logit transformation (logit (B/B0) = ln [B/B0/(1 - 
B/B0)]). Logit (B/B0) data were plotted versus log concentrations and a linear regression fit was 
performed. The concentration of each sample was finally determined using the equation 
obtained from the standard curve plot.  
 
2.2.5. Molecular Methods 
 
2.2.5.1. Polymerase Chain Reaction  
Polymerase Chain Reaction (PCR) is a method to amplify a piece of DNA. It relies on thermal 
cycles consisting of repeated heating and cooling to melt the DNA double strands and to allow 
enzymatic amplification. To target the DNA fragment of interest, short DNA oligonucleotides 
(primers) being complementary to the DNA sequence are used. The method is called chain 
reaction since the DNA generated in the previous cycle is used as a template for replication in 
the next one, allowing the DNA to be exponentially amplified by an enzyme called DNA 
polymerase. The first regular cycling event is a denaturation step in which the double stranded 
(ds) DNA is separated into single strands. To allow the annealing of the primers to their 
complementary sequence, the temperature is then lowered to ~50- 60°C. Subsequently, the 
temperature is raised to ~70°C so that the DNA polymerase can bind to the priming site and 
build up a new DNA strand in 5' to 3' direction, which is complementary to the DNA template 
strand. These temperature steps are usually repeated 20-40 times. After the last cycle, the 
reaction is kept at ~ 70°C for five minutes to make sure that all DNA strands are fully extended.  
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2.2.5.2. Generation Of Biotinylated GFP Via PCR 
To pull down DNA-binding proteins, DNA encoding biotinylated green fluorescent protein (GFP, 
full length) was generated via PCR. For one 50 µl reaction 1 µl template (0.5 ng DNA), 1 µl 
forward primer (10 µM), 1 µl reverse primer (10 µM), 1 µl dNTPs (10 mM), 5 µl 5 x Taq buffer, 
1.5 µl MgCl2 (50 mM) and 0.2 µl Taq polymerase were mixed and filled up to 50 µl with H2O 
(Ampuwa). The DNA was then amplified with a thermo cycler and the following program with 35 
cycles: 
94°C 05:00 
94°C 00:30 
60°C 00:30 
72°C 01:00 
72°C 10:00 
  8°C --:-- 
Table 2: PCR program for the generation of biotinylated GFP (35 cycles) 
 
2.2.5.3. Incorporation Of 8-OHG Into DNA  
Different amounts of 8-OH-dGTP (TriLink, San Diego (USA) were introduced into an arbitrary 
DNA sequence e.g. GFP by PCR. Afterwards, the PCR products were purified with the InnuPrep 
PCR pure kit from Analytik Jena to rule out that free 8-OH-dGTP was carried over. 
 
2.2.5.4. Purification Of PCR Products  
PCR products were purified with the innuPREP PCR pure kit from Analytik Jena according to the 
user’s manual. Shortly, binding buffer was added to the PCR product and the mixture was given 
onto a purification column on which the DNA binds to. After a washing step, the DNA was eluted 
in an appropriate amount of Ampuwa H2O.For further concentrating the DNA, a precipitation with 
Ethanol and Sodiumacetate was done. For that, 2/3 volume 100 % Ethanol and 1/10 volume 3 M 
Sodiumacetate was added to the DNA. The mixture was incubated for five minutes at -80°C and 
subsequently centrifuged for 15 minutes with maximal speed at 4°C.The pellet was washed with 
500 µl 70 % Ethanol and again centrifuged for five minutes. Finally, the pellet was dried at 37°C 
and taken up in Ampuwa H2O. 
 
2.2.5.5. RNA-Isolation From Cells 
For RNA isolation, 1 -5 x 107 cells were lysed in 1 ml RNA Magic (BioBudget) for five minutes at 
RT. Afterwards, 200 'l Chloroform were added and the samples were vortexed for 10 seconds. 
After an incubation on ice for five minutes and centrifugation at 12.000 x g and 4°C for five 
minutes, the samples were separated into three phases. The upper aqueous phase contained 
the RNA and was transferred into a new tube. Next, an equal amount of Isopropanol was added 
and the samples were incubated on ice for 15 minutes. Centrifugation for 10 minutes at 4°C and 
maximal speed resulted in a RNA pellet, which was then washed twice with 70 % Ethanol. RNA 
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was dissolved in with 32 'L RNase free H2O and digested with 4 'L DNaseI (1U/ 'l) and 4 'L 
DNaseI 10 x Buffer (Invitrogen) for 15 minutes at 37°C. 
 
2.2.5.6. cDNA Synthesis 
For cDNA synthesis, RNA was reverse-transcribed with RevertAid Reverse Transcriptase 
(Thermo Scientific) and oligo-dT Primer. The use of anchored oligo (dT) 18 primers ensured that 
full-length cDNA was generated only from RNAs containing a poly-A tail. 1 'g of total RNA was 
incubated with 1 'l anchored- oligo (dT) 18 primer for 10 minutes at 70°C. 4 'L 5 x First Strand 
Buffer, 1 'L dNTP mix (10mM) and 1 'L Moloney Murine Leukemia Virus Reverse Transcriptase 
(MMLV-RT) were added and the whole reaction was incubated at 42°C for one hour. Afterwards, 
80 'L H2O were added and 2ul of the cDNA mix was used for a 10 'l RT-PCR reaction. 
 
2.2.5.7. Quantitative Real Time PCR  
Gene expression levels were measured using the my-Budget EvaGreen QPCR Mix II (Bio-
Budget) on an Applied Biosystems ABI 7900 HT (Life Technologies). EvaGreen or SYBR green 
is a fluorescent dye that intercalates into dsDNA. Thus, the detected fluorescence increases 
proportionally to the amount of DNA. The Ct (cycle threshold) or Cp (crossing point) value 
describes the cycle when the fluorescence emitted from a sample exceeds the background 
threshold. The quantity of DNA ideally doubles with every PCR cycle during the exponential 
phase which allows the calculation of relative amounts of DNA, e.g. if the Cp values of two 
samples differ by 3, the amount of template DNA differs by 23 = 8 fold. However, often the 
efficiency of the chosen primer pair is not 100 %. Efficiency can be calculated with the help of a 
standard curve that results form a qPCR run with a cDNA dilution series. The logarithm of the 
input cDNA amount is plotted against the Ct values, which results in a linear regression curve 
with the slope –m. A slope of -3,32 results in an efficiency of 1 (100 %), meaning that the DNA 
doubles each PCR cycle. The efficiency is calculated with the following equation:  
E = (10-1/ -m -1) x 100 
To accurately compare gene expression independent of variations due to the preparation and 
quality of DNA between different samples, the gene of interest (GOI) was normalized to a 
housekeeping gene (beta- actin) of the same sample with delta Ct = Ct (GOI) – Ct (beta-actin). If 
samples were compared to an untreated control, data analysis was performed according to the 
Pfaffl model for relative quantification in RT-PCR, which considers the efficiency of each primer 
pair used: 
ratio = (E target) &Ct target (control – treated) / (E ref) &Ct ref (control – treated) 
 
2.2.5.8. In-vitro Transcription Of 3pRNA 
5’ triphosphate double stranded RNA (3pRNA) is a synthetic ligand for RIG-I and was often used 
as positive control in stimulation experiments. The enzyme T7-RNA polymerase, which 
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synthesizes RNA in 5’- 3’ direction, was used to transcribe 3pRNA. This enzyme needs a 
template with the complement sequence of the desired RNA and a ds T7 polymerase promoter. 
To generate this template, two ODNs were heated up to 70°C for five minutes and then slowly 
cooled to RT. Afterwards, the template was incubated with Klenow buffer, dNTPs and 
polymerase I for 30 minutes at 37°C. The Klenow reaction was stopped at 70°C for 10 minutes, 
and RNA synthesis was then performed with the help of the transcriptAid T7 high yield 
Transcription Kit (Thermo Scientific). Shortly, nucleotides, enzyme mix (recombinant T7 
polymerase), the according buffer and DTT (Dithiothreitol) were added to the Klenow reaction 
and incubated overnight at 37°C. Afterwards, DNase I was used to digest the DNA template, 
and the 3pRNA was adjusted to 1 µg/ µl and stored at -80°C until use. 
 
2.2.5.9. Isolation Of Genomic DNA 
To extract total genomic DNA out of cells, 5 x 106 cells were washed with 1 x PBS and 
centrifuged for five minutes with 1200 rcf and 4°C. The cell pellet was then taken up in 500 µl 
Tail-Puffer plus 2,5 µl Proteinase K (20 µg/ µl) and incubated for at least two hours at 55°C and 
800 rpm. Afterwards, 500 'l Phenol/Chloroform (mixed 1:1) were added and the samples were 
centrifuged for 10 minutes with 14000 x g at RT. The aqueous phase containing the DNA was 
transferred into a new tube and twice as much volume 100 % Ethanol was added. The mixture 
was centrifuged for two minutes with 14000 x g to pellet the DNA, which was then washed with 1 
ml 70 % Ethanol and subsequently dried at 37°C before taking up in H2O or PBS. 
 
2.2.5.10. Determining the Concentration of Nucleic Acids 
The concentration of nucleic acids was determined with the help of a Nanodrop 1000 
Spectrophotometer which measures the optical density at ( = 260 nm, the absorption peak of 
nucleic acids. 47 µg/ ml DNA, respectively 40 µg/ ml RNA equate an OD260 of 1, meaning that 
the extinction coefficient of DNA is 47 and 40 for RNA. The values are inserted into the Beer-
Lambert equation:  c = A/(E x b) with c being the nucleic acid concentration, A the absorbance, e 
the extinction coefficient and b the path length. To get information about the purity of the 
samples, the Nanodrop measures additionally the optical density at ( = 280 nm, which is the 
absorption maximum of proteins. The ratio of OD260/OD280 equals 1,8 if the sample only 
contains DNA and 2,0 if only RNA is included. Values below 1,8 are a sign of contaminations 
with proteins. 
 
2.2.6. Protein biochemistry 
 
2.2.6.1. Polyacrylamide Gel Electrophoresis  
Polyacrylamide gel electrophoresis is a method used for the separation of proteins according to 
their size. The principle behind this method is similar to that of an agarose gel electrophoresis. 
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The protein samples are mixed with sodium dodecyl sulfate (SDS), which denatures secondary 
and tertiary structures, and additionally applies a negative charge to each protein in proportion to 
its mass. Then, the samples are loaded onto a polyacrylamide gel and an electric field causes 
the movement of the negatively charged molecules towards the anode. Thereby, small 
molecules move faster than longer ones due to a smaller resistance of the gel. Thus, one can 
separate proteins according to their size. For tracking the progress of the proteins through the 
gel, a tracking dye is added which has a higher electrophoretic mobility. The gels are made up of 
acrylamide, bisacrylamide, SDS and Tris buffer (pH 8,8; respectively pH 6,8). A source of free 
radicals (APS) and a radical stabilizer (TEMED) initiate polymerization. This reaction leads to a 
gel since bisacrylamide can cross-link two polyacrylamide molecules. Changing the acrylamide 
concentration can vary the pore size. Generally, lower percentage gels are used to resolve high 
molecular weight proteins, while higher percentages are used for smaller proteins. For 
polyacrylamide gel electrophoresis the vertical electrophoresis system from C.B.S (80 x 85 x 
0,75 mm) was used. The concentration of the collection gel was 3 % and its height 
approximately 2 cm. The separation gel had a concentration of 10-12 % and a height of 
approximately 6 cm. Samples were mixed 1:1 with 1 x Laemmli buffer, dynabeads used for 
pulldowns were eluted in 20 'l 1 x Laemmlli buffer. Heating for five minutes at 95°C denatured 
the proteins, and after cooling to RT, the samples were loaded in the pockets of the gel. For 
electrophoresis, 100 Volts (V) were applied for two hours.  
 
2.2.6.2. Bacterial Expression Of TREX1 And cGAS 
Primers for overexpression were designed such that they comprise the whole coding sequence 
(CDS) of the gene of interest. Additionally, the forward primer contained a Kozak sequence with 
the consensus gccRccAUGg, with R being a purine base and AUG the start codon. This 
sequence is recognized by the ribosome as the translational start site. If the protein to be 
overexpressed should contain a Flag-Tag the reverse primer did not comprise a stop codon, and 
the gene was cloned into a pET derivative with N-Terminal His6-Flag-Tag. 
Molecular cloning of TREX1 and cGAS was performed by Thomas Zillinger. Shortly, the TREX1 
open reading frame (ORF) was amplified from murine genomic DNA and cloned into a pET 
derivative with N-terminal His6-Tag and C-terminal FLAG-tag. For lentiviral expression, TREX1 
was cloned into pLenti-EF1-MCS, kindly provided by Jonas Doerr (Institute of Reconstructive 
Neurobiology, University of Bonn). After positive verification by Sanger Sequencing (Seqlab, 
Göttingen, D), TREX1 protein expression was induced by Isopropyl-#-D-thiogalactopyranosid 
(IPTG) in E. coli and purified using Ni-NTA Agarose (Life Technologies, Darmstadt, D). The 
cGAS ORF was amplified from Open Biosystems Clone #BC145653 and cloned into a pET 
derivative with N-Terminal His6-Flag-Tag. Bacterial expression was performed as described for 
TREX1 and the eluted fraction was dialyzed against PBS before use.  
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2.2.6.3. Purification Of Proteins 
The purification of overexpressed proteins was performed with the Ni!NTA purification system 
from Invitrogen. Therefore, IPTG (final concentration 0.1 mM) was used to induce the expression 
in the E. coli strain Rosetta (DE3). After three hours, the bacteria were washed with 0,9 % NaCl, 
taken up in 10 ml Binding Buffer (20 mM Tris!HCl pH 7.9, 500 mM NaCl, 2 mM Imidazole, 
Protease Inhibitor) and sonicated for four minutes. To remove cellular debris, the lysate was 
centrifuged for 10 minutes at max speed (>12000 x g) and 4°C. 1 ml of Ni-!NTA resin was 
washed twice with Binding Buffer, taken up in 10 ml Binding Buffer and mixed with the cleared 
lysate. After one hour incubation under rotation at 4°C, the resin was washed twice with 8 ml of 
Wash Buffer (20 mM Tris!HCl pH 7.9, 500 mM NaCl, 20 mM Imidazole) and finally eluted with 2 
ml Elution Buffer (20 mM Tris!HCl pH 7.9, 500 mM NaCl, 250 mM Imidazole). The purification 
procedure was analyzed with SDS-polyacrylamide gel electrophoresis (PAGE) and coomassie 
staining. 
 
2.2.6.4. cGAS DNA Pulldown Assay 
A pull-down assay is a method to identify interaction partners of a bait molecule. It can be 
compared to immunoprecipitation, even though the antibody is substituted by some other affinity 
system. In this case, biotinylated DNA was used to catch the DNA-binding protein cGAS in a cell 
free system. The DNA-protein complexes were fished out with the help of Streptavidin-coated 
Dynabeads. 
1 'g of a biotinylated PCR product, either untreated or UV-C irradiated, was incubated for one 
hour at 4°C in 500 'l PBS, Proteinase inhibitor (Roche Complete Mini-EDTA free) and 0,5 % 
Bovine serum albumin (BSA) spiked with cGAS containing an N-terminal Flag-Tag extracted 
from bacteria (1:250). 10 'l Streptavidin Dynabeads MyOneT1 (Invitrogen) were then added to 
the mixture and further incubated for two hours at 4°C. After three washing steps with PBS, the 
eluted proteins were analyzed by Western blot. To determine the size of the isolated protein the 
PAGE Ruler Prestained Protein ladder from Piercenet was used. 
 
2.2.6.5. Western Blot  
Western blotting can be applied after a polyacrylamide gel electrophoresis to detect specific 
proteins from a heterogeneous sample. For this purpose, the proteins are transferred from the 
gel to a membrane (typically nylon, polyvinylidene difluoride or nitrocellulose). Thereby, the 
protein pattern is maintained. Protein binding is based upon hydrophobic interactions and 
charged interactions between the membrane and protein. Afterwards, the proteins can be 
detected by using antibodies linked to a reporter enzyme. When an appropriate substrate is 
added, the light of a colorimetric reaction causes an image on a photographic film.  
In the Barchet laboratory, wet blots were performed. The membrane was put on top of the gel, 
and whatman papers were placed on top and underneath of that. The entire stack was then 
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placed in a buffer solution and by applying voltage vertically to the running direction of the gel 
the proteins moved out of the gel and onto the membrane. To prevent unspecific binding of the 
antibody, the membrane was incubated in a 0,5 % milk solution. The proteins in the solution 
occupy all places on the membrane where the proteins from the gel have not bound. Thus, the 
antibody can only bind to the binding sites of the specific target protein and not to unspecific 
binding sites of the membrane. After blocking, the proteins of interest were labeled with an 
antibody. Thereby, either a combination of a primary and secondary antibody-horseradish 
peroxidase (HRP) conjugate was used, or an antibody directly linked to HRP. For detection, 
Pierce's Enhanced Chemiluminescent (ECL) Western Blotting Substrate was added which is a 
luminal based chemiluminescent substrate for the detection of HRP enzyme activity. It produces 
luminescence in proportion to the amount of protein. A photographic film was then placed onto 
the membrane, and exposure to the light from the reaction generated an image of the antibody-
labeled protein of interest. 
 
2.2.6.6. SybrGreen-based DNase I, II And III Activity Assay  
The protocol used was adapted from Brucet, Querol-Audı et al. (2007). 1 'g genomic DNA, 
respectively 2 'g of a 200 bp PCR product (GFP-200), were preincubated with SYBR Safe 
(Invitrogen) for 30 minutes at RT to allow the SYBR Green to incorporate into the DNA. The 
assay was performed in a 96-well plate in a final volume of 15 'l with 20 mM Tris-HCl, pH 7.5, 5 
mM MgCl2, 2 mM dithiothreitol (DTT), and 100 'g/ ml BSA for DNase I and III, or 80 mM sodium 
acetate buffer with 25 mM MgCl2, pH 4.6 for DNase II. To start the reactions simultaneously, 1 
unit DNase I (Sigma) or DNase II from bovine spleen (Sigma), respectively 1 'l of purified 
TREX1, were added to the wall of each well. After centrifugation, the degradation was real time 
followed with the Roche LightCycler® 480 Real-Time PCR System.  
 
2.2.6.7. Fluorescence Activated Cell Sorting  
Fluorescence activated cell sorting (FACS) is based on the labeling of specific cell surface 
molecules with antibodies that are fused to fluorescent dyes. Within the flow cytometer, the cell 
suspension enters a fast flowing liquid stream onto which a laser beam of a single wavelength is 
directed. Each cell that crosses the laser beam scatters the light ray and the fluorescent dyes 
are excited to emit light at different wavelengths. At the point where the cells pass the laser 
beam, a forward scatter (FSC), a side scatter (SSC) and several fluorescent detectors are 
located. The FSC correlates with the cell size and the SSC informs about the cell interior like 
nucleus dimension, the amount and type of cytoplasmic granules or the texture of the cell 
membrane. 
To stain cells with fluorescently labeled antibodies at least 2 x 105 cells were first blocked with 
10 % FCS in PBS (human cells) or anti-mouse CD16/CD32 (1:100 in FACS buffer) (murine 
cells) for 20 minutes at 4°C and then incubated with adequate antibody master mixes for 30 
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minutes at 4°C. Subsequently, cells were washed with FACS buffer and resuspended in 50 'L. 
FACS was executed with the BD LSR II flow cytometer, whereas cell sorting was performed with 
the BD FACSAriaTM III at the flow cytometry core facility in the institute of molecular medicine, 
Bonn. 
FACS analysis was performed with the FACS DiVa Software, while the evaluation was done with 
the Flowjo Software. For discriminating cell populations from each other and to exclude cell 
debris, the FCS was plotted against the SSC and the population of interested was gated. For 
evaluation of single markers a histogram was made to get the percentage of cells being positive 
for a specific marker. Expression of multiple markers was investigated with dot plots using 
quadrant statistic by calculating the percentage of positive cells. To determine positive cells, 
stringent gating criteria were used and gates for positive cells were set with reference to the 
unstained control at the 1 % border. 
 
2.2.6.8. Detection Of Cellular ROS And Superoxide Content In DNA 
For the measurement of reactive oxygen species (ROS) and superoxide in UV irradiated cells, 
the Total ROS/Superoxide Detection Kit (Enzo Life Sciences, Lörrach) was used according to 
the manufacturer’s protocol. After staining with the green fluorescent oxidative stress detection 
reagent and the orange fluorescent superoxide detection reagent, cells were immediately 
irradiated with different doses of UV light, then incubated for 30 minutes at 37°C and analyzed 
by FACS. 
 
2.2.7. In Vivo Experiments  
200 'g genomic DNA, either unmodified or UV irradiated, was administered i.v. and after four, 
six or eight hours blood was taken to analyze the serum type I IFN by ELISA. Additionally, 
splenocytes were individualized by incubation in Collagenase D for 10 minutes at 37°C followed 
by filtration with 150 'm gaze, and analyzed by FACS or RT-PCR. For the analysis of DNA 
uptaking cells, UV irradiated DNA was stained with Sytox Green (10 'M) for 15 minutes at RT 
before injection. Alternatively, mice were administered i.c. to the earlobes every third day with 10 
'g untreated or UV irradiated genomic DNA, or with PBS (Mock). Ear thickness was determined 
24 hours after the last injection.  
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3. Results 
 
3.1. Increased ROS Levels After UV-A/-B/-C Irradiation Correlate With Enhanced Immune 
Stimulatory Properties Of DNA 
UV irradiation can influence health in many ways. A certain level of UV-B exposure is required 
for vitamin D3 metabolism and calcium homeostasis. In addition, both UV-A and UV-B 
phototherapy are part of the treatment regimen of certain skin diseases, such as psoriasis, 
dermatitis and vitiligo. Nonetheless, prolonged UV exposure can result in sunburn and 
premature skin aging. Furthermore, it is also associated with several forms of skin cancer. These 
harmful effects of UV light are usually attributed to the suppression of immunity. However, under 
certain circumstances UV exposure can also lead to an activation of the immune system.  
Previous experiments in the Barchet laboratory revealed that co-cultures of bone marrow 
derived dendritic cells (bmDCs) with UV irradiated cells lead to a reduced release of pro-
inflammatory cytokines such as IL-6, IFN-" and IL12p40. In contrast to these co-culture 
experiments, stimulation of bmDCs with DNA isolated from UV irradiated cells resulted in an 
increased immune response compared to stimulation with DNA from untreated cells.  
UV light can cause DNA damage both directly by photocrosslinking and the generation of DNA 
base dimers, and indirectly through the generation of Reactive Oxygen Species (ROS). To test 
whether cells show elevated ROS levels upon UV irradiation and whether this correlates with 
immune stimulation, RMA cells were incubated with a ROS detection reagent (Enzo Life 
Sciences) and exposed to different doses of UV-A, UV-B or UV-C light. After an incubation at 
37°C for 30 minutes, the relative cellular ROS production was determined by flow cytometry. 
Simultaneously, DNA was isolated from the irradiated cells, complexed with the TransIT-LT1 
Transfection Reagent (Mirus) and used to stimulate murine bmDCs.  
As depicted in Figure 7 A, a UV dose-dependent increase in cellular ROS was observed shortly 
after UV irradiation. Moreover, these increased ROS levels were closely correlated with the 
immune stimulatory property of the DNA, here shown by the induction of IFN-" secretion. Of 
note, IFN-" levels were increased irrespective of whether the cells were irradiated with UV-A, 
UV-B or UV-C light prior to DNA isolation (Figure 7 B).  
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Figure 7: UV irradiation leads to increased intracellular ROS levels which correlate with increased DNA 
immunogenicity 
RMA cells were incubated with a ROS detection reagent (Enzo Life Science) and exposed to UV-A, -B or -C light at 
the doses indicated. After 30 min, relative cellular ROS production was determined by flow cytometry. Data shown are 
representative of two independent experiments (A). 2 x 105 WT bmDCs were stimulated with 400 ng DNA derived 
from cells that were exposed to different UV-A, -B or -C light doses. Stimulations with 200 ng poly(I:C) and poly(dAdT) 
were used as positive controls. After 18-24 h, IFN-! was measured in the supernatants via ELISA. Data shown are 
representative of two independent experiments. Shown are means +SDM (B). 
 
3.2. UV Irradiation Only Enhances The Immunogenic Potential Of DNA 
It was initially observed that both RNA and DNA isolated from UV irradiated cells were more 
immunogenic than when isolated from untreated cells. To further test whether UV irradiation 
really increases the immunostimulatory potential of RNA, RMA cells were either left untreated or 
UV-C irradiated with the doses indicated. Subsequently, RNA was isolated and digested with 
either DNase I or RNase A. Murine bmDCs were stimulated with 400 ng RNA complexed with 
transit LT1 (Mirus), a transfection reagent that delivers nucleic acids predominantly to the 
cytosol. After 18 hours, mIFN-! was measured in the supernatants via ELISA. As shown in 
Figure 8 A, stimulation with RNA that was not DNase I treated led to a substantial amount of 
type I IFN, which increased further when cells were irradiated with UV light prior to RNA 
isolation. However, in the RNA samples digested with DNase I, the type I IFN response was 
completely abrogated. In contrast, RNase A treatment had no significant influence on the type I 
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IFN response in comparison with the undigested RNA samples. These results were also 
observed when DNA isolated from untreated or UV irradiated cells was digested with either 
DNase I or RNase A (Figure 8 B). Thus, one can conclude that UV irradiation only enhances the 
stimulatory potential of DNA, but not of RNA. The enhanced activity observed after RNA 
isolation was due to contaminating DNA, and could be eliminated by treating RNA isolations with 
RNase free DNase I.  
 
Figure 8: RNA or DNA samples from UV irradiated cells lose their immunostimulatory capacity after DNase I 
treatment 
RNA (A) or DNA (B) was isolated from either untreated or UV irradiated RMA cells and digested with DNase I or 
RNase A for 30 min at 37°C. 2 x 105 bmDCs were stimulated with 400 ng RNA/ DNA complexed with TransIT-LT1 
(Mirus). 18 h later, IFN-! was measured in the supernatants via ELISA. This figure is representative of three 
independent experiments. Shown are means +SDM. 
 
3.3. DNA Double-strand Breaks Are Not The Reason For The Increased Immunogenicity 
Of Cell-free UV Irradiated DNA 
Previous experiments in the Barchet laboratory revealed that not only DNA isolated from UV 
irradiated cells, but also DNA that was directly UV irradiated in a cell-free system is more 
immunogenic than unmodified DNA. Thus, DNA fragmentation as part of the apoptotic process 
could be ruled out to play a role in the immunogenicity of UV-DNA. However, UV light can 
induce double-strand breakage either directly by the absorption of UV photons by DNA, or 
indirectly during nucleotide excision repair following UV damage (Sancar et al., 2004). 
In the case of direct DNA irradiation, repair mechanisms that account for the majority of double-
strand breaks occurring after UV exposure must not be considered. However, those double-
strand breaks that are caused by a direct energy absorption could theoretically enhance the 
immunogenicity of UV irradiated DNA, since moderate fragmentation may facilitate the uptake of 
genomic DNA into immune cells.  
To verify if the observed differences in the immunostimulatory potential of untreated and UV 
irradiated DNA are dependent on the length of the transfected DNA strand, untreated and UV-C 
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irradiated genomic DNA were loaded onto an agarose gel (Figure 9 A). There was no difference 
between these two DNA samples visible. However, to make sure that smaller fragment size of 
UV-DNA has nothing to do with the observed immunogenicity, the restriction enzymes EcoRI 
and EcoRV were used to generate DNA fragments with an average length of 2000 base pairs 
(bp). Stimulation with the fragmented DNA did indeed lead to slightly higher type I IFN levels 
compared to uncut DNA. However, stimulation with the fragmented genomic DNA was not 
comparable to stimulation with UV irradiated DNA, and the relative increase in stimulation by UV 
irradiation remained unchanged. Thus, a differential uptake of shorter DNA fragments generated 
via double-strand breaks could be excluded as cause for the enhanced recognition of UV-
damaged DNA (Figure 9 B). 
 
Figure 9: DNA fractionation is not the reason for the immunogenicity of UV irradiated DNA 
Genomic DNA from RMA cells was isolated and either left untreated or UV-C irradiated with 250 mJ/ cm2. 
Subsequently 500 ng were loaded on a 1% agarose gel (A). Genomic DNA from RMA cells was either left untreated 
or fragmented with the restriction enzymes EcoRI and EcoRV for 16 h at 37°C. After UV-C irradiation at the doses 
indicated, the DNA was used to transfect murine bmDCs, and IFN-! was measured in the culture supernatants 18 h 
later via ELISA. This figure is representative of three independent experiment, shown are means +SDM; * P < 0.05 
(Student’s t-test). (B). 
 
3.4. UV Irradiated DNA Induces A Prolonged Upregulation Of Type I IFN 
To further characterize the enhanced recognition of UV irradiated DNA, the kinetics of type I IFN 
production following UV-DNA stimulation was analyzed. Following stimulation with either 
unmodified or UV irradiated DNA, supernatants were collected four, five, six, seven, eight or 24 
hours after stimulation. IFN-" levels were quantified using ELISA, and detectable levels of the 
pro-inflammatory cytokine could be observed as soon as five hours after stimulation. Six hours 
after stimulation, a significant difference in the response to unmodified and UV irradiated DNA 
was measurable (Figure 10 A). These results indicate a fast upregulation and secretion of IFN-" 
in response to oxidatively modified DNA. Next, the time kinetics were analyzed by real-time 
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quantitative polymerase chain reaction (RT-PCR) following in vitro stimulation of bmDCs with 
unmodified and UV irradiated DNA. As shown in figure 10 B, IFN-" induction was observed 
within the first two hours after stimulation. For unmodified DNA, maximum transcript 
accumulation was obtained three hours after stimulation, followed by a rapid decrease in 
expression. In contrast, the response to UV irradiated DNA was several times greater than the 
response to unmodified DNA and reached its maximum after four hours of stimulation, followed 
by a moderate downregulation up to baseline expression levels. These results showed that cells 
react to UV irradiated DNA with cytokine expression that is not only increased but also 
prolonged, suggesting that oxidatively damaged DNA might remain in the cytosol for a longer 
duration than unmodified DNA.  
 
Figure 10: The kinetics of the type I IFN response to unmodified and UV irradiated DNA 
2 x 10 5 bmDCs were stimulated with 400 ng genomic DNA that was either left untreated or UV irradiated with the 
doses indicated and secretion of mIFN-! was quantified in the culture supernatants at the indicated time points after 
stimulation. Shown are means +SDM; * P < 0.05 (Student’s t-test). (A). Alternatively, RNA was reverse transcribed 
after 1–6 and 24 h, and subsequently analyzed by qPCR (B). The data are representative of three independent 
experiments. 
 
3.5. DNA Stimulus And UV Damage Signal Can Be Separated Temporally And Spatially 
Our initial observation took place before the identification of cGAS as the cytosolic DNA-receptor 
upstream of STING. Since it was then unknown how cytosolic DNA is recognized in general, it 
could not be excluded that a second distinct pathway might participate in UV-DNA recognition. 
To analyze whether a second synergistic pathway might be involved in the immune response to 
UV-DNA, co-transfection experiments were carried out with unmodified genomic DNA and an 
UV irradiated dsDNA oligonucleotide composed of the repetitive base triplets ATA / TAT, which 
is only weakly immunogenic by itself. Furthermore, it was analyzed whether an enhanced type I 
IFN response could still be observed if the UV irradiated oligonucleotide was first added two, 
four or six hours after the stimulation with genomic DNA (Figure 11). As expected, stimulation 
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with the unmodified as well as with the UV irradiated ATA oligonucleotide only induced low 
levels of IFN-!, while upon stimulation with genomic DNA substantial levels of IFN-! could be 
measured in the supernatant. Genomic DNA in combination with the unmodified oligonucleotide 
caused only a weak increase in type I IFN levels in comparison to stimulation with genomic DNA 
alone. However, genomic DNA together with the UV irradiated oligonucleotide led to significantly 
higher IFN-! levels. This was also true if the oligonucleotide was added to the cells two or four 
hours after genomic DNA stimulation. Even if the UV irradiated oligonucleotide was added six 
hours after genomic DNA stimulation, type I IFN levels were still increased, although to lesser 
extent. These results suggested that possibly two pathways could be interacting, one for DNA 
recognition and the other being specific for DNA base modifications.  
 
Figure 11: Co-stimulation with genomic DNA and an UV irradiated double stranded oligonucleotide induces 
enhanced IFN-! production in murine bmDCs 
Murine bmDCs were co-transfected with genomic DNA and a 54 bp ds ATA-oligonucleotide that was either left 
untreated or UV-C irradiated with 100 or 250 mJ/cm2. The ATA oligonucleotide was either added directly to the 
genomic DNA or added to the cells 2, 4, or 6 h after the cells were stimulated with genomic DNA. Stimulation with 
genomic DNA, the untreated or UV irradiated ATA oligonucleotide alone was carried out as a control. All nucleic acids 
were complexed with TransIt-LT (Mirus). 18 h later, IFN-! was measured in the supernatant via ELISA. The data 
shown are representative of four independent experiments. Shown are means +SDM. 
 
3.6. Using Inhibitors That Target Different Signal Transducers Or Regulators To Identify 
Signal Pathways Involved In The Enhanced Recognition of UV-DNA 
In order to identify a potential second pathway involved in the response to UV irradiated DNA, 
the influence of different inhibitors prior to DNA stimulation was tested. Previous experiments in 
the Barchet laboratory had already excluded a role for phosphoinositid-3 kinase (PI3K), protein 
kinase C (PKC), spleen tyrosine kinase (Syk), Vav1 guanine nucleotide exchange factor, janus 
kinase 3 (JAK3), nuclear factor of activated T cells (NFAT), nuclear factor 'kappa-light-chain-
enhancer' of activated B-cells (NFkB) and Signal Transducer or Activator of Transcription 5 
(Stat5) in the improved recognition of UV-DNA. However, promising results were observed when 
the well-established mitogen-activated protein kinase (MAPK) p38 inhibitor SB202190 (Sigma) 
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was applied prior to DNA stimulation in bmDCs. Preincubation with low doses of SB202190, led 
to a reduced IFN response to UV irradiated DNA, while cytokine production was unhindered 
upon stimulation with unmodified DNA or poly(I:C) (data not shown). These results indicated that 
p38 might have a specific involvement in the cytosolic recognition of UV irradiated DNA. 
However, in human monocytes no effect for SB202190 could be observed. Thus, a second p38 
inhibitor (SB203580, Sigma) was tested and experiments with the initially used p38 inhibitor, 
SB202190, were repeated. As shown in figure 12 A and B, a role for p38 in the improved 
recognition of UV irradiated DNA could not be confirmed since p38 inhibition globally reduced 
the type I IFN response. With increasing inhibitor concentrations the induction of IFN-" following 
DNA, UV-DNA and poly(I:C) stimulation was inhibited due to toxicity of the inhibitors which 
decreased cell viability (assessed with cell titer blue, data not shown).  
UV induced DNA damage can be repaired by a variety of intracellular DNA repair mechanisms. 
However, the involvement of DNA-dependent protein kinase (DNA-PK) involved in base excision 
repair (BER), or ataxia-telangiectasia mutated kinase (ATM), a key mediator of DNA damage 
response (DDR), in the immune sensing had already been excluded by previous experiments 
performed within the Barchet group (data not shown). To investigate whether other proteins 
involved in DNA damage repair might be important for the recognition of UV-DNA, different 
inhibitors of polymerase 1 (PARP-1), a protein involved in non-homologous end joining (NHEJ), 
were tested (Figure 12 C). In this experiments, the highest inhibitor concentrations not leading 
to decreased cell viability were used (tested by cell titer blue assay). There was however no 
indication for an involvement of PARP-1 in enhanced immune sensing of UV irradiated DNA.  
Next, the nucleotide exchange repair (NER) mechanism was blocked in the stimulated cells prior 
to DNA transfection. Specifically, xeroderma pigmentosum A (XPA), which is part of the NER 
complex, was inhibited by titrated doses of X80. As depicted in Figure 12 D, there was no 
specific inhibition of IFN-" secretion in response to UV-DNA visible, instead the DNA response 
was unchanged, while the immune reaction to poly(I:C) was slightly reduced with high inhibitor 
concentrations. These results suggested that NER, or at least XPA, is not involved in the 
recognition of UV-DNA. In addition, p53 was blocked with two different inhibitors (Figure 12 E 
and F). Nutlin-3 had no effect on the immune response to UV-DNA, while there was a specific 
reduction of the type I IFN secretion in response to UV irradiated DNA visible at low inhibitor 
concentrations of Pifithrin-mu. However, higher doses of this inhibitor did not further decrease 
IFN-" levels. Taken together, the involvement of DNA damage repair proteins in enhanced 
immune sensing of UV-DNA could be excluded. 
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Figure 12: Blocking of p38 or different DNA damage signaling pathways does not impair the immune 
detection of UV irradiated DNA 
Murine bmDCs were pre-treated with the p38 inhibitors SB202190 (A) and SB203580 (B) or different inhibitors 
blocking key proteins involved in base excision repair (C), nucleotide excision repair (D) or DNA damage repair (E and 
F). After 1h, cells were washed and subsequently stimulated with unmodified or UV irradiated genomic DNA. After 18 
h, mIFN-! was measured in the supernatants via ELISA. Stimulation with poly(I:C) served as control. These data are 
representative of three independent experiments.  
 
3.7. The Cytosolic DNA Receptor cGAS Recognizes Unmodified And UV Irradiated DNA In 
Equal Measure 
Knockdown experiments in the Barchet laboratory demonstrated that UV-DNA is recognized by 
the cytosolic DNA receptor cyclic GMP-AMP (cGAMP) synthase (cGAS). Upon DNA binding, 
cGAS produces the second messenger cGAMP, which then binds to STING and activates the 
STING-TBK1-IRF3 signaling axis, finally resulting in the production of type I IFNs (Wu et al., 
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2013; Sun et al., 2013). Since knocking down cGAS abolished the pro-inflammatory response to 
both untreated and UV irradiated DNA (data not shown), another hypothesis to explain the 
enhanced immunostimulatory activity of UV irradiated DNA was that the cytosolic receptor cGAS 
might have a higher affinity for UV-DNA compared to unmodified DNA. To test this, a pulldown 
experiment with cGAS and equal amounts of either untreated or UV irradiated DNA was 
performed in vitro. Biotinylated PCR products served as DNA probe and were incubated for one 
hour with recombinant Flag-tagged cGAS. Subsequently, the PCR products were recaptured 
using Streptavidin-coated magnetic Dynabeads and cGAS binding was visualized by anti-Flag 
western blot. As shown in Figure 13, no binding differences of cGAS to unmodified and UV 
irradiated DNA was observed. Thus, a higher binding affinity of cGAS for UV-DNA could be 
excluded as a reason for the enhanced recognition of UV irradiated DNA. 
 
Figure 13: Comparable cGAS affinity of unmodified and UV irradiated DNA 
Biotinylated PCR products were either left untreated or UV-C irradiated with 250 mJ/cm2, and subsequently incubated 
for 1 h with recombinant cGAS-Flag. DNA was recaptured using Streptavidin-coated magnetic Dynabeads T1 for 2 h. 
cGAS binding to beads without DNA served as specificity control. cGAS was visualized by anti-Flag western blot 
analysis. Pulldown was performed three times. 
 
3.8. Oxidative Modifications Protect DNA From TREX1-mediated Degradation 
Another possibility for the enhanced activation of cGAS by UV-DNA is that UV exposure might 
induce modifications, which protect the DNA from degradation. There are three major 
deoxyribonucleases (DNases) known to catalyze the hydrolytic cleavage of phosphodiester 
linkages in the DNA backbone and thus degrade extranuclear DNA in different cellular 
compartments: DNAse I, which is found extracellularly; DNase II, which works best at acidic pH 
and is present in lysosomes; and DNase III (also known as TREX1) that is located in the cytosol. 
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DNase I and II are endonucleases that cleave anywhere along the DNA chain, while DNase III/ 
TREX1 belongs to the group of exonucleases that cleave only residues at the ends of DNA 
molecules. 
To test whether these DNases have difficulties degrading UV-DNA, genomic DNA that was 
either left untreated or UV irradiated, was digested in vitro with recombinant DNase I, II and III 
(Figure 14). To visualize the activity of the different DNases, DNA was stained with SybrGreen, 
which allowed following DNA degradation via corresponding fluorescence decay in real time. 
While the endonucleases DNase I and DNase II both demonstrated no significant difference in 
their ability to degrade unmodified and UV irradiated DNA (Figure 14 A and B), degradation of 
UV-DNA by the cytosolic exonuclease TREX1 was less efficient than degradation of unmodified 
DNA (Figure 14 C). These results were of particular interest, since UV irradiated DNA is 
recognized in the cytosol where also TREX1 is predominantly located. Previous experiments in 
the Barchet laboratory demonstrated that the incorporation of the oxidized base 8-hydroxy 
guanosine (8-OHG) was sufficient to increase the immune response of myeloid cells to PCR 
products (data not shown). To analyze whether the presence of 8-OHG is adequate to protect 
DNA from degradation by TREX1, PCR products containing 10% 8-OHG were analyzed for 
resistance to TREX1-mediated degradation (Figure 14 D). Incorporation of 8-OHG protected the 
PCR products from TREX1-mediated degradation, suggesting that the oxidized base is indeed 
sufficient to shield DNA from destruction. 
 
Figure 14: Unmodified and oxidized DNA is degraded similarly by DNase I and DNase II, but differentially by 
TREX1 
Recombinant DNase I (A), DNase II (B) or TREX1 (C and D) was added to genomic DNA (A, B and C) or PCR 
products (D) that were either left unmodified (UV 0), UV damaged (UV 250; A, B and C) or contained 10 % 8-OHG 
(D). DNA degradation was monitored over time as vanishing SYBR Green signal. The data shown are representative 
of three independent experiments. 
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3.9. TREX1 Knockout Cells React To All Types Of DNA With High Amounts Of Type I IFN 
The role of the exonuclease TREX1 is to digest cytosolic DNA in order to prevent an 
inappropriate immune response. To confirm that oxidative DNA modifications conferring 
resistance to TREX1-mediated degradation are responsible for elevated immune responses 
upon UV-DNA stimulation, bmDCs generated from the bone marrow of TREX1-deficient mice 
were stimulated with UV irradiated or ROS damaged genomic DNA (Figure 15 A) or PCR 
products (Figure 15 B). Murine bmDCs that did not express TREX1 demonstrated a high 
responsiveness to all sorts of the DNA tested, irrespective of whether these DNAs were 
unmodified or oxidatively damaged. In contrast, WT bmDCs with functional TREX1 responded 
with low amounts of IFN-" to unmodified DNA but retained their high level of responsiveness to 
oxidized DNA. Likewise, could be demonstrated that lentiviral overexpression of TREX1 in the 
mouse leukemic monocyte/ macrophage cell line RAW 264.7 restored increased responsiveness 
to oxidized DNA as compared to unmodified DNA (data not shown). Taken together, these 
results suggest that oxidative modifications shelter DNA from degradation and that modified self-
DNA can cause cytosolic immune activation even in the presence of TREX1. 
 
Figure 15: TREX1-deficient bmDCs do not differentiate between unmodified and oxidized DNA 
WT and TREX1-deficient bmDCs were stimulated with either unmodified and oxidized genomic DNA (A) or with 
unmodified or oxidized PCR products (B). Stimulations with pdAdT or 3pRNA were used as positive controls. After 18-
24 h, secretion of mouse FN-! in the supernatants was quantified via ELISA. These data are representative of four 
independent experiments. Shown are means +SDM; * P < 0.05 (Student’s t-test). 
 
3.10. Ear Swelling Reactions Of Different Knockout Mice To UV-DNA 
To investigate the inflammatory response to UV-DNA in vivo, unmodified or UV irradiated DNA 
were repeatedly injected into the ears of WT mice. 24 hours after the last intracutaneous (i.c.) 
administration, ear thickness was determined as measure of inflammation. The injection of 
unmodified DNA induced only marginal ear swelling, whereas a significant increase in ear 
thickness was observed after injection of UV-DNA (Figure 16). In vitro, it was shown that UV-
DNA is recognized by a TLR9-independent and cGAS/STING-dependent pathway (data not 
shown). Thus, the same ear swelling assay was also carried out in TLR9- or STING-deficient 
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mice (golden ticket mutation). TLR9-deficient mice displayed similar ear swelling reactions as 
WT mice (Figure 16 A), while STING-deficient mice showed a reduced ear swelling in response 
to injections of both unmodified and UV damaged DNA (Figure 16 B). These results showed 
that also in vivo STING dependent signaling mediated the enhanced recognition of UV-DNA. 
Additionally, the same ear swelling experiment was also carried out in TREX1-deficient mice. As 
expected, an equally potent ear swelling reaction to both unmodified and UV-DNA could be 
observed in TREX1-deficient mice (Figure 16 C), demonstrating that in the absence of TREX1 
accumulating DNA induces a strong immune response. 
 
Figure 16: The ear swelling response to UV-DNA in WT, TLR9-, STING- and TREX1- deficient mice 
10 'g untreated or UV irradiated DNA were administered i.c. to the earlobes of WT, TLR 9-/-, STING(gt/gt) and TREX1-/- 
mice every third day for a period of one week. 24 h after the last i.c. injection, ear thickness was determined using a 
caliper (each group n=4). Shown are means +SDM; * P < 0.05 (Student’s t-test). 
 
3.11. ROS Also Increase The Immune Response To Pathogenic DNA 
After determining the mechanism behind the increased immune response to oxidatively modified 
DNA, we wished to address in which physiological situations this phenomenon might be 
important. ROS is not only produced after UV exposure, but can also be actively generated by 
cells to kill pathogens. Phagocytic cells such as macrophages create hydrogen peroxide in 
phagosomes, and neutrophils release both peroxide and hypochlorite to damage microbes in 
their direct vicinity. During a respiratory or oxidative burst, up to four nanomoles of oxygen are 
converted to ROS per 106 cells each minute (Segal and Coade, 1978). Professional phagocytes 
make use of an enzyme called NADPH oxidase, which catalyzes the reaction of oxygen and 
Nicotinamide adenine dinucleotide phosphate (NADPH) to hyperoxide anions (O2-). Hyperoxid 
anions are highly reactive and can be processed to a series of other ROS, such as hydrogen 
peroxide (H2O2) generated by the enzyme superoxide dismutase (SOD). H2O2 can easily 
penetrate cell membranes and can be transformed into highly reactive hydroxyl radicals (·OH), 
which attack a multiplicity of molecules, such as lipids, proteins or DNA. In addition, another 
enzyme called myeloperoxidase can further process H2O2 and chloride ions into hypochlorous 
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acid (HOCl), which is even more reactive with a wide variety of biomolecules (Albrich et al., 
1981). 
To study the impact of oxidative damage on immune sensing of microbial DNA, bacterial DNA 
isolated from E. coli, and viral DNA isolated from the dsDNA viruses HSV-1 and adenovirus 
were incubated with different micromolar concentrations of hydrogen peroxide (H2O2) or 
hypochlorous acid (HOCl). In addition, pathogen DNA was also UV-C irradiated with 100 
mJ/cm2. After precipitation to remove free ROS, pathogen DNAs were transfected into murine 
bmDCs. ROS exposure as well as UV irradiation further increased cytosolic DNA recognition of 
both bacterial and viral DNA (Figure 17). Thus, ROS might be used in two ways to fight 
microbes: on the one hand pathogens are directly damaged and eventually killed by the 
oxidation of their biomolecules, and on the other hand ROS can tag microbial DNA for detection 
by either the same phagocyte that produced ROS in the first place or by surrounding immune 
cells that come to fight the infection. 
 
Figure 17: Oxidative damage of pathogenic DNA enhances cytosolic recognition by bmDCs 
Bacterial genomic DNA from E. coli (A/ D), and viral genomic DNA from HSV-1 (B/ E) or adenovirus (C/ F) were 
oxidatively damaged with hydrogen peroxide (H2O2) or hypochlorite (HOCl), or alternatively UV-C irradiated with 100 
mJ/cm2. After precipitation to remove ROS, DNAs were transfected into murine bmDCs. IFN-! secretion of bmDCs 
was measured in the supernatants after 18-24 h. These data are representative of three independent experiments, 
shown are means +SDM; * P < 0.05 (Student’s t-test). 
 
3.12. Neutrophil Extracellular Trap - DNA Induces A Stronger Immune Response Than 
Genomic Neutrophil DNA  
Recently, ROS were also found to play an important role in another mechanism to fight 
pathogens, namely the formation of neutrophil extracellular traps (NETs). NETs are composed of 
DNA, histones and many granular proteins, and are released to trap and kill invading pathogens 
at the site of infection (Brinkman et al., 2004). Since this defense mechanism was shown to be 
!"#$%&#%' !"#$%&#%' !"#$%&#%'
*
*
('%")*+$,-./0(
!
1 211 311 411 511
6.78
61.78
6.78
61.78
!"-#+9:
9;<0=_.>?@A9BC 9;<0=_.>?@A9BC 9;<0=_.>?@A9BC
!"!#$%&!"/0(
#
*
*
1 2111 3111 4111
6.78
61.78
6.78
61.78
!"-#+9:
*
1 211 311 411 511
6.78
61.78
6.78
61.78
!"-#+9:
*
*
$
D2E2
DEFB
D2E2
DEFB
D2E2
DEFB
DGH=6./0(
1. 211. 311. 411. 511. 6111.
!"#$%&#%'.
!H.611.
1. 611. 211. I11. 311. J11.
!"#$%&#%'.
!H.611.
1. 6111. 2111. I111.
!"#$%&#%'.
!H.611.
9;<0=_.>?@A9BC 9;<0=_.>?@A9BC 9;<0=_.>?@A9BC
% & '
* * *
Results 
 57!
dependent on ROS (Fuchs et al., 2007), it was of interest whether NET-DNA might also cause 
an increased type I IFN response in comparison to genomic DNA isolated from neutrophils. 
Experimentally, the release of NETs can be triggered by the addition of phorbol 12-myristate 13-
acetate (PMA) to primary neutrophils or neutrophil-like cell lines. To investigate the kinetics of 
NET-DNA release, human neutrophils were treated with PMA for one, two or three hours. 
Subsequently, SytoxGreen, a nucleic acid stain that cannot penetrate the cell membranes of 
living cells, was added to allow the analysis of NET-DNA release. After the addition of PMA, 
neutrophils became adherent within 30 minutes, but for the majority of the cells it took more than 
one hour before the cell membrane ruptured and DNA was expelled in the form of NETs. As 
shown in Figure 18 A, there was a time dependent increase of extracellular NET-DNA visible, 
and after three hours nearly all neutrophils had released their DNA in form of NETs. These 
results were also confirmed with NET-DNA isolated from murine neutrophils (data not shown). 
However, murine neutrophils generated NETs more slowly and less efficiently. This difference 
could be attributable to differences in maturity of the cells being used, since murine neutrophils 
were isolated from bone marrow, while the source for human neutrophils was peripheral blood. 
Remijsen and co-workers have recently shown that NET formation needs superoxide 
generation, and that inhibition of NADPH oxidase activity prevents the release of NETs and 
instead leads to neutrophil cell death by apoptosis (Remijsen et al., 2011). To investigate 
whether the released NET-DNA harbors oxidative modifications and thus constitutes a potential 
immune trigger, human neutrophil DNA isolated following stimulation with PMA (hNETs) was 
compared to neutrophil DNA without prior PMA stimulation. As shown in Figure 18 B, the more 
cells which had undergone NETosis, the higher the amounts of type I IFN which was induced 
following stimulation with neutrophil DNA in bmDCs.  
ROS are highly reactive with DNA, and oxidation of guanine to 8-hydroxy-2-deoxy guanine (8-
OHG) is considered a hallmark of oxidative DNA damage (Wiseman and Halliwell, 1996). Thus, 
the amount of 8-OHG in neutrophil genomic DNA and NET-DNA was analyzed. The 8-OHG 
content increased with duration of NETosis (Figure 18 C) and correlated with the induction of 
increased type I IFN levels in myeloid cells after DNA stimulation. These results indicate that 
NETs may have a dual function: they may not only bind and kill pathogens but also render self-
DNA more immune stimulatory and induce an enhanced type I IFN response. 
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Figure 18: ROS damage enhances cytosolic recognition of self-DNA in the form of neutrophil extracellular 
traps 
Human neutrophils were purified from whole blood and exposed to 40 nM PMA for 1 2 or 3 h (hNETs). Neutrophils 
without PMA treatment were used as control (hNeutrophil DNA). 5 x 106 neutrophils were plated on cover slips in 24-
wells and imaged using a fluorescent microscope. Extracellular DNA was stained with SytoxGreen (A). Isolated 
genomic DNA from neutrophils and NET-DNA was transfected using TransIT-LT1 Transfection Reagent (Mirus) into 
murine bmDCs. After 18-24 h, secretion of mIFN-! was quantified via ELISA. The data shown are representative of 
three independent experiments. Shown are means +SDM. (B). The relative content of 8-OHG in human neutrophil 
and NET-DNA was determined with an 8-OHG ELISA. The data shown are representative of two independent 
experiments (C). 
 
3.13. High Amounts Of Oxidized DNA Alone Are Sufficient To Trigger A Type I IFN 
Response In Human Monocytes 
Neutrophils can release large amounts of NETs at the site of infection, but it is not clear whether 
the presence of oxidized DNA alone can induce an immune response without some sort of 
“uptake facilitator” either physiological or artificial to bring DNA into the cells. To this end, human 
monocytes were incubated with high doses of protein-free self-DNA isolated from cells 
previously treated with either hydrogen peroxide or hypochlorite. As shown in the upper panel of 
Figure 19, only oxidatively damaged DNA was able to induce a type I IFN response without an 
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additional uptake agent, while unaltered DNA did not lead to detectable IFN levels. These results 
indicated that DNA uptake facilitators are not mandatory if the oxidized DNA is present at very 
high local amounts.  
However, it is unlikely that high levels of protein-free extracellular DNA exist in vivo. NETs for 
example consist not only of DNA, but do also contain histones and granular proteins, including 
antimicrobial peptides (Brinkmann et al., 2004). The antimicrobial peptide LL37, which is present 
in NETs, is able to transfer extracellular plasmid DNA to the nucleus of mammalian cells 
(Sandgren et al., 2004). Furthermore, it can transport extracellular DNA into endosomal 
compartments of pDCs, and thus leads to an activation of TLR9 and the production of type I 
IFNs (Lande et al., 2007). Recently, it was also demonstrated that LL37 promotes cytosolic 
delivery of nucleic acids in non-pDCs such as monocytes (Chamilos et al., 2012). Thus, it was 
speculated about LL37 being able to further enhance the response to naked oxidized DNA. To 
test this hypothesis, high doses of untreated or oxidized DNA were incubated with LL37 and 
then added to human monocytes. As depicted in the lower panel of Figure 19, the immune 
response to oxidized DNA was increased when the DNA was complexed with LL37 prior to 
monocyte stimulation. Thus, oxidized self-DNA is sufficient to trigger the cytosolic DNA sensing 
pathway at high local concentrations, but in combination with natural cationic peptides such as 
LL37 lower DNA concentrations are sufficient to induce a potent immune response. 
 
Figure 19: The antimicrobial peptide LL37 further enhances the immune response to oxidized DNA 
Protein-free genomic DNA isolated from hydrogen peroxide- or hypochlorite-treated RMA cells alone, or complexed 
with LL37, was added to human monocytes. 18-24 h later, secretion of hIFN-! was quantified in the culture 
supernatants via ELISA. The data shown are representative of three independent experiments and given as means 
+SDM; * P < 0.05 (Student’s t-test). 
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3.14. NETing Neutrophils Induce A Type I IFN Response In Co-cultures With Myeloid Cells  
Since both the presence of high local amounts of oxidized DNA complexed with LL37 and the 
transfection of NET-DNA led to an enhanced type I IFN response, it was of interest to investigate 
whether NETing neutrophils can also induce IFN-" secretion in co-cultures with myeloid cells. 
Murine neutrophils were co-cultured with FLt3L DCs, bmDCs and a macrophage cell line derived 
from mice with 129 background respectively, and NETosis was induced with 40 nM PMA. After 
18 hours, the supernatants were analyzed for the presence of mIFN-". As depicted in Figure 
20, higher levels of IFN were measured when myeloid cells were co-cultured with neutrophils in 
the presence of PMA, further supporting that NET-DNA can boost the type I IFN response. 
 
Figure 20: NETing neutrophils induce higher IFN-! levels in co-cultures with DCs or macrophages 
1 x 105 Flt3L DCs, bmDCs or 129 Macrophages (129 M') were co-cultured with 1 x 105 murine neutrophils (N). 
NETosis was induced with 40 nM PMA for 3 h. 18 h later, secretion of mIFN-! was quantified in the culture 
supernatants via ELISA. Shown are means +SDM. 
 
3.15. Effects Of DNA Modifications By Chemotherapeutic Agents 
DNA cannot only be damaged by ROS but also by many other mutagens such as x-rays, toxins 
or chemicals. To test whether also other DNA modifications lead to an increased 
immunostimulatory capacity of DNA, RMA cells were incubated in the presence of five different 
chemotherapeutic agents that are known to interact with DNA: Cisplatin, Melphalan, 
Dactinomycin, Idarubicin and Etoposide. 
Cisplatin (cis-PtCl2(NH3)2 ) belongs to the class of platinum-containing anti-cancer drugs and 
causes crosslinking of DNA. Following administration, one of the chloride atoms is displaced by 
water, allowing the platinum atom to bind to DNA bases, preferentially to guanine. Crosslinking 
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then occurs via the removal of the other chloride by another DNA base and can result in either 
intra-strand adducts or inter-strand crosslinks (Johnson et al., 1989). Melphalan belongs to the 
class of nitrogen mustard alkylating agents and adds an alkyl group (CnH2n+1) to the DNA bases. 
It causes the linkage between DNA strands and thus blocks DNA replication and RNA synthesis 
in a manner similar to Cisplatin (Kohn, 1981). Dactinomycin, also known as actinomycin-D, is an 
antibiotic isolated from Streptomyces bacteria. It binds to DNA at the transcription initiation 
complex and thus interferes with RNA elongation (Golderg et al, 1962; Sentenac et al. 1968). 
Idarubicin or 4-demethoxydaunorubicin belongs to the group of anthracyclines. Like Doxorubicin 
and other anthracyclines, it intercalates between DNA base pairs and prevents replication. 
Moreover, it interferes with the enzyme topoisomerase II so that the DNA cannot be uncoiled for 
transcription. The inhibition of the topoisomerase II complex might also lead to DNA-cleavage 
and prevention of its repair (Jensen et al., 1993). Furthermore, it was shown that Idarubicin 
damages DNA through a mechanism that involves its redox cycling with P450 reductase to ROS 
(Celik and Arinç, 2008). Etoposide is a member of the topoisomerase inhibitor drug class, which 
does not intercalate with DNA. It forms a ternary complex with DNA and topoisomerase II, and 
thus, prevents re-ligation of the DNA strands, leading to DNA strand breaks (Pommier et al., 
2010). 
To investigate the influence of these chemotherapeutic agents on the stimulatory capacity of 
DNA, RMA cells were incubated with these substances for 24 hours. Subsequently, genomic 
DNA was isolated for stimulation of murine bmDCs. As shown in Figure 21, DNA isolated from 
cells that were treated with the crosslinking agents Cisplatin or Melphalan, as well as with the 
intercalating agents Dactinomycin and Idarubicin, induced higher IFN-" levels compared to DNA 
isolated from untreated cells. The DNA strand-breaking agent Etoposide did however not lead to 
an enhanced immune recognition of the DNA, which was expected since it has been previously 
shown that moderate DNA strand fragmentation does not dramatically change the 
immunogenicity of genomic DNA (Figure 9). To investigate whether a direct treatment of DNA 
with the described chemotherapeutic agents also has a comparable effect, genomic DNA 
isolated from untreated RMA cells was incubated with Cisplatin, Melphalan, Dactinomycin, 
Idarubicin or Etoposide for four hours at 37°C. Subsequently, the DNA was precipitated and then 
used to stimulate murine bmDCs. With the exception of Etoposide, cell-free treated DNA did also 
induced higher IFN-" levels (Figure 22). These results suggested that next to oxidative damage 
also other DNA modifications such as alkylation or intercalation could enhance the 
immunostimulatory capacity of DNA.  
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Figure 21: Treatment of RMA cells with alkylating or intercalating chemotherapeutic agents increases the 
immunostimulatory capacity of their DNA 
RMA cells were incubated with the alkylating agents Cisplatin (A) and Melphalan (B), or with the intercalating agents 
Dactinomycin (C) and Idarubicin (D), or with the DNA strand break-inducing Etoposide (E) for 4 h at 37°C. 
Subsequently, genomic DNA was isolated and used for stimulation of murine bmDCs. 18-24 h later, IFN-" was 
measured in the supernatant via ELISA. The data shown are representative of three independent experiments and 
given as means +SDM. 
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Figure 22: Cell-free treatment of DNA with alkylating or intercalating chemotherapeutic agents does also 
increase its immunogenicity 
Genomic DNA was isolated from untreated RMA cells and then incubated with Cisplatin, Melphalan, Dactinomycin, 
Idarubicin, or Etoposide for 4 h at 37°C. Subsequently, DNA was purified and then used for stimulation of murine 
bmDCs. After 18-24 h, IFN-" was measured in the supernatant via ELISA. These data are representative of two 
independent experiment, shown are means +SDM; * P < 0.05 (Student’s t-test). 
 
3.16. Oxidized DNA Can Induce Lupus-like Skin Lesions  
Lupus erythematosus (LE) is an autoimmune disease, which is characterized by anti-DNA 
autoantibodies and a type I IFN signature. In addition, mutations in the TREX1 gene are 
associated with LE and correlate with disease severity (Lee-Kirsch et al., 2007). However, 
impaired activity of TREX1 is only found in 3 % of LE patients. Interestingly, symptoms of UV-
phototoxicity after exposure to sunlight can be frequently observed in LE patients with functional 
TREX1, and it has been postulated that extracellular DNA accumulates in cutaneous LE lesions 
due to defects in phagocytic or enzymatic DNA clearance (Kuechle and Elkon, 2007).  
To investigate the immune mechanism triggering the formation of lesions in UV light exposed 
skin regions of LE patients, 10 'g of unmodified or UV-damaged DNA were repeatedly injected 
in the ears of lupus prone MRL/lpr mice over three weeks. Injection of UV-DNA led to local skin 
lesions (Figure 23 A) and massive ear swelling (Figure 23 B), while the response to unmodified 
DNA was comparatively weak. Furthermore, typical histological features of skin lesions in human 
LE such as lymphocyte infiltrate, hydropic degeneration of the basal epidermal layer and colloid 
bodies, were observed in the ears of MRL/lpr mice that were treated with UV irradiated DNA 
(data not shown). Importantly, this phenotype could only be observed in MRL/lpr mice that were 
!" #!!!" $!!!" %!!!"
&'()*+,+-*"
." /"0+12345+'"
.!" /"0+12345+'"
." /"/-326434'"
.!" /"/-326434'"
." /"7485+')(98+'"
.!" /"7485+')(98+'"
." /":*4;&<+8+'"
.!" /":*4;&<+8+'"
."=/">5)2)1+*-"
.!"=/">5)2)1+*-"
(:?@A "B2CD(3E"
8-33A",;--"7@F
G
G
G
G
G
G
'H1H
'H1H
'H1H
'H1H
Results 
 64!
at least 18 weeks old and had already developed lupus-like symptoms. These results indicate 
that the recognition of UV damaged DNA might play an important role in the development of 
lupus lesions in sun-exposed skin areas. 
 
Figure 23: Ear injection of UV irradiated DNA induces lupus-like skin lesions in MRL/lpr mice 
10 'g untreated or UV irradiated DNA were administered i.c. to the earlobes of MRL/lpr mice every third day. After 21 
days, mice were monitored for lupus-like skin lesions (A). 24 h after the last DNA injection ear thickness was 
determined using a caliper. Shown are means +SDM; * P < 0.05 (Student’s t-test). (B). 
 
3.17. Oxidized DNA Plays A Role In The Pathogenesis Of Lupus Erythematosus 
Lupus patients are often positive for a variety of serum autoantibodies, including antinuclear and 
anti-dsDNA autoantibodies that have been shown to promote the uptake of self nucleic acids 
(Boulé et al., 2004; Vallin et al., 1999). To analyze the role of oxidatively damaged DNA in the 
systemic form of lupus, uncomplexed unmodified or UV-DNA was administered i.v. to either WT 
(C57BL/6) or lupus-prone MRL/lpr mice and blood was analyzed for the presence of serum IFN-
!. WT mice did not respond to any form of uncomplexed DNA (Figure 24 A). However, they did 
produce low levels of type I IFN in response to oxidized DNA that was complexed with the 
transfection reagent Dotap prior to i.v. administration, while no serum IFN-" was measured after 
the injection of Dotap-complexed unmodified DNA (data not shown). By contrast, MRL/lpr mice 
reacted with low levels of serum type I IFN to the injection of naked unmodified DNA, and 
showed a significant induction of IFN-! in response to naked UV-DNA (Figure 24 B). These 
results suggest that extracellular DNA is indeed a trigger for elevated pro-inflammatory immune 
responses in a lupus-prone environment and that oxidative DNA damage further exacerbates 
this process.  
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Figure 24: The lupus prone MRL/lpr mouse responds to naked oxidized DNA 
200 'g of naked uncomplexed genomic DNA, that was either left untreated or UV irradiated, was i.v. administered to 
C57BL/6J (A) and MRL/lpr (B) mice. After 4, 6 and 8 h serum IFN-! was quantified via ELISA. Shown are means 
+SDM; ** P < 0.01 (Student’s t-test). 
 
3.18. CD11b+ CD11c- Cells Constitute The Largest Fraction Of IFN-producing Cells 
Demonstrating DNA Uptake 
To identify cell types that might be responsible for the type I IFN production in response to 
oxidized DNA in vivo, UV-DNA was stained with SytoxGreen and then administered i.v. to 
MRL/lpr and C57BL/6 mice. After one hour, splenocytes were harvested for analysis since one 
of the spleen’s functions is to collect antigens from blood. Alternatively, one could have taken 
lymph nodes for investigation; however, cell isolation would probably have not been so lucrative. 
After cell separation with Collagenase D and DNase I, splenocytes were visualized in a 
SytoxGreen (FITC) vs. PE dot plot (Figure 25 A). Roughly 1 % of the analyzed splenocytes 
were SytoxGreen-positive in both C57BL/6 and MRL/lpr mice (Figure 25 B). 
 
Figure 25: Uptake of SytoxGreen-stained oxidized DNA in WT and MRL/lpr splenocytes 
200 'g SytoxGreen-labeled UV-DNA was administered i.v. to C57BL/6 and MRL/lpr mice. After 1 h, splenocytes were 
analyzed by FACS. SytoxGreen-positive cells were defined in a SytoxGreen (FITC) vs. PE plot to exclude 
autofluorescence. The gate was drawn with regard to an untreated mouse (A). Quantification of SytoxGreen-positive 
splenocytes in C57BL/6 (n = 5) and MRL/lpr mice (n=6). These data are representative of five independent 
experiments; shown are means +SDM (B). 
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Type I IFNs can be produced by almost any cell type in the body (Trinchieri, 2010). However, 
phagocytic cells such as DCs and monocytes/macrophages are probably the most interesting 
cells being able to produce type I IFN in response to foreign DNA. DCs and 
monocytes/macrophages are known to express moderate to high levels of CD11b and/or CD11c 
(Figure 26). Therefore, further analysis of DNA uptaking cells was focused on splenocytes that 
expressed either one or both of these markers. 
SytoxGreen-positive splenocytes that expressed CD11c but no CD11b were found to a similar 
extent in both C57BL/6 and MRL/lpr mice. However, the combination of CD11b and CD11c was 
expressed on 8 % of the MRL/lpr SytoxGreen-positive splenocytes, but only on 2 % of the 
C57BL/6 SytoxGreen-positive splenocytes. The discrepancy was even larger for CD11b-positive 
cells that did not express CD11c, as these cells made up 8 % of the SytoxGreen-positive 
splenocytes in C57BL/6 mice, but 41 % in MRL/lpr mice (Figure 27 A). Interestingly, there was 
no significant difference in the total number of CD11b-positive splenocytes in C57BL/6 and 
MRL/lpr mice (Figure 27 B). 
 
 
Figure 26: CD11b and/ or CD11c expression on murine cell types 
In mice, CD11b is highly expressed on monocytes/macrophages and to a lower extent on granulocytes, NK cells, and 
myeloid DCs. Murine CD11c is highly expressed on conventional DCs (lymphoid and myeloid), at moderate levels on 
plasmacytoid DCs and weakly expressed on NK cells and some B and T cell subsets. This figure was drawn 
according to information provided by Miltenyi Biotec. 
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Figure 27: UV-DNA uptake by CD11b- and/or CD11c- positive splenocytes 
200 'g SytoxGreen-labeled UV irradiated DNA was administered i.v. to C57BL/6 and MRL/lpr mice. After 1 h, 
SytoxGreen-positive splenocytes were analyzed for the expression of CD11b and/or CD11c (A). Total splenocytes 
were analyzed for the expression of CD11b (B). These data are representative of five independent experiments, 
shown are means +SDM; * P < 0.05 (Student’s t-test).  
 
To better characterize the CD11b and/or CD11c positive cells, the proportion of CD8-DCs, 
plasmacytoid DCs (pDCs), CD4-DCs, conventional DCs (cDCs), F4/80-monocytes/macrophages 
and CD11bLy6C-positive cells were analyzed (Table 3). CD8-DCs made up a larger portion of 
the SytoxGreen-positive cells in C57BL/6 mice, while CD4-DCs and pDCs represented only a 
very small percentage of the SytoxGreen-positive cells in both mice strains. Conventional DCs 
as well as F4/80-positive monocytes/macrophages made up larger portions of the SytoxGreen-
positive cells in MRL/lpr mice compared to C57BL/6. Interestingly, the combination of CD11b 
and Ly6C, which is mostly expressed by monocytes/macrophages, was found on 6 % of the 
SytoxGreen-positive cells in C57BL/6 mice, but on 26 % in MRL/lpr mice. Taken together, these 
results suggest that in particular CD11b+Ly6C+ cells take up large amounts of injected UV-DNA 
in MRL/lpr mice. 
 
Cell population Cell surface markers Reference for cell 
surface markers 
SytoxGreen-positive 
splenocytes (%) 
C57BL/6 vs. MRL/lpr 
CD8-DCs CD11b- CD11c+ CD8+ Vremec et al., 2000 2,6 vs. 0,6 
CD4-DCs CD11b+ CD11c+ CD4+ Vremec et al., 2000 0,8 vs. 0,6 
pDCs CD11b- CD11c int B220+ Asselin-Paturel et 
al., 2001 
1,6 vs. 1,3 
cDCs CD11b+ CD11c+ CD4- 
CD8- 
Vremec and 
Shortman, 1997 
0,6 vs. 6,2 
F4/80-monocytes/ 
macrophages 
CD11b+ CD11c- F4/80 + Austyn and 
Gordon, 1981 
2,5 vs. 3,4 
monocytes/macrophages 
and granulocytes 
CD11b+ Ly6C+ Geismann et al., 
2003 
6,0 vs. 26,1 
Table 3: Percentages of SytoxGreen-positive cells 
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3.19. CD11b+Ly6ClowF4/80+ Cells Contribute To The Type I IFN Response To Oxidized DNA 
In Vivo 
To identify cells that produce type I IFN in response to UV-DNA in vivo, UV irradiated DNA was 
administered i.v. to three MRL/lpr mice, while two MRL/lpr mice were left untreated as negative 
control. Four hours after DNA injection, splenocytes were collected to analyze the levels of IFN-
" mRNA. Commonly, pDCs are known as professional IFN producing cells, which are able to 
release large amount of type I IFN in a very short period of time (Siegal et al., 1999; Cella et al., 
1999). However, over the years it was demonstrated that pDCs seem not necessarily required 
for the response to certain viruses (Delale et al., 2005; Geburts vanKessell et al, 2008; Jewell et 
al., 2007). Furthermore, pDC depletion experiments suggest that also other cell types produce 
IFN-! in SLE (Blanco et al., 2001). Thus, the focus of the IFN-" mRNA analysis was set on 
those cells that were shown to take up large amounts of UV-DNA: cDCs and monocytes/ 
macrophages.  
Splenocytes were separated by FACS sorting into four fractions. One sorting fraction contained 
cDCs (CD11chigh, visualized in yellow), and CD11b-positive cells were further separated into i) 
Ly6ClowF4/80+ (visualized in turquoise), ii) Ly6ChighF4/80+ (visualized in red) and iii) Ly6ClowF4/80- 
(visualized in light yellow) subpopulations (Figure 28 A). RNA was isolated from the separated 
cells and reverse transcribed into cDNA. Subsequently, IFN-"4 mRNA levels were measured by 
RT-PCR, normalized to ß-actin expression and compared to MRL/lpr mice that got no DNA 
injected. RT-PCR analysis revealed that IFN-"4 mRNA was highest upregulated in the 
CD11b+CD11c-Ly6ClowF4/80+ cell population (Figure 28 B). The combination of CD11b, Ly6C 
and F4/80 can be expressed by both monocytes and macrophages. Thus, these markers alone 
are not sufficient to discriminate between these two cells types. However, their appearance in 
the FCS vs. SSC plot pointed to macrophages rather than monocytes (large granular cells, 
visualized in turquoise). Thus, these sorting experiments with subsequent RT-PCR analysis 
revealed that in the lupus-prone MRL/lpr mice Ly6ClowF4/80-positive macrophages largely 
contribute to the type I IFN response to UV-DNA injection. 
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Figure 28: In MRL/lpr mice, Ly6Clow F4/80-positive splenocytes mostly upregulate mIFN-" in response to i.v. 
administration of naked UV-DNA 
250 'g UV irradiated genomic DNA was administered i.v. to MRL/lpr mice. After 4 h, splenocytes were harvested and 
separated into four cell populations: A DC fraction containing no pDCs (i), CD11b+ CD11c- Ly6C low F4/80+ cells (ii), 
CD11b+ CD11c- Ly6C low F4/80- cells (iii) and CD11b+ CD11c- Ly6C high F4/80+ cells (iv) (A). Upregulation of mIFN-"4 
mRNA was analyzed by RT-PCR, normalized to ß-actin and compared to untreated MRL/lpr mice (B).  
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4. Discussion 
 
4.1. UV Irradiation Causes ROS-dependent DNA Damage That Leads To Enhanced 
Immunogenicity 
UV radiation is present in sunlight and has many both beneficial and deleterious effects on 
organisms. Its energetic potential induces chemical reactions such as the conversion of 7-
dehydrocholesterol to vitamin D3. Nonetheless, uncontrolled UV exposure can also damage the 
integrity of the skin both macroscopically and through the impairment of intracellular 
biomolecules such as nucleic acids (NAs) and proteins (Maverakis et al., 2010).  
Previous experiments in the Barchet laboratory revealed that stimulation of myeloid cells with 
NAs isolated from UV irradiated cells resulted in an increased immune response when 
compared to stimulation with NAs from untreated cells. Although initial results indicated that the 
phenomenon applied to transfections with both DNA and RNA, in the current work, careful 
analysis revealed that RNA samples still contained traces of DNA, and that the observed 
phenomenon applied only to DNA but not to RNA.  
Before the discovery of intracellular DNA receptors, metazoan DNA was considered 
immunogenically inert due to a low frequency of non-methylated CpG motifs. These motifs are 
required to activate endosomal TLR9 and are frequent in viral or bacterial but not metazoan 
DNA (Wagner, 1999; Bird, 2002; Krieg, 2002). However many subsequent publications have 
described that vertebrate DNA also can become immunogenic when introduced into the 
cytoplasm. In 1999, double-stranded (ds) DNA was shown to increase the expression of genes 
necessary for antigen processing and presentation (Suzuki et al., 1999). Later, the same group 
reported that high amounts of genomic DNA released from dying cells are sufficient to induce 
antigen presenting cell (APC) maturation (Ishii et al., 2001). Moreover, it was described that 
mammalian DNA in complex with cytofection agents stimulated DCs to secrete substantial 
amounts of type I IFN, TNF-" and IL12p70 (Martin and Elkon, 2006; Boulé et al., 2004), which 
were induced by the TBK1 kinase-mediated activation of the transcription factor IRF3 (Ishii et al., 
2005; Stetson and Medzhitov, 2006). 
These publications described a TLR9-independent activation of the immune system by self-DNA 
and initiated the quest for the cytosolic DNA receptor. In 2008, stimulator of interferon genes 
(STING)/mediator of IRF3 activation (MITA) was identified to be critical to the cytosolic DNA 
signaling pathway, since ablation of STING/MITA inhibited non-CpG DNA triggered expression 
of type I IFNs (Ishikawa and Barber, 2008; Zhong et al., 2008; Ishikawa et al., 2009), although it 
was unclear if this molecule was acting concomitantly with or downstream to the cytosolic DNA 
receptor. However, the receptor acting upstream of STING was also later identified: cyclic-GMP-
AMP (cGAMP) synthase (cGAS). In response to DNA binding, cGAS synthesizes the second 
messenger cGAMP, which then activates the STING pathway (Sun et al., 2013; Wu et al., 2013; 
Gao et al., 2013).  
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In our experiments, silencing of cGAS or its signal transducing adaptor protein STING/ MITA 
resulted in a complete abrogation of the UV-DNA response (data not shown). Likewise, the 
concept that the internalization of self-DNA is important for cell activation is in line with our data, 
since a type I IFN response could only be measured if genomic DNA from untreated cells was 
complexed with transfection reagents. However, high concentrations of naked UV-DNA were 
adequate to induce an immune response in myeloid cells, suggesting that the traces of DNA that 
are taken in without transfection reagent are sufficient to activate cGAS when the DNA was UV 
irradiated beforehand. 
Since UV irradiation can cause indirect DNA damage through the generation of intracellular 
reactive oxygen species (ROS) (Halliwell and Aruoma, 1991; Davis, 1987; Wise and Naylor, 
1987; McKersie and Leshem, 1994; Imlay and Linn, 1998), it was tested whether cells produce 
ROS after exposure to UV-A, UV-B, or UV-C light. An UV-dose dependent increase in ROS was 
observed regardless of the type of UV light used, and it was in fact the ROS levels rather than 
the UV source that correlated with the enhanced immunogenicity of DNA from UV irradiated 
cells. This correlation strongly suggested that ROS-mediated DNA modifications were the 
reason for an enhanced immune recognition of UV irradiated DNA. In keeping with these results, 
elevated levels of 8-hydroxy-2’-desoxy-guanosine (8-OHG), a hallmark of oxidative DNA 
damage (Kasai et al., 1984; Floyd et al., 1988; Kasai, 1997), were found in UV-DNA, and the 
incorporation of 8-OHG was sufficient to increase the immunogenicity of a PCR product. 
Moreover, the treatment of cells or cell-free DNA with different ROS such as hydrogen peroxide 
(H2O2) or hypochlorite (HOCl) could mimic the immunostimulatory effect that was achieved with 
UV irradiation. These data demonstrated that oxidative damage of DNA was indeed central to 
the observed effect of UV treatment. 
 
4.2. UV Irradiated DNA Becomes Resistant To TREX1-mediated Degradation 
To find out how cells distinguish between untreated and UV-DNA, various proteins involved in 
signal transduction, regulation, transcriptional activation and DNA damage repair were inhibited 
prior to UV-DNA stimulation. However, none of the proteins analyzed seemed to be important for 
an enhanced immune sensing of UV-DNA. Additionally, since it was demonstrated that UV 
irradiated DNA is recognized by the cGAS/STING pathway (data not shown), the binding affinity 
of UV-DNA for cGAS was carefully investigated. Of note, a higher affinity binding of DNA from 
UV irradiated cells to cGAS could be excluded to play a role in the observed UV-dependent 
phenomenon. Since we noticed not only an increased but also a prolonged cytokine response 
after UV-DNA stimulation, it was hypothesized that DNA from UV irradiated cells might somehow 
be protected from degradation which would increase the availability within the cytosol and allow 
an extended stimulation of cGAS. There are three major DNases that degrade extranuclear DNA 
in different subcellular compartments: i) DNase I is an endonuclease, which is found in most 
body fluids (Laskowski, 1971; Lacks, 1981, Takeshita et al., 1997; Napirei et al., 2004). ii) 
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DNase II is an endonuclease that is present in lysosomes where it degrades DNA from 
phagocytized pathogens and apoptotic debris (Krieser et al., 2002). Iii) DNase III, also known as 
TREX1, is a 3’-5’ exonuclease that is localized in the cytosol (Atianand and Fitzgerald, 2013). 
To test if UV-induced DNA modifications might protect DNA from degradation, genomic DNA 
that was either left untreated or UV irradiated, was digested in vitro with the three DNases. 
DNase I and DNase II degraded both DNAs in equal measure, while TREX1 was unable to 
degrade UV-DNA compared to unmodified DNA. This finding can be explained by DNase I and II 
being endonucleases that attack DNA within the molecule, while TREX1 is a 3’-5’ exonuclease 
that can only degrade DNA from one end and is detained from degradation as soon as it 
encounters an obstruction.  
To further evaluate the role of oxidative DNA modifications conferring resistance to TREX1-
mediated degradation, bmDCs from TREX1-deficient mice were stimulated with UV irradiated or 
ROS damaged DNA. Cells that did not express TREX1 showed high responsiveness to both 
unmodified and oxidatively damaged DNA. In contrast, wild type (WT) bmDCs with functional 
TREX1 reacted to the same unmodified DNA with lower amounts of IFN-" and to oxidized DNA 
with an enhanced cytokine response. 
Importantly, the interplay of cGAS/STING and TREX1 could also be confirmed in vivo with 
repeated i.c. injections of unmodified and UV-DNA in the ears of WT, TLR9-/-, STINGgt/gt and 
TREX1-/- mice. Both WT and TLR9-deficient mice displayed an enhanced ear swelling to UV 
irradiated DNA in comparison to unmodified DNA, while STING-deficient mice (golden ticket 
mutation) reacted with a reduced ear swelling and TREX1-deficient mice with an equally potent 
ear swelling reaction to both forms of DNA. Importantly, these results confirmed that in vivo, 
oxidized DNA is also protected from TREX1-mediated degradation and that this process may 
allow an accumulation of cGAS ligands in the cytosol, triggering the activation of the 
cGAS/STING-signaling pathway (Figure 29).  
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Figure 29: Oxidative damage of DNA confers resistance to TREX1 degradation and potentiates cGAS-STING-
dependent immune sensing 
Upon entering the cellular cytosol, unmodified DNA is degraded by the exonuclease TREX1, which limits potential 
immune activation (left panel). However, oxidatively modified DNA becomes largely resistant to TREX1-mediated 
degradation and can accumulate in the cytosol where it engages the cytosolic DNA receptor cGAS (right panel).  
 
Strikingly, stimulation with UV-DNA leads to effects that are similar to those observed in people 
with defective DNase(s). Given that a dysfunction of DNase I, II or III can lead to the 
accumulation of innate immune ligands, it is unsurprising that all three are associated with 
autoimmune diseases. Defects in DNase I cause the accumulation of extracellular DNA released 
by dying cells (Yoshida et al., 2005), which is highly immunogenic and was shown to cause a 
lupus-like syndrome in DNAse I-deficient mice (Napirei et al, 2000). Moreover, mutations in the 
DNase I gene have been found in systemic lupus erythematosus (SLE) patients (Yasutomo et 
al., 2001), which are characterized by anti-dsDNA autoantibodies and a type I IFN signature.  
Although no human diseases have been linked to a deficiency in this enzyme, human DNase II 
polymorphisms have been associated with increased risk of renal disorder among SLE patients 
(Shin et al., 2005). In DNase II–deficient mice, undigested DNA induces fatal levels of type I 
IFNs (Krieser et al., 2002). However, lethality does not occur in DNaseII/STING-double knockout 
mice (Kawane et al., 2006; Ahn et al., 2012), indicating that in DNaseII-deficient mice DNA 
escapes from lysosomes and ends up in the cytosol where it triggers the cytosolic DNA signaling 
pathway. 
STING has also been shown to rescue TREX1!/! mice (Gall et al., 2012), which otherwise 
accumulate endogenous DNA substrates that trigger a lethal, type I IFN-dependent autoimmune 
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disease (Morita et al., 2004; Stetson et al., 2008). Loss-of-function mutations in the human 
TREX1 gene cause Aicardi-Goutières syndrome (AGS), a severe autoimmune disease that 
mimics the features of congenital viral infection, including elevated type I IFN levels (Crow et al., 
2006). Moreover, TREX1 mutations have also been associated with SLE and familial chilblain 
lupus (FCL), a rare cutaneous form of SLE (Rice et al., 2007; Lee-Kirsch et al., 2007; Kavanagh 
et al., 2008; Crow and Rehwinkel, 2009; deVries et al., 2010), both of which are also associated 
with elevated type I IFN levels. 
Importantly, TREX1 was identified as an essential negative regulator of the interferon-stimulatory 
DNA (ISD) response (Stetson et al., 2008), which is significantly upregulated in response to 
different pro-inflammatory cytokines, including type I IFNs (Xu et al., 2012), and limits excessive 
activation of cGAS/STING by cytosolic DNA. This feedback regulation allows immune 
recognition of cytosolic DNA at first but also limits the immune response to prevent 
autoimmunity. Our data suggest that oxidation might be a DNA modification contributing to the 
specific recognition of cytosolic DNA in the case of danger, allowing UV-DNA to avoid the 
safeguard usually provided by functional TREX1. 
 
4.3. The Physiological Role Of Enhanced Immune Recognition Of Oxidized DNA  
In the last years it has been shown that pattern recognition receptors (PRRs) do not only 
recognize pathogen-associated molecular patterns (PAMPs) but also altered self-molecules. 
These endogenous molecules, known as damage-associated molecular patterns (DAMPs), 
allow the host to distinguish between viable and damaged or dying cells (Matzinger, 2002). One 
example is the recognition of oxidized 1-palmitoyl-2-arachidonyl-sn-glyero-3-phosphocholine 
(OxPAPC), which was shown to activate alveolar macrophages via TLR4 (Imai et al., 2008). 
Another example includes the binding of oxidatively modified Low Density Lipoprotein (OxLDL) 
to CD36, which triggers a TLR4/TLR6-dependent inflammatory response in macrophages 
(Stewart et al., 2010). We hypothesize that oxidized self-DNA might also function as DAMP and 
envision three scenarios how oxidized self-DNA might become available in the cytosol (Figure 
30): Neutrophils provoked into undergoing oxidative burst release oxidized DNA in the form of 
neutrophil extracellular traps (NETs), which may be taken up by phagocytes (ii). Self-DNA 
released from dying cells may signal immunogenic forms of cell death (iii). Similarly, oxidation 
damaged mitochondrial (mt) DNA may be released from rupturing mitochondria during necrosis 
and apoptosis (iv). In addition, lysosomal ROS may transform pathogen DNA into an even more 
potent PAMP (i). 
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Figure 30: Scenarios how oxidized DNA might become available in the cytosol 
Phagocytes make use of reactive oxygen species (ROS) to damage and kill pathogens in their close vicinity or within 
phagosomes. Pathogen DNA might therefore be labeled for immune recognition (I). Neutrophils release their genomic 
DNA in a ROS-dependent manner to enclose pathogens within neutrophil extracellular traps (NETs). NET DNA might 
improve the recognition of the associated pathogens (II). Oxidized genomic DNA might be released and recognized as 
damage associated molecular pattern (DAMP) to indicate ‘dangerous’ forms of cell death (III). Upon contact with 
pathogens or during apoptosis mitochondrial DNA might be released to promote cytosolic immune activation of 
adjacent cells (IV). ROS = reactive oxygen species, RNS = reactive nitrogen species, HOCl = hypochlorous acid 
 
Pathogen DNA 
ROS can be actively generated by phagocytes to kill pathogens (Sbarra and Karnovsky, 1959; 
Hampton et al., 1998). During an oxidative burst microbes are damaged and eventually killed by 
the oxidation of their biomolecules. In this process, also microbial DNA comes into contact with 
the released ROS. Thus, it is possible that ROS are not only used to kill pathogens within the 
phagolysosome but also to tag microbial DNA for detection in the cytosol in case of an escape 
from the phagolysosomal compartment. Since ROS in the form of hydrogen peroxide (H2O2) or 
hypochlorite (HOCl) are also released by neutrophils to damage microbes in their direct vicinity, 
oxidation would serve as a label for pathogen DNA not only for an intrinsic, but also for an 
extrinsic detection by surrounding immune cells. This scenario was modeled by the stimulation 
of bmDCs with pathogen DNA that was beforehand incubated with H2O2 or HOCl. ROS 
exposure increased cytosolic recognition of both bacterial and viral DNA in a dose-dependent 
manner. Additionally, the response of macrophages to H2O2-treated E. coli was also 
investigated. However, there was no difference in the secreted type I IFN levels in response to 
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untreated or oxidatively damaged bacteria observed (data not shown). This might be explained 
by the fact that most bacteria utilize catalases or dismutases to minimize ROS damage. It 
therefore remains to be determined to what degree DNA of different pathogenic bacteria will de 
facto incur oxidative damage in the course of infections of the host. To ascertain whether 
oxidative modifications of pathogen DNA really contribute to the antibacterial innate immune 
response further investigation is needed. One possibility would be the incubation of 
macrophages with superoxide dismutase-deficient E. coli or alternatively the usage of ROS-
deficient macrophages. Furthermore, it would be interesting to recover intact bacteria from 
phagolysosomes to assess the oxidative state of bacterial genomic DNA directly.  
Another important aspect that needs to be resolved is whether and in what circumstances 
oxidized pathogen DNA may end up in the cytosol of a target cell. Pathogen DNA could be 
oxidized extrinsically or intrinsically within the phagolysosome, yet the oxidized DNA must then 
somehow get into the cytosol. However, pathogens have developed numerous mechanisms to 
escape the endosomal pathway. Enveloped viruses for example use their viral envelope to fuse 
with the lipid bilayer and non-enveloped viruses as well as bacteria either lyse the vesicular 
membrane or generate a pore through which the viral genome or the bacteria, respectively, is 
released into the cytosol (Meier et al., 2003; Hogle et al., 2002; Mandall and Lee, 2002; Parente 
et al., 1988). Thus, it could be very interesting to track the route of pathogen DNA for example 
with the help of intercalating dyes in order to analyze under which circumstances oxidized 
pathogen DNA is recognized in the cytosol of a host cell. 
 
Neutrophil NET-DNA 
In 2004, a novel mechanism utilized by neutrophils to fight pathogens was described by 
Brinkman et al. Their study demonstrated that neutrophils release net-like DNA structures, called 
neutrophil extracellular traps (NETs), to capture pathogens in their surroundings (Brinkman et 
al., 2004). NETs are composed of a meshwork of chromatin fibers that are decorated with 
granule-derived antimicrobial peptides and enzymes such as neutrophil elastase and 
myeloperoxidase (MPO).  
Experimentally, the release of NETs can be triggered by the addition of phorbol 12-myristate 13-
acetate (PMA), which is a potent activator of protein kinase C (PKC). There is evidence that the 
induction of NETs by PMA depends on active nicotine amide adenine dinucleotide phosphate 
(NADPH) oxidase, since NET formation could be suppressed by a NADPH oxidase inhibitor 
(Fuchs et al., 2006) and were not observed in NADPH oxidase knockout mice (Ermert et al., 
2009). We investigated the immunogenicity of NET-DNA that was released by neutrophils 
following PMA treatment. Murine bmDCs as well as human monocytes reacted to NET-DNA with 
an enhanced type I IFN response, which could be correlated with an increased concentration of 
the oxidatively damaged DNA base 8-OHG.  
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It was demonstrated that neutrophils can release large amounts of NETs, but it is not clear 
whether the presence of oxidized DNA alone can induce an immune response without some sort 
of “uptake facilitator”. Thus, it was analyzed whether the presence of oxidized DNA alone can 
provoke an immune response in cells taking up the DNA. A robust type I IFN response was 
achieved when human monocytes were incubated with micrograms/ml of oxidatively damaged 
DNA, while unaltered DNA without transfection reagent did not lead to detectable IFN levels. 
These data supported that high local amounts of oxidized DNA are sufficient to induce an 
immune response. Interestingly, the antimicrobial peptides LL37, which is present in NETs and 
has recently been shown to promote endosomal as well as cytosolic delivery of nucleic acids 
(Lande et al., 2007; Hurtado and Peh, 2010; Chamilos et al., 2012), was able to amplify the 
response to oxidized DNA. Thus, NET-DNA might function as endogenous adjuvant that further 
boosts the response to the associated pathogens. 
To investigate whether NETing neutrophils can also induce IFN-" secretion in co-cultures with 
myeloid cells, murine neutrophils were incubated with FLt3L DCs, bmDCs or a 129-
macrophages. As expected, the presence of the NETosis-inducing stimulus PMA led to higher 
type I IFN levels compared to co-cultures without PMA. However, the amounts of IFN-" that 
could be measured were quite low. Three possible explanations for these low IFN levels are: i) 
The myeloid cells chosen for experimentation are not the cell type that is most responsive, ii) 
PMA might itself inhibit IFN signaling (Petricoin et al., 1996; Du et al., 2005), iii) NET-DNA might 
bind to the plastic of the 96-well plate and can in this state not be taken up by the myeloid cells. 
To analyze if the low IFN-" levels were due to poor IFN production in general, the co-culture 
experiment was repeated with human monocytes that we previously found to respond well to 
high local amounts of oxidized DNA. However, in human co-cultures as well only low levels of 
IFN-" were measured in the supernatant (data not shown), indicating that probably not the cell 
type but the co-culture scenario must be optimized in a way that the uptake of NET-DNA is 
better facilitated.  
Next, the effect of PMA on IFN-" secretion was tested in bmDCs that were stimulated with 
genomic unmodified or UV irradiated DNA complexed with the transfection reagent TransIT-LT1 
(Mirus). The presence of PMA did indeed reduce the immune response to both unmodified and 
oxidized DNA, but IFN secretion was not completely inhibited (data not shown). The PKC 
activator PMA causes the dephosphorylation of the tyrosine kinase Tyk2 and can thus inhibit the 
Jak/ STAT signaling pathway downstream of the IFN receptor (Petricoin et al, 1996; Du et al, 
2005). To test if one can rescue the type I IFN response to PMA-induced NETing neutrophils, 
the co-culture experiments were repeated in bmDCs and Flt3L-DCs that were treated for one 
hour with the PKC inhibitor Go6983 before stimulation. However, preincubation with increasing 
inhibitor concentrations did not lead to an improved IFN response (data not shown). In the 
future, it would be interesting to investigate co-cultures with other NETosis inducing stimuli that 
do not interfere with IFN-signaling. 
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To circumvent the interaction of NET-DNA with the plastic walls of the culture plate, co-culture 
experiments were repeated in a hanging drop culture system, originally developed for protein 
crystallization. However, this alternative culture system also did not enhance the type I IFN 
response (data not shown). Thus, while we were able to show that NET-DNA, released after 
PMA treatment, is able to directly induce an IFN response in myeloid cells, it is possible that we 
did not find the right parameters for a robust in vitro co-culture assay. It is nevertheless attractive 
to suggest that in the presence of infection neutrophils are able to transform their self-DNA into a 
DAMP to further boost an immune response to the associated pathogens. 
There is increasing evidence that different pathways of NET-formation exist. Depending on the 
inducing stimulus, lytic as well as non-lytic mechanisms make use of either nuclear or 
mitochondrial DNA to form NETs (Yipp and Kubes, 2013). So far, we cannot clearly say whether 
each NET-DNA would become more immunogenic due to ROS-induced modifications. Even 
though it has been shown that PMA is not able to induce NETs in the absence of oxidants or a 
functional NADPH oxidase (Bianchi et al., 2009; Patel et al., 2010; Remijsen et al., 2011b; 
Palmer et al., 2012; Keshari et al., 2013), there are other data suggesting that some stimuli such 
as S.aureus or Aspergillus induce NETs independently of ROS (Pilsczek et al., 2010; Byrd et al., 
2013). Fittingly, 3-hydroxy 3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors, which 
are used to lower cholesterol in humans, block the oxidative burst, but cause an enhanced 
release of NETs in response to staphylococci (Chow et al., 2010). Thus, it would be interesting 
to further evaluate which stimuli promote the generation of immunogenic oxidatively modified 
NET-DNA. 
 
Genomic DNA 
Pathogens have developed different mechanisms to disarm ROS and thereby prevent oxidative 
damage to their DNA. Thus, cells that expel their own oxidized DNA as a danger signal may 
represent a host strategy to enhance the immune response to an associated pathogen. The 
release of nuclear DNA in the form of extracellular traps (ETs) is not exclusively found to be 
used by neutrophils but has also been reported to be utilized by mast cells (von Kockritz-
Blickwede et al., 2008). Typically, mast cell ETs (MCETs) are released in response to the same 
stimuli that also trigger NET release from neutrophils. Additionally, they were reported to contain 
the same components as NETs, namely DNA, nuclear histones and the antimicrobial cathelicidin 
LL37. Digestion of the DNA within MCETs by DNase abolished the extracellular bacterial killing 
effect (von Kockritz-Blickwede et al., 2008). Importantly, MCETs seem also to be generated by a 
ROS-dependent cell death mechanism, since the NADPH oxidase inhibitor DPI prevented 
MCET formation. Experiments with dihydrorhodamine 123 further demonstrated that ROS 
production was dependent of the cytosolic rather than mitochondrial oxidase activity (von 
Kockritz-Blickwede et al., 2008). The formation of ETs has also been described playing a role in 
host defense when used by monocytes and macrophages in response to certain pathogens. 
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E.coli and K.pneumoniae induced monocyte ETs within one hour postexposure, while S.aureus, 
H.somni, M.haemolytica and PMA were shown to cause nuclear DNA release from primary 
macrophages and macrophage cell lines (Webster et al., 2010; Chow et al., 2010; Aulik et al., 
2012; Hellenbrand et al., 2013).  
It is unknown why only some pathogens cause the release of ETs and what the overall 
contribution to antimicrobial defense by ETs is. Some pathogens such as S.pyogenes can form 
clumps in order to escape phagocytic killing, since the clumps are too big to be phagocytosed 
(Dinkla et al., 2003). Thus, it is conceivable that ETs might support killing of large pathogen 
clumps by delivering ROS and antimicrobial peptides that dissolve these structures and at the 
same time by providing oxidized self-DNA for the uptake by surrounding phagocytes, which are 
subsequently activated by the cytosolic DNA recognition pathway and in turn clear the dissolved 
bacterial clumps and recruit more immune cells to the site of infection.  
 
Mitochondrial DNA 
A few years ago, Yousefi et al. broadened the understanding of extracellular trap formation when 
they observed both that the released DNA can also be of mitochondrial (mt) origin and ET 
formation must not necessarily lead to the death of the ET expelling cell. In their studies, 
eosinophils and neutrophils were primed with IL-5/ IFN-gamma or with GM-CSF/ C5a, 
respectively. Subsequent stimulation with LPS resulted in a rapid release of mt DNA. Similar to 
ETs containing nuclear DNA, the structures composed of mt DNA and granule proteins were 
able to bind and kill bacteria both in vitro and in vivo (Yousefi et al., 2008; Yousefi et al., 2009). 
Release of mt DNA by viable cells would have the advantage that the cells can still fulfill other 
functions like phagocytosis or the production of cytokines. Moreover, mt DNA is particularly 
prone to accumulate oxidative damage due to the immediate vicinity of the ROS producing 
respiratory chain in the mitochondrial inner membrane. In preliminary experiments, the 
immunostimulatory capacity of mt DNA was directly compared to that of nuclear DNA and as 
expected, stimulation with mt DNA induced higher type I IFN levels compared to nuclear DNA 
(data not shown). Thus, mt DNA seems to be predestinated to be part of ETs and to function as 
DAMP that can activate the innate immune system.  
In 2004, Collins and colleagues showed that the intra-articular injection of mt DNA induced 
arthritis, while nuclear DNA did not. Since mt DNA contains unmethylated CpG motifs, they next 
investigated whether unmethylated CpG motifs or oxidative DNA modifications were required for 
inflammation. Oligonucleotides (ODNs) that lacked CpG motifs but contained a single 8-OHG 
residue were immunogenic, while the same ODNs with CpG motif and without the oxidized base 
did not induce inflammation (Collins et al., 2004). However, a few years later, Yoshida and his 
group made contradictory observations. Using footpad swelling as readout for rheumatoid 
inflammation, they only observed a significant increase in inflammation when a CpG-bearing 
ODN was injected in combination with an 8-OHG-bearing nonCpG-ODN, but not for footpad 
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treatment with CpG or 8-OHG ODNs alone (Yoshida et al., 2011). Recently, also another group 
published that oxidative modifications enhance the immunostimulatory effects of extracellular 
mtDNA on TLR9 bearing pDCs (Pazmandi et al., 2014). Pazmandi and colleagues could show 
that the exposure to oxidatively modified mt DNA led to a significant higher upregulation of 
CD86, CD83 and HLA-DQ on the cell surface of primary human pDCs when compared to native 
mt DNA. Furthermore, these cells secreted significant amounts of TNF-" and IL-8 in response to 
oxidized mt DNA. Interestingly, simultaneous administration of a TLR9 antagonist abrogated the 
effects of both native and oxidized mt DNAs on human pDCs. The results by Yoshida and 
Pazmandi suggested that oxidatively damaged DNA alone is not able to induce an immune 
response although it could enhance the CpG-dependent activation of TLR9. 
In contrast to Yoshida and Pazmandi and in line with Collins study, we observed that oxidatively 
damaged DNA alone was sufficient to induce an inflammatory response. The participation of 
TLR9 in the enhanced recognition of oxidized DNA was excluded by stimulation of bone marrow 
(bm) cells and bmDCs derived from TLR9-deficient mice, which reacted to UV irradiated DNA in 
a manner similar to WT cells (data not shown). In line with these results, an increased immune 
response to oxidatively damaged DNA was also observed in human monocytes, which do not 
express TLR9.  
It is not only conceivable that mt DNA is released in the extracellular space in the form of ETs, 
but it might be also possible that mt DNA is directly delivered into the cytosol where it then 
activates the cGAS/STING pathway. Very recently, it was shown that cells release mt DNA 
during Bax/Bak-dependent apoptosis. This mt DNA is recognized by the cGAS/STING pathway 
and can lead to type I IFN production. However, apoptotic caspases normally block this pathway 
to protect the host from unnecessary inflammation (White et al., 2014; Rongvaux et al., 2014). 
Moreover, West et al. described that herpes virus infections cause mitochondrial instability and 
thus promote the escape of mt DNA into the cytosol, where it engages the cGAS/ STING-
signaling pathway to potentiate type I interferon responses and enhance the expression of 
interferon-stimulated genes (West et al., 2015). The authors did however not comment on the 
oxidative status of the mt DNA.  
Under normal circumstances, mt DNA is organized as circular ds DNA and thus not accessible 
for TREX1, but in case of mitochondrial stress it might get released in a fragmented form and 
then oxidative modifications would ensure that it stays long enough in the cytosol for a potent 
activation of the cGAS/STING signaling pathway. Thus, it would be interesting to analyze 
mitochondria ROS production during the course of an infection and to track the intra- and 
extracellular location of mt DNA as well as its integrity. 
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4.4. Not Only DNA Oxidation Enhances The DNA-induced Immune Response 
DNA cannot only be damaged by UV irradiation or ROS exposure but also by many other 
mutagens such as chemotherapeutic agents that directly interact with DNA. To test whether 
other DNA modifications in addition to oxidation also lead to an increased immunostimulatory 
capacity of DNA, cells were treated with Cisplatin, Melphalan, Dactinomycin, Idarubicin or 
Etoposide prior to DNA isolation. Cisplatin and Melphalan are DNA alkylating agents and cause 
either intra-strand adducts or inter-strand crosslinks (Johnson et al., 1989; Kohn, 1981). In 
contrast, Dactinomycin and Idarubicin belong to the group of DNA intercalating agents, which 
prevent transcription and replication (Golderg et al., 1962; Sentenac et al., 1968; Jensen et al., 
1993). Etoposide is a member of the topoisomerase inhibitor drug class, which does not 
intercalate into DNA but causes DNA strand breaks (Pommier et al., 2010).  
Stimulation of murine bmDCs with DNA isolated from cells that were treated with DNA alkylating 
or intercalating agents induced higher IFN-" levels compared to DNA from untreated cells. 
Etoposide was however unable to enhance the immunogenicity of the DNA. Similar results were 
obtained when cell-free DNA was directly treated with the described chemotherapeutic agents, 
showing that next to oxidative damage also other DNA modifications like alkylation or 
intercalation can enhance the immunostimulatory capacity of DNA. To date, there are no reports 
on chemotherapeutic agents directly changing the immunostimulatory potential of DNA. 
Nonetheless, there are indications that chemotherapeutic agents can influence the type I IFN 
signaling pathway.  
In 2001, Melphalan was shown to induce IFN-ß expression in mice. Even though the precise 
signaling pathway was not revealed, the authors suggested that ROS are involved in the 
transcriptional regulation of Melphalan-induced IFN-# gene expression. Melphalan-induced 
accumulation of IFN-# mRNA could be mimicked with H2O2 and was prevented with the 
antioxidant N-acetyl-L-cysteine (Jovasevic, V.M. and Mokyr, 2001). Thus, it might be possible 
that the enhanced immunogenicity of DNA from Melphalan-treated cells is not or not only due to 
DNA intercalation but indirectly emerges from an upregulation of ROS, which then oxidatively 
damage the DNA. To evaluate which kind of DNA modification is eventual responsible for the 
observed immunogenicity, an analysis by mass spectrometry of DNA from Melphalan-treated 
cells would be necessary. In 2012, a cell-based high-throughput screening (HTS) assay 
identified Idarubicin as an enhancer of STAT1-dependent interferon stimulated gene (ISG) 
expression. However, this effect was shown to be independent of IFN production or IFN–IFN-
receptor interaction, suggesting that Idarubicin works distal to ligand-receptor binding. In the 
same assay, Etoposide was shown as a control to not influence IFN-stimulated response 
element (ISRE) activity (Patel et al., 2012). Very recently the group of Barber published that 
Cisplatin and Etoposide induce nuclear DNA leakage into the cytosol that then intrinsically 
activates STING- dependent cytokine production (Ahn et al., 2014). However, the authors did 
not comment on the constitution of the nuclear DNA.  
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4.5. The Role Of Oxidized DNA In The Pathogenesis Of Lupus Erythematosus  
Continuous activation of nucleic acid receptors is usually prevented by the physiological 
subcellular compartmentalization of the sensors (Barton and Kagan, 2009) as well as by several 
nucleases that degrade nucleic acids and thus deplete the respective ligands. However, in 
autoimmune diseases such as systemic lupus erythematosus (SLE) and psoriasis, a chronic 
activation of nucleic acid receptors has been described (Barrat et al., 2005; Hari et al., 2010). 
Importantly, impairment in TREX1 activity is also strongly associated with autoimmunity (Stetson 
et al., 2008). There are at least 15 different mutations in TREX1 which have been associated 
with Aicardi-Goutières syndrome (AGS), a severe inflammatory neurodevelopmental disorder 
(Crow et al., 2006). Several groups have highlighted the phenotypic overlap of AGS with lupus 
(Crow et al., 2003; Dale et al., 2000; Aicardi and Goutières, 2000; Rasmussen et al., 2005; De 
Laet et al., 2005). Thus, TREX1 mutations were also analyzed in lupus patients. Familial 
Chilblain Lupus (FCL) is a rare, inherited form of cutaneous lupus in which autosomal dominant 
mutations in TREX1 that decrease exonuclease activity have been described (Lee-Kirsch et al., 
2006; Rice et al., 2007a/b). In addition, heterozygous mutations in TREX1 have also been found 
in ~3 % of SLE patients (Lee-Kirsch et al., 2007). These mutations are more diverse compared 
to FCL; some disrupt exonuclease activity, others result in altered intracellular localization 
(Rasmussen et al., 2005; Lee-Kirsch et al., 2007). However, in 97 % of lupus patients TREX1 is 
functional (Lee-Kirsch et al., 2007), and the majority of these patients react to UV exposure with 
the development of skin lesions. Since UV-exposure could theoretically cause inflammation in a 
variety of ways, the specific role of UV-DNA in UV-induced inflammation was investigated by 
injecting unmodified or UV irradiated DNA repeatedly in the ears of lupus prone MRL/lpr mice. 
After three weeks, massive ear swelling and local skin lesions could be observed in the ears that 
had been exposed to UV-DNA. These results demonstrate the specific inflammatory potential of 
UV irradiated DNA in vivo as well as its role in the development of cutaneous lupus in an 
accepted lupus mouse model. 
Anti-dsDNA autoantibodies are a characteristic of SLE and are also found in MRL/lpr mice 
(Pisetsky et al. 1982). Since they can facilitate the uptake of DNA into cells, it was analyzed 
whether MRL/lpr mice are in general more susceptible to DNA. Unmodified or UV-DNA was 
administered i.v. to either WT or lupus-prone MRL/lpr mice and several hours later serum type I 
IFN levels were determined. C57BL/6 mice that were used as WT control, did not respond to any 
form of DNA, whereas MRL/lpr mice reacted lightly to unmodified and heavily to UV-DNA. These 
findings demonstrate that UV-DNA is a very potent inflammatory stimulus in a lupus-like 
environment and in combination with the in vitro resistance to TREX1 degradation demonstrated 
for UV-DNA, these data allow the conclusion that in lupus patients UV-DNA leads to effects that 
are similar to TREX1 deficiency as exemplarily shown by the administration of unmodified DNA 
causing a massive ear swelling in TREX1-deficient mice. 
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One plausible explanation for UV phototoxicity in lupus patients would be that UV exposure 
leads to the death of keratinocytes, which are not efficiently cleared by phagocytes  (Herrmann 
et al., 1998; Baumann et al., 2002; Kuhn et al., 2006). These keratinocytes would then release a 
variety of inflammatory mediators and display autoantigens such as oxidized self-DNA. This 
DNA could be taken up by surrounding immune cells and potently activate the cGAS/STING-
signaling pathway, contributing to an inflammatory micromilieu that finally leads to formation of 
skin lesions. 
According to Baccala and colleagues, the development of SLE can be divided into two phases 
(Baccala et al., 2007). At the cellular level, the initial phase is characterized by DCs that take up 
apoptotic cell debris and associated nucleic acids. These then start to produce type I IFNs in a 
TLR7/9- independent fashion. In turn, lymphoid and myeloid DCs differentiate into self-antigen 
presenting cells (self-APCs), which induce the activation of autoreactive T and B cells. In 
contrast, the subsequent amplification phase is mainly dependent on pDCs that take up immune 
complexes consisting of autoantibodies and endogenous RNA or DNA. The antibody/FcR-
mediated uptake targets the nucleic acids into endosomes, where they induce a TLR7/9-
dependent production of type I IFN (Barrat et al., 2005). According to this two-phase paradigm of 
autoimmunity, our finding that oxidatively damaged DNA causes a TLR9-independent induction 
of IFN via the cGAS/STING-signaling pathway might be especially important in the 
understanding of the dynamics of initial disease development as well as that of acute relapses or 
disease flares.  
Since type I IFN has already been shown to play an important role in the pathogenesis of SLE, 
different treatments targeting IFN-! have emerged over the years. Treatment strategies involve 
antibodies against IFN-" or its receptor, as well as approaches that specifically target pDCs or 
the signaling downstream of TLR7/9 in pDCs (Kirou and Ckrouzman, 2013). In the light of our 
results, it might also be clinically advantageous to block cGAS and/or STING, although this 
would also require careful consideration of the suppressive effects such a treatment may have 
on anti-viral immunity. However, when compared to treatments directly targeting IFN-" signaling, 
blocking the cGAS/STING pathway would have the advantage that MAVS-dependent signaling 
downstream of the critical cytosolic RNA receptors RIG-I and MDA-5 would remain intact, thus 
preserving immunity against important viral threats such as influenza. 
 
4.6. Identification Of IFN Producing Cells In The MRL/lpr Mouse Model 
Plasmacytoid DCs (pDCs) are known as professional IFN producing cells and have been shown 
to contribute to the IFN signature in lupus patients (Vallin et al., 1999; Bennet et al., 2003; 
Sisirak et al., 2014; Rowland et al., 2014). However, they respond to DNA via a TLR9-dependent 
pathway (Brawand et al., 2002; Lund et al., 2003; Barrat et al., 2005; Means et al, 2005; 
Guiducci et al., 2009) and our data clearly exclude a role for TLR9 in the enhanced recognition 
of UV-DNA. Furthermore, depletion experiments showed that not only pDCs, but also other cell 
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types might contribute to type I IFN levels in SLE (Blanco et al., 2001). Thus, we set out to 
identify cell types other than pDCs that are responsible for the uptake and response to 
oxidatively damaged DNA in vivo. In MRL/lpr mice, CD11b+Ly6ClowF4/80+cells internalized large 
amounts of untransfected UV-DNA and showed the highest upregulation of IFN-" mRNA among 
cDCs and monocytes/macrophages. Although the combination of these cell surface markers can 
be expressed by both monocytes and macrophages, the morphology of the cells in the FCS vs. 
SSC plot pointed to macrophages (large granular cells) rather than monocytes.  
Murine spleen macrophages can be divided into five different subsets based on their localization 
and surface marker signature: marginal zone, metallophilic, red pulp, white pulp and from blood 
immigrated monocyte-derived macrophages. Marginal zone, metallophilic and white pulp 
macrophages are F4/80-negative, whereas red pulp and monocyte-derived macrophages were 
shown to express F4/80 (Davies et al, 2013). Thus, the identified IFN-producing cells must 
belong to either red pulp or monocyte-derived macrophages. Red pulp macrophages are defined 
as CD11blowF4/80high and monocyte-derived macrophages as Ly6ClowF4/80+. Since the IFN-
producing cells expressed high levels of CD11b and medium amounts of F4/80, they likely 
derive from blood immigrated monocyte-derived macrophages. This conclusion is in line with the 
classical M1/M2 division of macrophages: monocyte-derived macrophages characteristically 
produce IFN-" as part of their pro-inflammatory cytokine profile, whereas tissue-resident 
macrophages such as red pulp macrophages are thought to belong to the anti-inflammatory M2 
subtype (Mantovani et al., 2004). Nevertheless, these cells need to be further characterized to 
allow a specific treatment of the UV-DNA response in lupus patients. Conceivable therapeutic 
treatments include the inhibition of inflammatory M1 macrophages and simultaneous promotion 
of M2 macrophages. Promising are anti-TNF treatments as well as PPAR) agonists that 
stimulate M2a expansion and mildened murine lupus nephritis (Venegas-Pont et al., 2009; Zhao 
et al., 2009; Lefèvre et al., 2010). 
Our results suggest that the two-phase paradigm of autoimmunity suggested by Baccala and 
colleagues (Baccala et al., 2007) should to be amended. While Baccala et al. ascribed the type I 
IFN signature in lupus to specific DC subsets, DCs did not contribute much of the type I IFN 
observed in response to UV-DNA, at least in the MRL/lpr lupus model. However, there are also 
indications that the cell types involved may vary between different lupus models. Lee and 
colleagues investigated the pristane-induced lupus model and demonstrated that pristane 
treatment induced an accumulation of immature Ly6Chigh monocytes, which were identified as 
major source of IFN-I in this lupus model. Ly6C-positive monocytes can differentiate into both 
macrophages and DCs depending on the environmental signal they receive. However, Lee et al. 
also excluded a substantial role for DCs in this lupus model, as only monocyte depletion led to a 
decreased expression of IFN and ISGs, whereas systemic ablation of DCs had little effect (Lee 
et al., 2008). Taken altogether, lupus remains a very complex disease with many different cell 
types being involved in its initiation and conduction. It appears reasonable that in genetically 
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different forms of SLE also distinct cell types contribute to the sustained overproduction of IFN-
!/#, with varying contributions depending on the disease trigger. 
 
4.7. Final Summary And Outlook 
When DNA accumulates in the cytosol, it activates the cGAS/STING pathway, leading to type I 
IFN production. The compartmentalization of cGAS to the cytosol and the presence of several 
nucleases, in particular TREX1, that degrade DNA in this compartment contribute to preventing 
the erroneous recognition of self-DNA. However, here we provided evidence that DNA 
modifications can transform self-DNA into a damage-associated molecular pattern (DAMP) that 
becomes resistant to degradation by the cytosolic exonuclease TREX1, allowing the activation of 
cGAS by endogenous DNA. 
Oxidative modifications of self-DNA occurred due to antimicrobial ROS production or upon 
physical damage such as the absorption of UV light. In future studies, it will be important to 
investigate in which physiological and pathophysiological conditions oxidized self-DNAs are 
released. Likewise, it should be studied whether only phagocytes are able to take up the 
modified DNA from the extracellular space, and in which situations oxidized DNA is intrinsically 
released into the cytosol. Similar to what has been observed with self-DNA, exposure to ROS 
also increased the immunogenicity of pathogen DNA. It therefore needs to be determined 
whether there are instances in which the DNA of infectious microbes becomes oxidatively 
tagged during an infection and whether these modifications contribute to the innate immune 
detection via the cGAS/STING-signaling pathway. 
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6. Appendix 
 
6.1. Abbreviations 
 
A 
Absent in melanoma 2 (AIM2) 
Activating protein-1 (AP-1) 
Adenosine triphosphate (ATP) 
Aicardi-Goutières syndrome (AGS) 
Antibody (ab) 
Antigen presenting cell (APC) 
Antinuclear antibodies (ANA) 
AP endonucleases (APE) 
Apoptosis-associated speck-like protein containing a 
CARD (ASC) 
A proliferation inducing ligand (APRIL) 
 
B 
Base excision repair (BER) 
B cell activating factor of the TNF family (BAFF) 
Bcl2-Antagonist of Cell Death (BAD) 
Bcl-2- associated x protein (BAX) 
Blank (blk) 
Bone marrow derived DCs (bmDCs) 
Bovine serum albumin (BSA) 
 
C 
CARD adaptor inducing IFN-# (CARDif) 
Caspase-recruitment domain (CARD) 
Central nervous system (CNS)  
Cluster of differentiation (CD) 
Coding sequence (CDS) 
Conventional DCs (cDCs) 
C-terminal domain (CTD) 
Cutaneous LE (CLE) 
Cyclic dinucleotides (CDNs) 
Cyclic GMP-AMP (cGAMP) 
cGAMP synthase (cGAS) 
Cycle threshold (Ct) 
Cyclobutane pyrimidine dimer (CPD)  
Cytotoxic T cells (Tc) 
 
D 
Damage- associated molecular pattern (DAMP) 
Dendritic cells (DCs) 
Desoxynucleic acid (DNA) 
Desoxynucleoside triphosphate (dNTP) 
Desoxyribonuclease (DNase) 
Diethylpyrocarbonat (DEPC) 
Dimethylsulfoxid (DMSO) 
Dithiothreitol (DTT) 
DNA damage response (DDR) 
DNA-dependent activator of IRFs (DAI) 
DNA-dependent protein kinase (DNA-PK) 
DNA double-strand break (DSB) 
Double stranded (ds) 
Drug-induced LE (DILE) 
Dulbecco's Modified Eagle's Medium (DMEM) 
 
E 
Endoplasmatic reticulum (ER) 
Enhanced Chemiluminescent (ECL) 
Enzyme Linked Immunosorbent Assay (ELISA) 
Ethylenediaminetetraacetic acid (EDTA) 
 
F 
Familial Chilblain Lupus (FCL) 
FAS-associated death domain (FADD) 
Fetal Calf Serum (FCS) 
Fluorescence-activated cell sorting (FACS) 
Forward scatter (FSC) 
 
G 
Gene of interest (GOI) 
GMP-AMP synthase (cGAS) 
Granulocyte-macrophage colony-stimulating factor 
(GM-CSF) 
Green fluorescent protein (GFP) 
 
H 
Helper T cells (TH) 
Herpes simplex virus (HSV) 
High-mobility group box 1 (HMGB1) 
Horseradish peroxidase (HRP) 
Human immunodeficiency virus (HIV) 
Hydrogen peroxide (H2O2) 
8-Hydroxy-2’-desoxy-guanosine (8-OH-dG) 
8-Hydroxy-7,8- didemethyl-5-deazariboflavin (8-HDF) 
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Hydroxyl radicals (HO.) 
Hypochlorous acid (HOCl) 
 
I 
Inhibitor of nuclear factor kappa-B kinase (IKK#) 
Interferon (IFN) 
IFN-alpha receptor (IFNAR) 
IFN-inducible protein (IFI) 
IFN-promoter-stimulating factor 1 (IPS-1) 
IFN-regulatory factor (IRF) 
IFN-stimulated gene (ISG) 
IFN-stimulated gene factor (ISGF) 
IFN-stimulated response elements (ISREs) 
IL-1 receptor-associated kinases (IRAK) 
Immunoglobulin (Ig) 
Immunoreceptory tyrosine-based activation motif 
(ITAM) 
Interleukin (IL) 
Isopropyl-#-D-thiogalactopyranosid (IPTG) 
 
J 
Janus kinase (JAK) 
Jun N-terminal kinase (JNK) 
 
L 
Laboratory of genetics and physiology 2 (LGP2) 
Leucine rich repeat (LRR) 
Lipopolysaccharide (LPS) 
Lymphoproliferation (lpr) 
Lupus erythematosus (LE) 
 
M 
Magnetic- activated cell sorting (MACS) 
Major Histocompatibility Complex (MHC) 
MAP kinase (MAPK) 
Mean fluorescence intensity (MFI) 
Mediator of IRF-3 activation (MITA) 
Melanoma differentiation- associated gene-5 (MDA5) 
Mitochondrial (mt) 
Mitochondrial antiviral signalling protein (MAVS) 
Mitogen activated protein (MAP) 
Mouse embryonic fibroblasts (MEFs) 
Meiotic recombination 11 (Mre11) 
Murphy Roth Large (MRL) 
Myeloid DCs (mDC) 
Myeloid differentiation factor 88 (MyD88) 
Myeloperoxidase (MPO) 
N 
NADPH oxidase (Nox) 
Natural killer cells (NK) 
Neutrophil Extracellular Traps (NETs) 
NF-"B-activating kinase (NAK) 
Nicotinamide-adenine-dinucleotide-phosphate 
(NADPH) 
NOD-like receptors (NLRs) 
Non-essential amino acids (NAAs) 
Non-homologous end joining (NHEJ) 
Nucleic acid (NA) 
Nuclear factor kappa-light-chain-enhancer of activated 
B-cells (NF-"B) 
Nucleotide-binding oligomerization domain (NOD) 
Nucleotide excision repair (NER) 
 
O 
Oligodeoxyribonucleotide (ODN) 
Open reading frame (ORF) 
8-oxo-2´-desoxy-guanosine (8-oxo-dG) 
Ozone (O3)  
 
P 
Pathogen- associated molecular patterns (PAMPs) 
Pattern recognition receptors (PRRs) 
Peripheral blood mononuclear cells (PBMC) 
Phorbol-12-myristate-13-acetate (PMA) 
Phosphate buffered saline (PBS) 
Plasmacytoid DCs (pDCs) 
Polyacrylamide gel electrophoresis (PAGE) 
Polyinosine-polycytidylic acid (poly(I:C)) 
Polymerase (Pol) 
Polymerase chain reaction (PCR) 
Prostaglandin E2 (PGE2) 
Psoralen plus UV-A (PUVA) 
6-4 Pyrimidine-pyrimidone photoproduct (6-4-PP) 
 
R 
Reactive oxygen species (ROS) 
Receptor interacting protein 1 (RIP1) 
Repressor domain (RP) 
Retinoic acid-inducible gene 1 (RIG-I) 
Rheumatoid arthritis (RA) 
Ribonuclease (RNase) 
Ribonucleic acid (RNA) 
RIG-I-like receptor (RLR) 
Room temperature (RT) 
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Roswell Park Memorial Institute (RPMI) 
 
S 
Side scatter (SSC) 
Single stranded (ss) 
Singlet oxygen (1O2) 
Signal transducer and activator of transcription (STAT) 
Sodium dodecyl sulfate (SDS) 
Subacute CLE (SCLE) 
Stimulator of interferon genes (STING) 
Sunburn cell (SBC) 
Superoxide (O2-) 
Superoxide dismutase (SOD) 
Systemic lupus erythematosus (SLE) 
 
T 
TAK1- binding proteins  (TAB) 
TANK-binding kinase 1 (TBK1) 
Tetramethylbenzidine (TMB) 
Three prime repair exonuclease 1 (TREX1) 
TIR domain-containing adapter molecule (TRIF) 
TNFR1 associated death domain protein (TRADD) 
TNF-receptor associated-factor (TRAF) 
TNF-related apoptosis-inducing ligand (TRAIL) 
Toll/ interleukin-1 receptor homology (TIR) 
Toll-like receptor (TLR) 
Topoisomerase (Top) 
TRAF-family member associated NF-"B activator  
(TANK) 
Transfer RNAs (tRNAs) 
Transforming growth factor (TGF) 
Transforming growth factor-beta-activated protein  
kinase 1 (TAK1) 
Triphosphate RNA (3-P-RNA) 
Tris-Acetat-EDTA buffer (TAE) 
Tris-EDTA (TE) 
Tumor necrosis factor alpha (TNF-!) 
Tyrosine kinase (Tyk) 
 
U 
Ultraviolet (UV) 
Uridine (U) 
Urocanic acid (UCA) 
UV radiation (UVR) 
UV irradiated DNA (UV-DNA) 
V 
Virus-induced signaling adaptor (VISA) 
Volt (V) 
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